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ABSTRACT
This thesis examines some of the factors which play a role in determining 
lactation persistency in the goat with the overall aim of improving persistency.
The plasticity of mammary gland growth during pregnancy and lactation was 
investigated by treatments of growth hormone and stimulation of compensatory growth. 
Cell activities and differentiation could be altered but the effects were dependent on the 
physiological state of the animal with longer term responses in milk production 
associated with treatments given during late gestation.
The endocrine influence of prolactin and oxytocin were examined by attempting 
to elevate circulating prolactin by administering perphenazine and by giving exogenous 
oxytocin during lactation. The former treatment was successful in the short-term when 
given by intravenous infusion but oral and injected doses given during lactation were 
not. Oxytocin had a small and positive effect on persistency, most marked when 
combined with reduced milking frequency in late lactation.
The effects of once- and thrice-daily milking, suckling and continuous drainage 
of milk from the mammary gland for the first six weeks of lactation, followed by 
routine milking for the remainder of lactation were examined in conjunction with the 
influence of parity on the responses obtained. Drainage proved ineffective in increasing 
yields or improving persistency. Suckling and thrice-daily milking enhanced milk yields 
in the short-term but no long-term alteration of persistency was seen. Once-daily 
milking was tolerated well by multiparous but not primiparous animals, but there was 
a trend of improved persistency with this treatment, regardless of parity. This may 
reflect alterations in the partitioning of milk stored within the udder but measurements 
made 5 hours post-milking did not show any differences between these and 
contralateral thrice-daily milked glands.
Finally the effectiveness of caseins (milk proteins) in providing a measurement 
of lactation persistency by indirect measurement of cellular involution was studied. It 
was found that the production of caseins varied over lactation, and that 7 -casein 
production was highly (negatively) correlated with milk production. However, the best 
measure of cellular function was to measure milk yield itself.
In conclusion, the timing of treatments can be crucial in determining the 
response obtained and alteration of lactation persistency was very difficult to achieve. 
The most promising route suggested by this work is reducing milking frequency during 
established lactation, in combination with early lactation treatments to enhance yields.
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CHAPTER 1 
CONTEXTS
1. INTRODUCTION
Lactation is a vital process for the development of young mammals. The milk 
produced is the primary, if not only, energy source for the offspring initially, it 
improves their immunity and the close contact of the young aids maternal bonding 
(Peaker, 1989; Grove et al, 1991). The development of the mammary gland to support 
the process of lactation occurs over a variable period depending on a variety of factors 
including the expected lifespan and reproductive life of the animal, and the lengths of 
the ovarian cycle and gestation. These contribute towards determining a general 
’timetable’ of development for a particular species and can be divided into several 
reasonably defined stages, most being hormonally directed: pre- and post-pubertal, 
pregnancy, lactation and non-lactating (dry) periods (Cowie et al, 1980). Lactation 
itself usually follows a distinct pattern in a species in terms of milk production. In the 
dairy industry this often reflects management techniques rather than the ’natural’ 
rhythm of the species; in goats lactation commences after a gestation of approximately 
5 months, milk yields increase to a peak 6 - 8  weeks post partum, steadily decline over 
the remaining period, and secretion stops after approximately nine months if the animal 
becomes pregnant again. However, continuing milking during pregnancy has no effect 
on milk yields after parturition (Fowler et al, 1991) and production can continue in the 
absence of pregnancy, with seasonal oscillations in yield, for several years (Linzell, 
1973). Cow lactation shares many common features with that of goats; a 9 month 
gestation is followed by approximately 1 0  months of lactation, with peak production 
occurring about 6  weeks post partum (Linzell, 1973). However, in contrast to goats, 
cows require a pre-partum non-lactating period for normal milk production to occur in 
the following lactation (Swanson, 1965; Smith et al, 1967). When the gland is no 
longer lactating it is in a state broadly similar to that seen before pregnancy although 
this state varies between species. Rodent mammary glands regress to a state similar to 
that of the virgin (Strange et al, 1992) while goat mammary structures are more 
developed and the gland larger in animals which are between pregnancies in 
comparison to those in the mature virgin state (Knight & Wilde, 1993).
This chapter will firstly examine aspects of milk composition, production and 
subsequent processing, then will briefly summarise the growth and development of the 
mammary gland required to support this process. Endocrine and local control of milk
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production and other influences on lactation (such as udder anatomy) will be 
considered, and finally lactation persistency and the potential for manipulation of 
lactation will be discussed.
2. MILK
2.1 Composition
Milk provides the primary source of nutrition for young mammals until they are 
able to digest more solid food. It contains protein (providing a source of amino acids), 
minerals (such as calcium, sodium, potassium, phosphorous, magnesium and chloride), 
trace elements, carbohydrates (mainly lactose which regulates milk volume) and lipids 
(including phospholipids, cholesterol and triglycerides) (for reviews see Parkash & 
Jenness, 1968; Jenness, 1980). Immunoglobulins present in the serum fraction of milk 
help to confer passive immunity upon the offspring with the highest levels found in 
colostrum (the ’first milk’) (Dalgleish, 1992).
The proteins present in milk divide into two main categories, caseins (defined 
as the proteins which precipitate at pH 4.6 at 20°C) (Dalgleish, 1992) and those that 
remain in the serum, known as whey proteins. Ruminants produce six major proteins 
which represent 95% of output; the whey proteins /3-lactoglobulin and a-lactalbumin, 
and a sl-, a s2-, /?- and k - caseins (Martin & Grosclaude, 1993). A major difference in 
nomenclature between ruminant caseins and those of some other species (humans or 
rodents, for example) is that ruminants do not have a gene coding for 7 -casein 
(Vonderhaar & Ziska, 1989). Much work has been carried out in the analysis of cows’ 
milk but there are distinct differences in the milk obtained from different species, 
indeed contamination of goats milk with that of cows can be detected by high- 
performance liquid chromatography (HPLC) (Kaminarides & Anifantakis, 1993). In 
general, comparing goats’ milk to that of cows’ shows that the former contains more 
fat and the globules tend to be smaller, but both milks have similar ratios of fatty 
acids. Total casein concentrations tend to be lower in goats milk but it has a much 
higher (3-cn content and more non-protein nitrogen constituents (Juarez & Ramos, 
1986).
Hormones are also present in milk and have been locally produced by the 
mammary gland or transported over the mammary epithelium from the maternal 
bloodstream. Some act on the mammary gland itself and affect the mother, but these 
do not necessarily play a biological role in the young. Hormones and growth factors
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such as prolactin, prostaglandins, oestrogens, insulin, relaxin, epidermal growth factor 
and lactoferrin are all detected in milk (Peaker, 1991; Peaker & Neville, 1991) as well 
as a variety of enzymes, some of which are specific to certain fractions of milk 
(Brunner, 1981).
2.2 Casein genes and their expression
In the goat, casein accounts for 77% of the total protein present in milk and a sl, 
as2-, fi- and /c-caseins are present in a ratio of 1:2:5:1 with a typical protein 
concentration of 21 g/1 (Jaubert & Martin, 1992). Cow and goat caseins are broadly 
similar, although a caprine homologue for bovine a sl-cn has not been found. The 
nomenclature for the caseins can be confusing as caprine a sl-cn is homologous to 
bovine a s2-cn, not cesl-cn as cited in the early literature (Jenness, 1980).
The four ruminant caseins are produced from closely linked genes with an 
overall genetic organisation conserved through evolution. Three of the major caseins 
(asl-, as2- and /3-caseins) are calcium-sensitive with common motifs in their promoter, 
signal peptide and phosphorylation sites, while k - casein has a different gene structure 
and is calcium-insensitive (Martin & Grosclaude, 1993; Mercier & Vilotte, 1993). 
Each casein gene has a variety of genetic polymorphs (for summary see Brunner, 
1981). For example, there are two /3-cn variants, /3,- and /?2-cn, differing by one 
phosphate per molecule (Richardson et al, 1974) and more variation is seen in a sl- 
casein; seven polymorphs have so far been described, each giving different levels of 
expression of the protein (Grosclaude et al, 1987; Mahe & Grosclaude, 1989).
Lactogenic hormones can stimulate transcription of these genes; prolactin, 
insulin and hydrocortisone are necessary for maximal induction of casein synthesis in 
vitro and a close relationship between the proportion of caseins in milk and the relative 
amount of their mRNAs present has been found in bovine mammary explants. Prolactin 
and glucocorticoids can increase the stability of casein mRNA, increasing its 
transcription and half-life (Choi et al, 1988) while progesterone can antagonise the 
effect by preventing accumulation of casein mRNA, thereby reducing casein synthesis 
and secretion (Matusik & Rosen, 1978). These in vitro findings support the in vivo 
observations of rapidly dropping progesterone concentrations at parturition coinciding 
with the initiation of full milk secretion and lactogenic gene expression (Vonderhaar 
& Ziska, 1989).
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2.3 Caseins and their modifications
Caseins, in combination with calcium, phosphate and small amounts of citrate, 
form spherical micelles, composed of probably between 1000 and 100 000 submicellar 
units (Dalgleish, 1992). Each unit is 10-15nm in diameter (Richardson et al, 1974) and 
they are held together by electrostatic and hydrophobic bonds (Walstra, 1990). Total 
micelle diameters range from 30-300nm while weights of 107 to 109 Da can be obtained 
(Brunner, 1981). Goat casein micelles have, in general, a lower maximum frequency 
distribution than those of cows (Ono & Creamer, 1986) but the micellar substructures 
are similar in goat, cow and sheep milk (Richardson et al, 1974). The ratio of a 8- to 
/3-casein remains almost constant over a range of micellar diameters (Ono & Creamer,
1986) but a s-cn is evenly distributed between the micelle interior and exterior, while 
/3-cn can have up to 90% present in the interior. In contrast, the interior of the micelle 
contains only 0.6 to 1.2% of the total x-casein present (Dalgleish et al, 1989), the 
remainder being on the surface. This asymmetrical distribution of hydrophobic k - cn 
places a physical limit on the total surface area of a particular micelle (Brunner, 1981), 
indeed the relative amount of k - cn present is inversely related to micellar diameter. 
This is in contrast to /3-cn which decreases its relative amount proportionately with 
micellar diameter (Davies & Law, 1983). x-Casein is also unique among the caseins 
in binding relatively little calcium (due to the presence of only one or two 
phosphoserine residues) and consequently it does not precipitate from milk as easily as 
ota- and /3-caseins do (Dalgleish, 1992).
Changes in micelle structure and composition alter the physico-chemical 
characteristics of milk, important in industrial processing as milk products provide one- 
quarter of the total dietary protein consumed in industrialised countries (Martin & 
Grosclaude, 1993). One major process is cheesemaking, in which the enzyme chymosin 
(present in rennet/rennin) is added to milk and proteolytically cleaves /c-casein, leaving 
para-/c-casein (caprine residues 1-105) on the micellar surface and a free 
caseinomacropeptide (corresponding to residues 106-171) (for review see Jenness, 
1980). This alters micellar stability and causes aggregation and formation of a curd 
(mainly casein and fat) which is further processed to make cheese. Changes in 
concentration and the ratio of protein to fat determines the texture and optimum yield 
of the cheese but changing one component without alteration of the other can also be 
detrimental to production (Dalgleish, 1992). Breakdown of other caseins by proteolysis 
is desirable in certain types of cheesemaking, for example, during maturation Swiss-
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type cheese decreases its /3-cn content, dependent on plasmin activity. Variations in 
proteolysis between cheeses are probably due to the different water, salt and pH levels, 
providing more or less favourable conditions for plasmin activity (Richardson & 
Pearce, 1981).
2.4 Degradation of caseins
Proteolysis of proteins in milk produces a variety of products known as 
proteose-peptones, of which approximately two-thirds are believed to be produced by 
plasmin degradation of caseins (Andrews & Alichanidis, 1983). When purified bovine 
plasmin is incubated with milk, /3-casein is rapidly degraded, producing 7 -cn 
fragments, each corresponding to different sections of the /3-cn polypeptide chain 
(Eigel, 1977b). a sl-Cn has an intermediate resistance to plasmin attack while k - cn is 
even more resistant (Eigel, 1977a). Active plasmin is produced by cleavage of its 
zymogen, plasminogen, by plasminogen activators associated with the casein fraction 
(Politis et al, 1992b). Inhibitors of plasminogen activators and plasmin are found in the 
serum fraction of milk (Korycka-Dahl et al, 1983) and the major whey proteins (a- 
lactalbumin, /3-lactoglobulin and serum albumin) inhibit both plasminogen activators 
and plasmin. This can cause underestimation of their activities when they are measured 
in milk (Politis et al, 1993).
In vivo, plasmin activity has been significantly correlated with increases in the 
relative amounts of 7 - and a s-caseins and decreases in /3-cn (Aaltonen et al, 1988; 
Politis et al, 1989b) and seasonal increases in plasmin and plasminogen concentrations 
have been well documented (Richardson, 1983; Politis et al, 1989a & b). These 
observations can be explained by increasing activation of plasminogen and/or by 
leakage through the mammary epithelium from blood (often seen during mastitis). This 
may, in turn, be related to an increase in mammary involution (Politis et al, 1989a). 
However, these components are not only involved with involution and regression of the 
gland. The presence and activity of plasmin during the period of mammary gland 
growth and development is also vital for the process of tissue reorganisation 
(remodelling) and for the facilitation of cellular proliferation (Turner & Huynh, 1991), 
especially during phases of rapid growth such as pregnancy.
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3. GROWTH AND DEVELOPMENT OF THE MAMMARY GLAND
3.1 Overview
The process of growth and development of the mammary gland determines its 
potential secretory capacity, and the secretion of milk during lactation is itself 
influenced by a variety of other factors. These include the extent of neonatal milk 
demand, maternal nutritional status and the hormonal environment experienced by the 
mammary gland. The main development of the mammary gland commences at puberty; 
pre-pubertal cows have few mammary ducts but these increase in size, number and 
complexity after puberty (Delouis et al, 1980). The hormonal balance changes again 
when mature virgin animals become pregnant, stimulating further mammary growth 
and development. Oestrogens stimulate the development of ductular tissue and, in 
combination with progesterone, increase the proliferation of secretory epithelial cells. 
The rough endoplasmic reticulum content of these cells also increases in response to 
glucocorticoid action, again increasing the potential for the production of proteins. As 
this growth of secretory tissue progresses, the ’fat pads’ of connective and adipose 
tissue account for an ever-decreasing proportion of tissue mass. Vascularisation and cell 
numbers increase (hyperplasia) and as cells mature the degree of cellular differentiation 
also increases (hypertrophy) (for review see Erb, 1977).
Mammary growth is also influenced by the foetus during pregnancy via 
placental lactogen, signalling to the mother that milk demand will be from one or more 
offspring post partum. Placental lactogen and placental mass during pregnancy (day 77 
to term) correlate with milk production over the first fifty days of lactation and foetal 
number is positively related to the rate of growth and mass of secretory tissue. This 
maximises the production potential of the animal and goats with twins or triplets 
produce 27% and 46% more milk, respectively, than those with single kids (Hayden 
et al, 1979).
Initially it was believed that the majority of mammary development occurred 
during pregnancy (Convey, 1974) but it is now recognised that it continues beyond this 
point: mice double their secretory cell population approximately every six days during 
pregnancy and into early lactation (Knight & Peaker, 1982), in spite of the major 
changes in the hormonal environment of the gland. Goat mammary tissue also 
proliferates exponentially during pregnancy and growth continues post partum, albeit 
at a reduced rate (Knight & Peaker, 1984). Predictive equations for goat mammary 
growth during pregnancy have been tested and the best fit was achieved using an
6
exponential model, Y = A.ebX where Y=index of mammary growth, A = parameter 
measured, e=base for natural logarithms, b=rate constant for growth and X=day or 
month of pregnancy (Anderson et al, 1981). In early lactation, mammary growth and 
milk production can be modified by post-natal demand for milk and milking frequency, 
most probably through local, rather than endocrine, control (Bar-Peled et al, 1995). In 
goats, both secretory cell number and differentiation increased between parturition and 
week 3 of lactation and the subsequent rise in milk yield to its peak was supported by 
continuing differentiation, indicated by increased secretory cell enzyme activities 
(Knight & Wilde, 1993). However in rodents 75% of the increase in milk production 
between parturition and peak lactation was supported by increased cell numbers, and 
the remainder by increased differentiation (Knight et al, 1984).
Changes in mammary growth after parturition could have longer-term effects 
on milk production as this is determined by the summation of secretory cell numbers 
and the activity of those cells. Indeed, if these parameters could be altered during 
pregnancy or early lactation, then it could potentially alter the magnitude, and/or the 
profile, of subsequent milk production.
3.2 Measurements of mammary growth
Growth measurements usually involve a compromise between obtaining a 
representative sample and minimising the disturbance to the animal. Samples can be 
obtained by a variety of methods, one of which is by biopsy. The advantages of this 
technique include it being a relatively straightforward surgical procedure, glands 
remain in situ, recovery is rapid and there is usually only a temporary reduction in 
milk yield (Knight & Peaker, 1984). Disadvantages are that the tissue sample can be 
unrepresentative of the whole mammary gland, especially if there has been a previous 
biopsy and scar tissue is present. There may also be some internal bleeding but this can 
be minimised by using electrocautery to remove the sample.
Removal of the whole gland allows an accurate assessment of gland size, 
composition and differentiation but this is a complex procedure and raises the problem 
of stimulation of ’compensatory growth’ in the remaining gland(s). This phenomenon 
is observed in cows (Turner et al, 1963) and goats (Linzell, 1963; Knight & Peaker, 
1982a; Knight, 1987) and raises the question of the extent to which mammary growth 
can be influenced by loss of a gland during pregnancy or early lactation when growth 
is still occurring.
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A non-invasive method that can be used is magnetic resonance imaging. This 
accurately determines the amount of secretory tissue present within a gland. 
Unfortunately it is expensive, the size of the animal that can be measured is restricted 
(goats being the largest practicable) and the degree of cellular differentiation of the 
secretory cell population cannot be determined (Knight & Wilde, 1993).
The level of differentiation of mature secretory cells can be measured by 
assaying key enzymes involved in the synthesis of the major components of milk; 
caseins, lactose and fat. In vitro measurement of synthesis rates of casein and lactose 
can also be used and more imprecise estimates of cellular differentiation can be made 
by measurement of RNA/DNA ratios (Wilde et al, 1987).
Cell DNA content remains relatively constant regardless of the animal’s 
physiological status, allowing estimation of the total cell population from measurement 
of total glandular DNA content, but this does not distinguish between different cell 
types (Knight & Peaker, 1982b). If DNA concentration is determined from a tissue 
sample of known weight, and the size of the udder determined by, for example, water 
displacement (Linzell, 1966), then total DNA, and therefore cell number, can be 
estimated. However, this method measures the gross size of the gland which is 
dependent on the mass of secretory and non-secretory tissue, on the thickness of the 
skin covering the udder and on teat size (Knight & Peaker, 1982b).
3.3 Declining lactation and involution
The decline in milk yield after peak lactation has been attributed, in the goat, 
to decreasing cell numbers, rather than a loss in synthetic capacity due to de- 
differentiation of those cells already present (Wilde & Knight, 1989). If this loss could 
be slowed somehow it would provide a potential route for reducing the rate of decline 
in milk production. When milking stops, the cessation of milk secretion is mainly due 
to increased intramammary pressure and other factors attributable to a lack of milk 
removal (Fleet & Peaker, 1978). In cows, within two weeks, synthetic and secretory 
capacities drop to very low levels and alveolar surface area (both epithelial and 
lumenal) decreases. Within about three weeks the gland has regressed to a ’resting 
state’ but some synthetic and secretory capacity still remains (Sordillo & Nickerson, 
1988). This is in contrast to many other species and probably reflects the small loss of 
alveolar epithelial cells and the maintenance of organelle integrity, despite major 
changes in cell histology (Holst et al, 1987). Rodent milk secretion stops
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when suckling stimuli stop, mainly due to the reduction in the release of lactogenic 
hormones (Grosvenor & Turner, 1959). Cell activity drops rapidly, followed by a 
substantial loss of secretory epithelial cells which separate from the basement 
membrane. Myoepithelial cells increase in size, filling the gaps and the gland becomes 
fully involuted after approximately two weeks (Knight & Peaker, 1982b; Holst et al,
1987).
The apparent differences between ruminant and rodent involution may also 
reflect the different ’timetable’ of pregnancy and lactation rather than mechanistic 
differences in the process of involution. As a result of general farming practice, cows 
usually become pregnant while they are still producing milk, while laboratory rodents 
are generally either pregnant, or lactating. When mice were concurrently pregnant and 
lactating, a retardation of involution was observed, cell numbers were maintained, but 
they stopped lactating just prior to the second lactation despite continued lactogenic 
stimulation (Mizuno & Sensui, 1978). This requirement for a ’dry period’ in 
concurrently pregnant and lactating animals is similar to that seen in cows which 
require a non-lactating period of between 40 and 60 days. If less it can be detrimental 
to milk production during the subsequent lactation (Smith et al, 1967) however the non- 
lactating period appears to be less essential to goats (Fowler et al, 1991).
Changes in gross cell number reflect the balance between the rates of cell death 
and cell replication (Stringer et al, 1990) and during late lactation and involution, cell 
death rates exceed those of replacement. Metabolic and local factors influence this 
process but there is also evidence for a process of apoptosis (’programmed cell death’) 
in addition to necrosis in mammary tissue. Apoptosis is characterised by the induction 
and expression of specific genes which correlate closely with morphological changes 
that occur after the cessation of milking and DNA becomes fragmented giving a 
distinctive ’laddering’ pattern when separated by (gel) electrophoresis (Gerschenson & 
Rotello, 1992). Apoptosis occurs at different rates in mice and rats, but in both it 
leaves the mammary gland with a degree of organisation in its cytoarchitecture (Walker 
et al, 1989). Apoptosis has also been detected in goat mammary tissue during declining 
lactation, at slower rate than rodents, although this was affected by milking frequency 
(Quarrie et al, 1994).
The gradual remodelling of mammary tissue during involution also involves 
activation of serine proteases, notably plasmin (Ossowski et al, 1979). Plasmin is 
sensitive to changes in the hormonal environment of the mammary gland, for example,
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its activity can be rapidly induced by early removal of rat pups (cessation of the 
suckling stimulus) (Ossowski et al, 1979). Both plasmin and plasminogen are present 
in milk and the breed of animal, udder health and individual variations between animals 
also influence their presence (Richardson, 1983). In cows, concentrations of both 
plasmin and plasminogen increase as stage of lactation increases and Politis et al 
(1989a) found a strong correlation between plasmin, stage of lactation and involution. 
They postulated that the sharp rise in plasmin concentrations immediately before 
involution was directly due to the increased activation of plasmin from plasminogen, 
and that the positive relationship between increasing somatic cell counts with lactation 
stage was also indicative of this process. However, it has been estimated that only 12% 
of the total protease activity in milk is due to plasmin activation and correlations reflect 
the increased permeability of the mammary epithelium, transferring plasmin and 
plasminogen from the blood to milk (Korycka-Dahl et al, 1983; Richardson, 1983). 
Similar changes are seen during mastitis when somatic cell counts and mammary 
permeability increase (Politis et al, 1989b). So correlations between the various factors 
must be treated with care, especially when looking at lactational trends. Subsequent 
work by Politis et al (1989b and 1993) have also found that the assays for plasmin and 
plasminogen can be influenced by the presence of other milk proteins and that the assay 
conditions have to be carefully standardised to ensure accurate and reproducible results.
4. ENDOCRINE ASPECTS OF LACTATION
4.1 Hormonal control of mammary function
The mammary gland is a target organ for many hormones (Figure 1.1) which 
have various roles including the regulation of parturition and the onset of copious milk 
secretion (for review see Tucker, 1988). Briefly the major endocrine changes around 
parturition are increases in the concentrations of prostaglandins and glucocorticoids, 
and steadily increasing oestrogen and growth hormone levels. Progesterone levels drop 
very sharply before birth, allowing prolactin concentrations to increase rapidly and 
triggering the onset of milk secretion, lactogenesis (Erb et al, 1976). The alteration in 
maternal glucocorticoid concentrations partly reflect the effects of labour, but fetal 
glucocorticoids also increase as parturition nears, and the blocking action of 
progesterone on lactogenesis is overcome. Indeed, they compete with progesterone for 
binding to glucocorticoid receptors and synergise with prolactin to enhance casein and 
lactose production (Convey, 1974) and may well play a role in
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initiating milk secretion.
Once lactogenesis has commenced the hormonal requirements of the mammary 
gland change and prolactin, growth hormone and glucocorticoids, insulin, parathyroid 
and thyroid hormones are all required, to varying degrees, for continuing milk 
production, termed galactopoiesis. Some are released in response to suckling by the 
young (and often in response to machine milking of commercial dairy animals), while 
others, insulin and growth hormone in particular, vary with nutritional status and food 
intake. Fertility and environmental factors such as temperature and photoperiod can 
also play a role in the complex hormonal interactions controlling lactation. The roles 
of prolactin, growth hormone and a neuropeptide, oxytocin, will be considered in more 
detail in the following sections.
4.2 Evolution of prolactin and growth hormone
Prolactin and growth hormone are present in most vertebrates and probably 
originated from a single gene duplication during the early stages of vertebrate 
evolution, 60-70 million years ago (Sinha, 1992). They are members of the growth 
hormone/prolactin family of peptide hormones, related phylogenically, and have 
common structural features at primary to tertiary levels, and in their receptors. Bovine 
growth hormone and prolactin have 37% homology in their amino acid sequences 
(allowing for conservative replacements) (Vonderhaar, 1987). Other members of the 
family show variable degrees of prolactin and growth hormone-like characteristics, for 
example, ruminant placental lactogens have many prolactin-like features and appear to 
have arisen from duplication of a prolactin gene (Wallis, 1992).
4.3 PROLACTIN 
Prolactin and its receptor
Prolactin molecules show heterogeneity in their amino acid sequence and have 
variable molecular weights depending on both sequence length and post-translational 
modifications. Generally prolactin comprises of 197-199 amino acids with a molecular 
weight of 23 to 24KDa. The human pituitary gland contains many variants, the most 
abundant forms being 23K, 2IK and 25KDa respectively, and glycosylation is the most 
common modification. These variants have differing biological potencies and specific 
types may possibly carry out particular biological functions (Sinha, 1992). This may 
go some way to explaining how prolactin can modulate such a wide
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variety of biological functions without losing specificity. Discrepancies in determination 
of in vivo prolactin levels using bioassay (for example the pigeon crop sac assay) and 
radioimmunoassay methods have been attributed to the different systems picking up 
different molecular variants. A further complication in determining ’prolactin’ is that 
there is no apparent relationship between in vivo activity and the detectability of 
variants (Klindt et al, 1982) so direct comparison of results obtained using different 
assay methods and antibodies should be regarded cautiously, although strong 
correlations between bioassay and radioimmunoassays have been derived (Leung et al,
1978).
The prolactin receptor is a member of the cytokine-growth hormone-prolactin 
receptor family with characteristic features of a conserved region near the C-terminal 
containing a WSXWS motif and two pairs of conserved cysteines in the N-terminal 
region. A wide range of tissues have prolactin binding sites (sizes range from 28 to 320 
KDa) but some ’cryptic’ sites do not elicit biological effects (Vonderhaar, 1987). Two 
classes of prolactin receptor isoforms have been determined- short and long- probably 
generated by alternative splicing of a single gene (Kelly et al, 1992). The two forms 
of receptor in rabbit mammary gland have similar binding affinities for prolactin, but 
only the long-form could stimulate milk protein gene transcription. In rats the short- 
form can represent up to 70% of the total receptor number (Lesueur et al, 1991) and 
although it cannot initiate milk protein transcription, it can still bind prolactin, 
dimerise, carry out signal transduction and is involved in receptor turnover (Rozakis- 
Adcock & Kelly, 1991). Differential expression of four distinct molecular forms of the 
prolactin receptor has been observed in the rodent mammary gland, dependent on 
physiological state (Guillamot & Cohen, 1994) and a 33K caprine receptor has been 
found in the mammary gland throughout pregnancy and lactation (Smith et al, 1993). 
The prolactin response is further modified by alteration of receptor numbers and hence 
the sensitivity of the target tissue can be varied. For example, receptor numbers 
increase during pregnancy and more so during lactation, and are ’fine-tuned’ by up- 
or down-regulation (Delouis et al, 1980). Negative and positive co-operativity between 
prolactin and its receptor also occurs and this further modulates the binding process, 
possibly causing further stimulation of the mammary gland (Sakai, 1994).
There have been some recent advances in the elucidation of the cytokine-growth 
hormone-prolactin receptor family signal transduction cascade. None of these receptors
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contain intrinsic enzyme activity (Wakao et al, 1994), however Janus kinases (JAKs) 
were identified as being closely associated with the receptor. These proteins recruit 
transcription factors (STAT proteins) which are subsequently phosphorylated. This 
triggers the formation of a complex which leads to transcriptional activation of the 
appropriate genes (for review see Finidori & Kelly, 1995).
Secretion and release
Evidence for a direct relationship between the amount of prolactin present in 
the pituitary and that present in the blood after its release is conflicting (Ben-David et 
al, 1970; Sinha et al, 1975). The observations could be explained if a two-stage release 
process occurs (Shani et al, 1976), consisting of an initial transformation phase 
followed by release into the circulation (Whitworth et al, 1981). Factors which increase 
prolactin, such as dopamine antagonists and perphenazine, are believed to act on the 
former rather than the latter stage (Grosvenor et al, 1980). Circulating prolactin 
concentrations increase with the stimulus of suckling or milking although the pituitary 
release of prolactin tends to decrease with lactation stage (Hart, 1975a; Beck et al,
1979), probably due to the influence of seasonal factors such as photoperiod and 
temperature (Hart, 1975b). The synthesis and storage of prolactin in the pituitary and 
alterations in tissue response will, in turn, modify the availability and effectiveness of 
prolactin’s action (Johke, 1970). For example, the binding capacity of the mammary 
gland for prolactin increases with lactation stage (Beck et al, 1979), increasing the 
gland’s sensitivity.
Its role in lactation
Prolactin is involved in many physiological processes (Figure 1.2) and the most 
common approaches to determining its role during lactation generally either reduce it 
to minimal levels by administering prolactin suppressants, or increase it, directly or 
otherwise. It became clear that prolactin played different roles in different species at 
different times.
Prolactin concentrations increase shortly before parturition and, in general, high 
levels of prolactin are essential for full lactogenesis to occur. When the periparturient 
prolactin surge is blocked in goats by bromocriptine, lactogenesis was delayed for 
several days (Forsyth & Lee, 1993). Other species, especially non-ruminants, can show
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more profound responses to prolactin restriction. For example, rabbit lactation is highly 
dependent on prolactin and yields could drop by 90% within 24 hours of prolactin 
suppression (Taylor & Peaker, 1975) and in rats milk production can be suppressed by 
bromocriptine treatment (Flint & Gardner, 1994). Unfortunately the precise role of 
prolactin during established lactation is less clear in ruminants and cows and goats, 
specifically bred for traits of high milk production, cannot always be compared with 
other ruminants such as sheep (Cowie et al, 1980). In the latter, bromocriptine does 
suppress established milk yield (Kann et al, 1978). In the former, data have been 
interpreted to indicate that it has no inhibitory effect, although individual cows (for 
instance) showed responses varying from 0 to 20% inhibition (Karg et al, 1972). Over 
the long-term, bromocriptine treatment of goats has little effect on gross milk 
production but secretory cell activity decreases (determined by measurement of 
RNA/DNA ratio) as does alveolar cell size. Lactotrophs (prolactin-producing cells in 
the pituitary gland) are probably also negatively affected by treatment, causing a 
decrease in pituitary response to prolactin-releasing stimuli (Forsyth & Lee, 1993). 
Exogenous administration of prolactin to increase basal concentrations also fails to 
influence milk secretion rates in goats (Jacquemet & Prigge, 1991) or improve total 
milk yields in cows (Plaut et al, 1987). These observations led to the conclusion that 
in established lactation, prolactin is not normally rate-limiting (Tucker, 1981). However 
there is much evidence to be found (even in the above citations) to suggest that this is 
not entirely true. Schams et al (1972) gave three cows bromocriptine over 9 days pre- 
partum and for 3 days post partum, and one out of three animals significantly reduced 
yields compared to the previous year. Post-treatment, prolactin concentrations and milk 
yields remained low, indicating a prolactin effect during established lactation. 
Bromocriptine given to goats during late lactation causes a drop in yield of 77 % and 
increases the rate of decline of milk production (Gabai et al, 1992). So why are there 
conflicting results for the role of prolactin during established lactation? Although it has 
clearly been shown that bromocriptine suppresses prolactin to very low levels, prolactin 
may still be at an adequate level to sustain lactation. This depends on the threshold 
limit for prolactin to continue acting effectively on milk production and Smith et al 
(1974) calculated that a concentration of lng prolactin per millilitre of serum would 
still deliver 20mg of prolactin per day to a ’typical’ cow mammary gland. Prolactin 
may also compensate for the bromocriptine suppression by increasing the production 
of high activity variants (not necessarily detectable by RIA), or it may be
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produced locally in the mammary gland and not be detectable in the circulation 
(Forsyth & Lee, 1993).
So is there a direct relationship between prolactin and milk yields? There is 
evidence both to support and refute a link- basal prolactin correlates positively with 
milk yields over a 3 month post partum period in cows (Beck et al, 1979) and Walsh 
et al (1980) calculated that for the first sixty days of lactation an increase of 1 ng/ml 
serum prolactin was associated with an increase in total daily yield of 6kg. But over 
lactation as a whole they found no significant correlation between prolactin and milk 
yield. This latter finding supports the work of Hart (1974 & 1975a) and Koprowski & 
Tucker (1973) who found no correlations between basal or milking-induced release of 
prolactin in goats and cows over a lactation. These results could be explained on the 
basis that prolactin is important throughout lactation, but more so during early lactation 
when it helps maximise milk production. When yields are declining it is not a limiting 
factor but when concentrations are restricted (using bromocriptine), bringing it to 
negligible levels (Gabai et al, 1992), then it becomes limiting, showing that its 
presence is still required for the maintenance of lactation. Confirmation of its effect 
could possibly be determined by keeping prolactin at a high level throughout lactation 
although the relative importance of basal compared to milking-induced levels of 
prolactin are also yet to be elucidated.
Manipulation of endogenous prolactin
The mechanism by which prolactin is released from the pituitary gland was 
initially suggested to be through stimulation of prolactin-releasing factors (PRFs) 
(Mishkinsky et al, 1966). However, later work proposed that the increased prolactin 
release was due to inhibition of a tonic prolactin-inhibitory factor (PIF) (Ben-David et 
al, 1970) through tuberoinfundibular neurons regulated by prolactin, but the regulation 
of this process is still under debate (for review see Frawley, 1994). The regulation of 
these neurons at the level of the hypothalamus is independent of direct dopamine 
control (Ireland et al, 1991) although dopamine does have a role in influencing 
prolactin secretion at both the hypothalamic and pituitary level (Langer et al, 1977; 
Higuchi et al, 1983).
Prolactin release can be manipulated experimentally in a variety of ways. Direct 
methods include administration of exogenous prolactin to increase circulating 
concentrations of the hormone, or by interruption of the pituitary-hypothalamic
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connection which increases prolactin as the pituitary inhibition by PIFs is lost (Ben- 
David et al, 1965). Indirect methods can use pharmacological agents such as 
bromocriptine, a dopamine antagonist (Karg et al, 1972) to reduce prolactin, or 
stimulate it with ’psychopharmocologic prolactin releasers’, more commonly used for 
their sedative properties. Some of these have side-effects which include mammary 
development and/or enhancement of milk secretion, caused by a different active part 
of the molecule (Ben-David et al, 1965; Bass et al, 1974).
One of these agents, perphenazine, a phenothiazine derivative (Figure 1.3), 
causes a rapid release of prolactin in a variety of species including male and female 
mice, rats and rabbits (Mishkinsky et al, 1966; Blackwell et al, 1973; Sinha et al, 
1975). It stimulates growth of rat mammary epithelial cells, particularly in alveolar 
regions (Stringer et al, 1990) while sheep show dose-dependent increases in the size 
of both ducts and alveoli (Morag et al, 1971). Administration of perphenazine to small 
animals and sheep is generally by intramuscular, intravenous or intraperitoneal injection 
(McNeilly & Lamming, 1971; Morag et al, 1971) but side-effects (particularly in 
ruminants) include loss of appetite, weight loss, lethargy and tenderness at the injection 
site (Shani et al, 1975). Implantation of perphenazine into the brain median eminence 
of rabbits (Mishkinsky et al, 1966) and goats (Vandeputte-Van Messom & Peeters,
1982) removed these side-effects but the surgical procedures used were complex and 
had inherent disadvantages. An alternative approach of oral dosing in mares (Ireland 
et al, 1991) and rats (Stringer et al, 1990) has also increased prolactin concentrations.
4.4 GROWTH HORMONE 
Growth hormone and its receptor
Growth hormone is produced in the anterior pituitary and comprises up to 10% 
of the weight of a dried pituitary, far in excess of any other hormone present (Lewis, 
1992). It has a single polypeptide chain (with 2 disulphide bridges) of about 200 amino 
acids with a typical molecular weight of 22KDa (Wallis et al, 1985). As with prolactin, 
variants are produced by alternative splicing of mRNA and there are a variety of post- 
translational modifications which alter its biological activity (Lewis, 1992). Growth 
hormone appears to be modified to an active form in the pituitary before release into 
the circulation where between 5 and 20% of the hormone exists in a relatively stable 
dimeric form (Wallis et al, 1985). Both bioassays and radioimmunoassays are used to 
determine its activity and concentrations but again, as with prolactin, the difference
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between detectability and activity of the hormone must be borne in mind. Growth 
hormone has certain features in common with prolactin and some cytokines; its tertiary 
structure contains four a-helices in an ’up-up-down-down’ orientation (Wallis, 1992). 
Growth hormone receptors have not been detected on mammary gland epithelial cells 
using conventional receptor binding methods and
in vitro growth hormone was unable to bind directly to mammary epithelial cell 
homogenates or explants. These observations suggest that the stimulatory action of the 
hormone on milk production is not a direct effect of the hormone binding to the 
secretory epithelium (Gluckman & Breier, 1987), however, mRNA coding for the 
receptor has been detected by in situ hybridisation in bovine mammary tissue (Hauser 
et al, 1990), specifically on the alveolar epithelium (Glimm et al, 1990).
Regulation and secretion
In most mammals growth hormone release is pulsatile and circulating 
concentrations exhibit circadian periodicity- children and pubertal humans have 
maximal growth hormone secretion within the first hour of sleep. In cows hormonal 
release occurs episodically but there is no apparent circadian influence on secretion 
(Wallis et al, 1985) and no response to changes in photoperiod or ambient temperature 
(Peters & Tucker, 1978). Wide variations in hormonal release patterns are seen 
between individuals and are probably determined, in part, genetically (Wallis et al, 
1985). Growth hormone release is inhibited by somatostatin and stimulated by growth 
hormone-releasing hormone, both of which are produced in the hypothalamus 
(Wehrenberg & Gaillard, 1989). They are, in turn, regulated by opioid peptides 
(Moore et al, 1992). These are transported via the hypothalamic-hypophyseal portal 
vessels to the pituitary gland where they act on growth hormone-secreting cells, 
somatotrophs (Gluckman & Breier, 1987). Acute or chronic growth hormone treatment 
causes negative feedback of its own release, via stimulation of somatostatin, but 
accumulation of growth hormone during inhibitory periods may increase a subsequent 
response to a stimulatory factor (Lanzi & Tannenbaum, 1992). Growth hormone acts 
directly on target tissues when receptors are present but many of its actions indirect and 
are mediated via insulin-like growth factors. For example, immunisation against growth 
hormone-releasing hormone reduces growth hormone and IGF-I concentrations also 
drop (Moore et al, 1992). IGF’s are produced mainly in the liver and, as they are not 
stored to any great extent, are present predominantly in the circulation.
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But when associated with binding proteins, their half-lives can be increased up to 18- 
fold. Receptors for these factors are present in a variety of tissues and mRNA for IGF- 
I has been detected at high levels in stromal and blood fractions from bovine mammary 
gland. IGF-I receptors are structurally similar to insulin and both have protein kinase 
activity (Wallis et al, 1985).
Physiological roles and mode of action
A major role for growth hormone is to promote growth by acting on many 
metabolic processes and balancing the demands of this with nutritional supply. It 
simulates protein synthesis (de novo and increases amino acid uptake and transport 
mechanisms), and increases lipid catabolism at the expense of carbohydrate catabolism 
(antagonising insulin’s action) (Wallis et al, 1985). Anabolic processes such as cell 
division, skeletal growth (especially cartilage and muscle) and galactopoietic activity 
are also modulated by changes in growth hormone (Gluckman & Breier, 1987). In 
humans a lack of growth hormone, or of factors mediating its action, can lead to a 
variety of medical conditions which can have significant and negative effects on 
growth, dwarfism for example (Wallis et al, 1985). The plane of nutrition of the 
animal and the level of feeding are important as they also determine the amount of 
circulating growth hormone (Gluckman et al, 1987) and in times of nutritional 
constraint growth hormone concentrations will increase (Breier & Gluckman, 1991), 
directing energy towards conservation of tissue mass. Genetic and seasonal factors also 
play a role in determining basal growth hormone levels (Hart, 1973b & 1983).
However, there are still many questions to be answered about the mechanics of 
how growth hormone actually acts on the mammary gland. The body of experimental 
evidence suggests that growth hormone cannot bind directly to mammary secretory 
cells so it must therefore be acting through some sort of mediator system. In an attempt 
to elucidate the pathway of growth hormone’s action in rats, endogenous growth 
hormone and prolactin were supressed to such an extent that milk production virtually 
ceased. Various test substances or hormones were then given exogenously in an attempt 
to restore milk secretion to pre-treatment levels. Both growth hormone and prolactin 
partially restored yields and IGF-I concentrations increased when growth hormone was 
administered systemically. However IGF-I alone, or when pre-complexed to binding 
proteins, was unable to mimic this effect (Flint et al, 1994). Follow-up studies found 
that locally administered growth hormone could partially restore milk production in
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treated glands, without affecting IGF-I levels (Flint & Gardner, 1994), suggesting that 
growth hormone was able to act directly on the mammary gland. In goats, growth 
hormone introduced into the mammary gland via the teat canal (intraductal 
administration) with EGTA to allow paracellular movement through to the basal 
surface, had no effect on milk production (Sejrsen & Knight, 1994). This again 
supports the case for growth hormone being unable to bind to secretory cells but it 
could also be due to the growth hormone not being successfully delivered by this route.
So is IGF-I involved in the modulation of growth hormone’s action? Systemic 
growth hormone increases IGF-1 concentrations and milk production in ruminants 
(Davis et al, 1987) supporting the observations made in rodents. The elevation of 
IGF-I concentrations in response to growth hormone was measured in goats then 
reproduced by giving IGF-I systemically. However this had no effect on milk 
production while growth hormone gave increases of up to 30% (Davis et al, 1989). 
Direct infusion of IGF-I into the mammary gland increased milk yields but 
unfortunately this was combined with increased milking frequency (2 hourly) and 
oxytocin administration which themselves have stimulatory effects on milk yields 
(Prosser et al, 1990). So in conclusion, growth hormone appears to act locally, but not 
necessarily directly, on the secretory cell. A mediator is probably involved, possibly 
IGF-I, but more evidence is required and growth hormone’s action could be mediated 
through a factor which has, as yet, not been identified.
4.5 OXYTOCIN 
Physiological roles
Oxytocin is a neuropeptide synthesised in the neural lobe of the posterior 
pituitary and has an amino acid sequence sequentially similar to mammalian vasopressin 
(Benson & Folley, 1957; Richard et al, 1991):
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-(NH2)
It’s physiological roles include eliciting milk ejection, it is involved in the regulation 
of ruminant oestrus cycles (Wathes et al, 1992) and it induces uterine contractions 
which lead to foetal expulsion during parturition (Folley & Knaggs, 1965). In a 
lactating cow approximately 3% of the total oxytocin present is in the circulation, but 
milking (which provides a potent stimulus for oxytocin release) can cause up to one 
third of the stored oxytocin to be released in a pulsatile manner. The magnitude of 
release tends to decrease with time of stimulation (Gorewit et al, 1983) although high
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sustained levels are also observed, probably due to inadequate sampling frequencies 
(see Wakerley et al, 1988). Estimates of oxytocin’s half life in the circulation generally 
range between 60 and 216 seconds (Thompson et al, 1973; Gorewit, 1979). However, 
when measured during a steady state infusion of oxytocin, two half lives have been 
determined-fast (about 4 minutes) and slow (25 minutes) and these are likely to be 
closer to the normal physiological values (Gorewit et al, 1983).
Oxytocin acts in concert with a-adrenergic and ^-adrenergic receptor systems 
to control, respectively, milk ejection and milk flow (Bruckmaier et al, 1991) and 
exogenous oxytocin decreases the time to milk ejection and increases the duration of 
maximal milk flow (Graf, 1968). Cleverly & Folley (1970) calculated that exogenous 
oxytocin reaches the mammary gland within 50 seconds of intravenous injection and 
in vivo the milk ejection response can be elicited in cows within 0.4 minutes of giving 
iv oxytocin. An intramuscular administration route is also frequently used and the time 
to milk ejection increases to an average time of approximately 4 minutes, although 
response times vary with individuals and with dose levels (Graf, 1968). The effect of 
oxytocin on the mammary gland is modulated by its receptors (present on myoepithelial 
cells) whose numbers vary with physiological state; in the rat mammary gland they 
increase exponentially during pregnancy, continue to increase at a slower rate during 
lactation and once mammary regression (involution) begins, receptor numbers drop off 
sharply (Soloff & Wieder, 1983).
Role in milk removal
Milk removal from secretory epithelial cells is facilitated by contraction of 
myoepithelial cells which form a network over alveolar epithelium. When oxytocin 
binds the contraction of the myoepithelium forces milk out of the alveolar lumenal 
spaces and small ducts into the gland cistern (Sagi et al, 1980). This process of milk 
ejection is the natural response to the vigorous teat stimulation of the suckling offspring 
(Benson & Folley, 1957) and maximises the milk available to them. Other types of 
physical contact with the gland, for example washing the udder before milking 
(Cleverley & Folley, 1970) or placing teat cups on the teats (Folley & Knaggs, 1966) 
provide potent stimuli. Conditioned stimuli, generally associated with a milking 
routine, elicit milk ejection, the recognition of auditory cues such as the milking 
machine being switched on, for example. Cows moved to an unfamiliar milking 
environment show a depression in peak oxytocin concentrations attained during milking
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(Bruckmaier et al, 1993) but within ten days of a new milking routine commencing, 
a full conditioned reflex release is seen (Cleverley & Folley, 1970). Presence of the 
calf without physical contact can be stimulatory but can also depress the ejection 
response (and milk yield) if it is subsequently removed from sight and/or sound of the 
mother (Bar-Peled et al, 1995).
The movement of milk from the alveolar to the cisternal areas causes an 
increase in intramammary pressure, usually within 44-126 seconds of increased 
oxytocin being detected in the blood (Cleverly & Folley, 1970). The increased pressure 
can be sustained for about 10 minutes if milk is not removed (Bruckmaier et al, 1991) 
although observations of increased pressure as long as 60 minutes later have been 
reported in cows (Cleverly & Folley, 1970). This overestimate was probably due to the 
technique employed to measure the pressure changes: after oxytocin administration 
three glands were emptied while the measured gland remained full and the physical 
effects of ’one full, three empty’ probably accounted for the result. Measurement of 
intramammary pressure in goats using an intraductal pressure transducer shows a rapid 
and characteristic peak in pressure in response to exogenous oxytocin administration 
(at a physiological level). Pressure then drops to a level similar, or slightly above, that 
measured pre-treatment (CH Knight & JR Brown, unpublished results). Some milk 
remains in the alveoli and small ducts of the gland after machine milking (residual 
milk) which is only removed if oxytocin levels increase to above those experienced at 
a normal milking (Thompson et al, 1973). In goats, if milk is removed and the milk 
ejection reflex avoided (by, for example, cannulation of the teat allowing passive 
drainage of milk through a catheter) then 86% of the milk obtained by hand milking 
can be removed. If passive drainage is combined with adminstration of exogenous 
oxytocin then 97% of the milk can be obtained (Henderson & Peaker, 1987), 
illustrating the importance of oxytocin for efficient milk removal.
Effects on milk production
Administration of high, non-physiological concentrations of oxytocin has 
detrimental effects in several species including rabbits (Linzell, 1975), goats (Linzell 
& Peaker, 1971a) and cows (Allen, 1990). The excessive contraction of the 
myoepithelial cells is thought to cause damage and loss of integrity of secretory cells, 
milk yields drop and milk composition changes. The latter effect is probably due to 
increased permeability of the mammary epithelium allowing sodium and other
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components to leak from the blood into milk through previously ’tight’ cell-cell 
junctions (Linzell & Peaker, 1971b). This process is detectable by alteration of milk 
Na:K ratios and is also seen during mastitis, often providing an early indication of 
mammary infection in apparently healthy cows (Allen, 1990).
In contrast, giving smaller, physiological doses of oxytocin over variable 
periods often has a positive effect on milk yields, although responses vary between 
individuals and studies. When oxytocin is given before milking the improvement in 
yield can be explained by the more efficient removal of milk. However, debate has 
arisen as to whether or not this is its only effect as oxytocin has been claimed to 
increase milk yields when given after milking. Ballou et al (1993) designed an 
experiment in which cows were given oxytocin or control saline injections before or 
after milking. Their summary stated that oxytocin significantly increased milk 
production by 3% given either before or after milking. However, these increases were 
equivalent to a kilogram, or less, of milk and absolute levels of significance were 
p<0.08. So their suggestion that oxytocin was not only acting by ’emptying’ but by 
positively altering the production, or by maintaining secretory cell activity requires 
further substantiation. Recent work in cows (Knight, 1994) shows that oxytocin 
adminstration increases milk yields only if milk is removed from the gland at the time 
of treatment, challenging the proposal that oxytocin was acting at a metabolic or 
hormonal level.
It has been suggested that oxytocin’s effects are due to a direct relationship 
between oxytocin and prolactin (Benson et al, 1960), however, subsequent evidence is 
equivocal. Cultured anterior pituitary cells release prolactin specifically in response to 
oxytocin addition but are probably not significantly involved in modulating basal 
concentrations of prolactin or in regulating acute prolactin release in vivo (Johnston & 
Negro-Villar, 1988). Peaks in circulating oxytocin concentrations in response to 
suckling occur at prolactin minima in rats (Higuchi et al, 1983) but administration of 
oxytocin antagonists and anti-oxytocin antibodies reduce the magnitude and duration 
of the prolactin response to suckling (Samson et al, 1986). It is probable that any link 
between the two is probably at the neuroendocrine level, although they are temporally 
related to each other (Higuchi et al, 1983; Johnston & Negro-Villar, 1988). In 
conclusion, it appears that the direct effects of oxytocin are mainly confined to local 
effects associated with improved milk removal around the alveoli and small ducts in 
particular (Sagi et al, 1980), but the mammary gland must be in a favourable hormonal
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environment for a full realisation of oxytocin’s potential.
5. LOCAL CONTROL OF MILK PRODUCTION
5.1 Alterations in milking frequency
In goats, the rate of milk secretion is negatively related to the interval since 
milking with a curvilinear relationship seen between them (Wheelock et al 1967). 
Accumulation of secreted milk in the goat udder is relatively constant for 
approximately 6 hours after emptying, slows considerably after this period and 
eventually reaches a plateau (Peaker & Blatchford, 1988). In cows, milk accumulation 
is fairly constant for about 12 hours before markedly decreasing (Wheelock et al, 1966; 
Knight et al, 1994). Normal milking practices generally operate on a twice daily 
regime and it would be predicted that a switch from the usual 8 and 16 hour milking 
intervals to two 12 hour intervals would increase yields by virtue of extending the time 
of maximal milk production. The response to more frequent milking (shortening 
intervals between milkings) has been investigated and well documented- it increases 
milk yields. When goats are milked thrice-daily, at equal 8 hour intervals, milk yields 
increase by between 4.7 and 10.7%, depending on lactation stage (Henderson et al,
1983). Hourly milking of glands enhances yields even more (up to 20%) although the 
effect is abolished in fasted animals (Linzell, 1967), probably due to nutritional 
constraints. Other researchers have applied different milking frequencies to individual 
glands in the same animal. For example, twice-daily milking two udder quarters of a 
cow, and thrice-daily milking of the contralateral quarters increases milk yield in the 
more frequently milked gland alone (Shinde, 1978). Similar results are obtained in 
goats and the increased yield curve is parallel to that of normally milked gland 
(Henderson et al, 1983) illustrating the local nature of the effect and in both studies 
yields rapidly returned to twice-daily levels on the cessation of the extra milking. The 
enhancement of milk yield achieved by increased milking frequency is restricted to the 
period of treatment, is reversible and confined to those glands receiving more frequent 
milking. However if a more frequent milking regime is continued over longer periods 
of time there is evidence to suggest that there are longer term changes to the mammary 
gland secretory cell population (Shinde, 1978; Knight et al, 1990).
5.2 The evidence for local control by FIL
Milk secretion and its subsequent accumulation of milk in the mammary gland
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does not occur at a constant rate but tends to slow (at varying times) as time after 
milking increases. This natural constraint on milk production was thought to reflect the 
limit of the physical stretching of the gland, with increasing intramammary pressure 
inhibiting further milk production (Turner, 1955). However, it was later found that 
pressure was not playing a major role as the enhanced rate of milk secretion continues 
after removed milk is replaced with an equal volume of isosmotic sucrose solution at 
the extra milking, maintaining intramammary pressure (Henderson & Peaker, 1984). 
It seemed as though a local control process associated with milk removal was acting 
in the mammary gland. Hourly milking a denervated, autotransplanted mammary gland 
which had no neural connections and could therefore not respond to, or release into the 
circulation, hormones associated with milking still showed an increase in milk yield. 
This shows that it is milk removal that is essential for the effect rather than the 
hormonal factors associated with milking (Linzell & Peaker, 1971a). The close positive 
correlation between mammary blood flow and milk secretion led to suggestions that the 
increased supply of metabolites to the gland might enhance milk production. The 
vasoconstrictory properties of certain prostaglandins and the decrease in milk secretion 
with decreased blood flow led to the identification of PGE^ as being a potential 
inhibitor of milk production. However, doubt was shed on its importance when 
intraductal adminstration initially stimulated milk secretion, then caused a period of 
inhibition (Maule Walker, 1984). The action of milk removal seemed to provide the 
key.
It has been noted that changes in milk secretion rates during lactation when milk 
was diluted or replaced with an isosmotic solution are consistent with the presence of 
a chemical inhibitor in milk (Henderson & Peaker, 1987). The field was narrowed by 
finding that the whey fraction of goat milk inhibited casein and lactose synthesis in 
rabbit mammary gland explants (Wilde et al, 1987). Subsequent separation and 
purification of whey proteins into definable fractions resulted in identification of a 
single protein (Mr 7600) which had an inhibitory action in rabbit mammary cell 
cultures. It was named FIL- the feedback inhibitor of lactation. In vivo, various doses 
of FIL intraductally administered to goats cause a local inhibition of milk secretion up 
to a maximum of 17.4% at the highest dose of 750 fig (Wilde et al, 1995).
In conclusion, the rapid and reversible alterations in milk yields with changing 
milking frequency are consistent with the hypothesis of local control of milk secretion 
by FIL; more frequent removal of milk, hence FIL, reduces the level of autocrine
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inhibition on milk secretion, allowing cells to secrete maximally for longer periods as 
FIL concentrations are reduced (Wilde & Knight, 1990). The positive effects of 
oxytocin on milk yields can also be explained by improved removal of milk from the 
secretory areas. Although the component responsible for the local control of milk 
secretion has been identified it must be remembered that milk secretion is not only 
under local control. It represents a complex systemic interaction between many 
hormones and other factors, for example, increased milking frequency has increased 
prolactin receptor numbers on secretory cell surfaces (McKinnon et al, 1988) and can 
increase the size of the secretory cell population (Henderson et al, 1985).
5.3 The importance of the sites of milk storage
The compartmentalisation of secreted milk within the udder plays an important 
role in determining the productivity of an animal and this can be, in part, related to the 
presence of FIL in the mammary gland. Milk is stored in alveolar and cisternal areas 
(see Figure 1.4). Cisternal milk is that which is stored in large ducts and the cistern 
and can be removed by catheter drainage (thereby avoiding the milk ejection reflex). 
Alveolar milk is stored in small ducts and the alveolar lumenal spaces and is removable 
after drainage by milking with simultaneous administration of oxytocin (Knight et al, 
1994). These descriptions of the milk fractions will be used in this thesis. There will 
also be a negligible amount of milk which remains in the gland which is not removable 
by milking or giving exogenous oxytocin (Henderson & Peaker, 1987). However, it 
must be noted that not all authors define cisternal and alveolar fractions in this way and 
care should be taken when making comparisons between studies. Stelwagen et al 
(1994), for example, define alveolar milk as that being obtained after hand-milking, by 
a further milking with administration of oxytocin. The initial hand-milking would 
stimulate endogenous oxytocin release and milk ejection, resulting in an overestimation 
of ’cisternal milk’ and the second milking with exogenous oxytocin would therefore, 
by the present definition, underestimate ’alveolar milk’. The milk remaining after a 
normal milking is also called residual milk by some authors (for example, Peaker & 
Blatchford, 1988).
Milk accumulation in the udder is not evenly balanced between alveolar and 
cisternal areas; in goats, catheter plus hand milk increases linearly over a 16 hour 
period while residual milk increases steadily over 6 hours, then remains constant 
(Peaker & Blatchford, 1988). Filling in the cow follows a similar trend, but on a
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Teat canal
Figure 1.4 Illustration o f a goat udder with one gland shown in 
partial cross-section. Adapted from Mepham (1984).
different timescale; shortly after milking some milk moves into the cistern but the main 
accumulation occurs more than 6 hours later. Meanwhile alveolar milk volume steadily 
increases for at least 12 hours (Knight et al, 1994). The greater resistance to cistern 
filling in cows reflects the relative amount of milk stored cistemally (approximately 
30%) (Dewhurst & Knight, 1994) compared to goats which have cisternal percentages 
of about 80% (Peaker & Blatchford, 1988). Wide variations in storage characteristics 
are seen between individuals, between species, and both age and parity tend to increase 
cistern capacity in cows (Dewhurst & Knight, 1994).
So what is the relationship between FIL and the site of milk storage? Milk must 
be removed specifically from the alveolar areas of the mammary gland to relieve FIL 
inhibition of milk secretion- secretion rate increases by 11% only if oxytocin is 
administered during frequent catheter milking, ensuring emptying of alveolar areas 
(Henderson & Peaker, 1987) as catheter drainage alone avoids the milk ejection reflex. 
Conversely, FIL must be in contact with secretory cells to exert its effects. So once 
milk has moved away from the alveolar secretory cells and begins to accumulate in the 
cistern, FIL effectively becomes inactive (Dewhurst & Knight, 1993). An inverse 
relationship between milk secretion and the proportional amount of milk present in the 
alveolar areas has been found in goats (Peaker & Blatchford, 1988). Animals storing 
proportionately more milk in the alveolar areas have lower rates of milk secretion. The 
responses in milk production to alterations in milking frequency have also been related 
to cistern proportion in goats (Wilde & Peaker, 1990) and cows (Dewhurst & Knight, 
1994). Cows with large cisterns are more tolerant of infrequent milking (Knight & 
Dewhurst, 1994), while those with small cisterns (and therefore with relatively more 
milk present in alveolar areas) respond best to increases in milking frequency, due to 
the increased removal of FIL. It was suggested thirty years ago that udder morphology 
played a more important role in determining the tolerance of infrequent milking than 
factors such as secretion rate, milk yield and intramammary pressure (Turner, 1955). 
The latest findings support a role for udder morphology in this process but there are 
complex inter-relationships between the various factors which inextricably link them 
together. For example, udder morphology determines the relative sites of milk storage 
which in turn influence milk secretion rates and hence milk production. But the level 
of milk production can subsequently modify udder morphology by stretching or 
shrinking the gland.
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6. LACTATION PERSISTENCY
6.1 Definition
There are two main factors which determine the shape of the lactation curve for 
an animal, the peak yield achieved and the rate of decline in yield after this point. The 
latter, or both, can be used in calculations to quantify ’lactation persistency’ (for 
summary see Broster & Broster, 1984). A variety of methods are used to measure 
persistency; some use the yield obtained at mid-lactation to compare the productivity 
of animals, while others look at lactation as a whole using, for example, the number 
of days that milk is produced, or the proportion of the total milk yield produced over 
a particular defined period of lactation. Two animals which have identical rates of 
decline in milk yields but different levels of peak production will have different total 
yields, different lengths of lactation and possibly different ’persistencies’ depending on 
the terminology used. Other authors have used algebraic models to evaluate lactational 
trends in milk composition and yields (Wood, 1976) or complex statistical models have 
been fitted to the data; in some cases treatment animals have been excluded as they do 
not fit the model applied (Nostrand et al, 1991). In this thesis, persistency is measured 
and defined as the rate of decline in milk yield with time after peak lactation has been 
achieved. The rate of decline in yield was determined over defined periods and was 
calculated by regression analysis of average daily milk yield against lactation week. 
This method was applicable to all animals used in the various studies, and by 
monitoring yield losses after peak lactation rather than, for example, total production 
over a lactation, it gave a more accurate reflection of the changing status of the 
mammary gland during declining lactation as milk yields themselves reflect secretory 
cell activity and number.
6.2 Biological and imposed constraints on lactation
There are natural constraints on lactation as its main purpose is to provide a 
source of nutrients for the neonate. Once weaned there is little point, biologically, in 
production continuing as lactation is an energy-draining metabolic process for the 
mother. The level (or plane) of nutrition and body condition influences milk yields- 
well-fed goats generally produce more milk than those given restricted diets although 
there is some species variation (Sachdeva et al, 1974) and the yield-enhancing effects 
seen with frequent milking are abolished when dietary intake is reduced (Blatchford & 
Peaker, 1983). In India the food supply is so scarce and nutritional constraints so high
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that the indigenous species {bos indicus) lactate only while calves are present and 
regularly suckling (Crotty, 1980).
The amount of secretory tissue in the mammary gland and its activity also 
determine the level of milk production and consequently affect lactation persistency. 
Once peak lactation has been achieved cell numbers decline, secretion drops and most, 
or all, of the secretory tissue involutes and lactation ceases. A favourable hormonal 
environment is required for continued cell survival and maintenance of secretion. A 
reduction in, for example, the amount of suckling as the young mature will affect 
persistency as prolactin levels change in response to changes in the physical stimulus 
of suckling and the pattern of milk removal from the gland. The maintenance of 
functional secretory cells is also important, particularly so during declining lactation, 
and the process of apoptosis has been detected in goat mammary tissue during 
involution (Quarrie et al, 1994). If this process of ’programmed cell death’ could be 
delayed by, for example, application of appropriate stimuli, then there could be a 
potential route for improved persistency by virtue of increasing the longevity of cells - 
reducing cell death and maintaining milk yields (Knight & Wilde, 1993). Seasonal 
factors such as photoperiod and temperature can also alter hormone secretion; reduced 
daylight and lower ambient temperatures are temporally correlated with decreasing 
prolactin concentrations in cows (Peters & Tucker, 1978). Photoperiodicity controls 
fertility in goats as they exhibit seasonal anoestrus, usually coinciding with the period 
of peak milk production (Shelton, 1978), and they ’come into season’ in the autumn 
when yields are dropping. Fertility and subsequent pregnancy both influence milk 
production during established lactation and this situation of concurrent pregnancy and 
lactation usually has a negative effect on milk production during the later stages of 
pregnancy, especially immediately pre partum. It can also reduce milk production 
during the subsequent lactation (Mizuno & Sensui, 1978; Knight & Wilde, 1988). The 
resumption of oestrus in rats, even without recurring pregnancy, causes yields to 
decline markedly (Flint et al, 1984b).
Imposed management effects are particularly important in breeds which have 
been selected for high, commercial milk production, particularly cows. Dairy herd 
calving is generally designed (and regulated by artificial insemination) to be 
concentrated over a few months, or more evenly spread through the year. Animals 
calving between January and July tend to produce less milk than those calving between 
August and December but the spring-calving cows may still be profitable for the
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farmer, dependent on the economic conditions at that time (Castle & Watkins, 1984). 
Cows are generally fed in slight excess during early lactation to minimise any 
nutritional constraints on peak lactation and they tend to be remated when yields are 
still relatively high (weeks 12-24). This pattern of concurrent pregnancy and lactation 
allows a reduction in the time that the animal is not lactating and consequently a 
’calving index’ of 360 to 380 days becomes possible (although a non-lactating period 
is required for optimising subsequent production) (Morris, 1976). This intensive and 
artificially regulated production system results in very high metabolic demands being 
placed on animals and even during the short non-lactating period they are providing for 
a rapidly growing foetus which places ever-increasing demands on them.
6.3 The potential for manipulation of lactation persistency
The secretory cell population
So to what degree are animal management techniques restricting lactation? If 
goats are not remated at the end of lactation and continue to be milked, milk secretion 
continues at a low level for several years with small seasonal oscillations, notably an 
increase in production in springtime and a nadir at midwinter. Total milk production 
gradually drops and lactation curves show decreasing variability in maximum and 
minimum yields (Linzell, 1973). Similar results are obtained in ovariectomised animals 
and the pattern could therefore reflect seasonal or nutritional influences. In rodents, 
lactation can be extended by continuing suckling; replacing rat litters every 10 days 
with a new-born litter can extend lactation from the usual 21 days to 70, although milk 
production is at a reduced level from day 20 onwards. This extension of lactation is 
possible due to a combination of events, for example, maintenance of a favourable 
hormonal environment and delayed involution of the mammary glands (Nicoll & 
Meites, 1959) and provides an avenue for manipulation of lactation. Closer study of 
secretory cell function during extended lactation in rodents shows that cell numbers are 
maintained and the gradual loss in secretory capacity is attributable to reduced cell 
activity (Nagasawa & Yanai, 1976) in contrast to the normal situation when there is a 
substantial loss of cells after peak lactation (Knight & Peaker, 1982c). In the former 
case there may be an increase in the amount of cell replacement or a reduction in the 
rate of cell death (extending cell life) but the overall effect is to substantially alter the 
lactation profile and change persistency. Reduction of cell loss has been achieved 
experimentally by a long-term increase in milking frequency (from twice to thrice-
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daily) in goats by a combination of increased cell proliferation and improved cell 
longevity (Wilde et al, 1987b). The latter effect is also seen in mice when litter 
swapping extends lactation (Shipman et al, 1987). There is some carry-over of 
secretory cells from one lactation to the next in rats (Pitkow et al, 1972), ruminant 
mammary gland size generally increases with parity (although this includes non- 
secretory tissue (Knight et al, 1994) and cows which do not have a dry period retain 
more cells than those which do (Pitkow et al, 1972). However, cows respond poorly 
to a shortening of the non-lactating period, possibly reflecting overall nutritional 
constraints rather than limitations on the secretory cells (Knight, 1989). If more cells 
can be carried over then there would be an increased stock of cells, increasing the 
overall production potential of the animal (Knight, 1989). So manipulation of the 
secretory cell population will potentially affect subsequent lactations, as well as the 
current lactation.
Prolactin
Decreasing prolactin concentrations are clearly a factor in reducing milk yields 
in rats (Flint et al, 1984) but direct administration of prolactin to elevate circulating 
concentrations has little effect on milk yield in cows (Plaut et al, 1987). Indirect 
elevation of prolactin can be successful; hypothalamically implanted perphenazine 
stimulates mammary development and initiates lactogenesis in rabbits (Mishkinsky et 
al, 1966), oestradiol-primed rats (Ben-David et al, 1965) and virgin goats (Vandeputte- 
Van Messom et al, 1976). Intravenous injection of perphenazine also stimulates 
mammogenesis, but does not affect milk yields during established lactation (Morag et 
al, 1971). Indications seem to be that perphenazine, hence prolactin, was stimulating 
mammary growth but not elevating milk production directly. However much of this 
work was carried out during early or mid-lactation when prolactin may not have been 
the limiting factor on secretion. If this was the case then increasing prolactin 
concentrations would not necessarily have had any effect. In late lactation, prolactin 
manipulation seems to be more effective in altering production, perhaps reflecting that 
this is the time when endogenous prolactin levels are dropping (Hart, 1972). 
Perphenazine sulphoxide given to late lactation ewes significantly reduces the rate of 
decline in yields (Morag et al, 1971) and a similar pattern is seen with hypothalamic 
perphenazine in goats, although there was an initial drop in yields due to the side- 
effects of surgery (Vandeputte-Van Messom & Peeters, 1982). Unfortunately in the
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studies cited above, no blood samples were collected and analysed for prolactin 
content, although Danon et al (1963) and Bryant et al (1968a,b) clearly show that 
perphenazine stimulates prolactin release both in vitro and in vivo. Hence, the full 
effect of perphenazine on circulating prolactin concentrations throughout a lactation, 
and any subsequent effects on milk production are yet to be determined.
Growth hormone
Growth hormone has a proven galactopoietic action and high yielding cows 
generally have higher growth hormone levels then lower yielding cows of the same 
species. Changes in milk yield are positively related to fluctuations in growth hormone 
(Hart & Morant, 1980) although both high- and low-yielding cows have similar insulin 
concentrations at peak lactation (Hart, 1983). When exogenous growth hormone is 
administered (often referred to as bST, bovine somatotropin) milk yields can be 
increased substantially and significantly and, in general, increases of between 10 and 
15% are commonly obtained in ruminants (Bines & Hart, 1982).
So how is growth hormone achieving this effect? It acts on metabolism in a co­
ordinated manner by redirecting (’repartitioning’) nutrients, rather than increasing the 
absolute nutrient supply of the animal in the short term. The effects of bST on milk 
production can be explained by more energy being directed towards the mammary 
gland, increasing milk production, with no overall increase in the gross energy intake 
of the animal. However this improvement in the ’efficiency of milk production’ is at 
the expense of other metabolic processes (Bauman et al, 1985). The repartitioning 
process is facilitated, in part, by increased blood flow delivering more substrates to the 
mammary gland (Mepham et al, 1984) and can be amplified by increasing milking 
frequency to further elevate milk yields in goats. For example, increases in milk yields 
of 18% (bST only) and 36% (bST and thrice-daily milking) are possible, contrasting 
with a rise of 8% with thrice-daily milking only (Knight et al, 1990). However growth 
hormone’s effects seem to be confined to influencing the plane of milk production and 
it does not appear to affect lactation persistency (the rate of decline in milk yields) 
(Bauman et al, 1985). However, other definitions of ’persistency’ may produce an 
apparent improvement, for example if persistency is measured as days of milk 
production before yield drops to a standard value, because peak yields are higher with 
growth hormone treatment.
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Oxvtocin
The question of whether or not oxytocin affects lactation persistency and if 
oxytocin’s effects are due merely to milk removal has given rise to debate. The first 
indications of a positive effect on persistency were seen in rats when mammary 
involution was delayed for up to nine days after litters were prematurely removed and 
mothers given oxytocin thrice-daily (Benson & Folley, 1957). Oxytocin was 
synergising with pituitary hormones as there was no effect when hypophysectomised 
animals were used but hormone replacement with a complex of prolactin, cortisol and 
oxytocin restored the delay in involution (Meites & Hopkins, 1961). The clearest 
evidence for an effect on persistency in ruminants is provided by Nostrand et a l{\99\) 
who administered oxytocin to cows immediately before every milking over a ten month 
period. Treated animals produced significantly more milk than controls and most of the 
increase was obtained by improved yields during declining lactation, improving 
persistency. In contrast, oxytocin given on alternate four day periods through lactation 
increased milk yields but did not significantly alter persistency (Sprain et al, 1954). 
However the statistics were carried out using group means and the authors noted that 
the best responses were obtained in animals with poor persistency records. A closer 
examination of the data may show that there was a persistency effect in this sub group. 
Normal milking was probably providing an inadequate stimulation of the milk ejection 
reflex, causing a more rapid decline in milk production due to increased involution 
(Knodt & Petersen, 1942). Incomplete milking of goats during late lactation also 
reduced persistency, probably due to short-term and local inhibitory effects on 
secretory cells (Wilde et al, 1989b) and longer term cell loss (Knight, 1989). If the 
sole effect of oxytocin was to increase the efficiency of milk removal from the gland 
there would be an absolute yield increase at the first oxytocin-assisted milking (as the 
gland was completely emptied for the first time) but no further effects. So how can 
oxytocin delay involution at the cellular level? It clearly improves the efficiency of 
milk removal from the alveoli and small ducts (Sagi et al, 1980b) and this may extend 
cell longevity and maintain activity, possibly due to local effects, as long as 
physiological doses are administered. Much of the data is equivocal about oxytocin’s 
effects, particularly on persistency, and more long-term studies are needed.
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7. AIMS OF THIS WORK
This thesis examined some of the influences on mammary gland function in 
goats. The overall aim was to investigate a variety of approaches which might allow 
lactation to be manipulated, and in particular to improve lactation persistency, the rate 
of decline in yield after peak lactation is achieved.
The potential for manipulation of mammary growth during either late gestation 
or immediately post partum (ie early lactation) was investigated. Two treatments were 
applied- exogenous growth hormone was given, and an attempt was made to stimulate 
compensatory growth by removing a single mammary gland at the start of the 
experimental period and monitoring the subsequent effects on the remaining gland. 
Milk yields obtained during lactation were recorded and various parameters were 
measured to determine if there had been mammary cell proliferation and differentiation, 
facilitating measurement of ’mammary function’ (Chapter 3).
An endocrine approach to manipulation of persistency was also attempted. A 
pharmacological agent, perphenazine, was used to stimulate prolactin’s circulating 
concentrations (Chapter 4) and exogenous oxytocin was given at milking to supplement 
endogenous release at that time (Chapter 5) in the hope that they would influence the 
duration of lactation and increase or maintain milk production, thereby altering 
persistency.
The local effects of altering the frequency and method of milk removal during 
early lactation and the consequences of this for later lactation and persistency were 
studied, with some groups being comprised of primiparous or multiparous animals to 
investigate the effect of parity on the response to treatment. Methods of suckling, 
draining, once- and thrice-daily milking were applied (Chapter 6).
Finally a comprehensive study of the lactational changes in casein composition 
in goat’s milk was carried out with the aim of elucidating whether or not this could 
provide an indirect marker for involution in the mammary gland, providing another 
method for the measurement of lactation persistency (Chapter 7).
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CHAPTER 2 
MATERIALS AND METHODS
1. INTRODUCTION
This chapter describes the methods commonly used in the experiments detailed 
in this thesis. Techniques used in specific experiments are detailed in the chapter 
describing that work.
All chemicals used, unless stated otherwise, were supplied by Sigma Chemical 
Company Ltd, by BDH (Merck Ltd), both Poole, UK or by Fisons Scientific 
Equipment, Loughborough, UK.
Radiochemicals were supplied by ICN Flow, High Wycombe, UK (125I-sodium 
iodide and 14C-sodium bicarbonate) and by DuPont (UK) Ltd, Stevenage, UK (UDP- 
[14C]-galactose).
Veterinary products and medications were supplied by Veterinary Drug 
Company, York, UK.
Single-distilled tap water was used throughout with the exception of the 
galactosyl transferase assay detailed in Chapter 3, when double-distilled water was used 
to re-equilibrate DOWEX resin filtration columns.
2. COLLECTION AND PREPARATION OF PLASMA SAMPLES
Individual blood samples of approximately 5ml were collected by jugular
venepuncture into a plastic syringe containing heparin (1000 IU/ml mucous injection).
Blood and heparin were mixed by inverting the syringe several times, cooled to 4°C
and plasma prepared by centrifuging the mixture (1800g, 15 minutes, 4°C). The
resulting supernatant (plasma) was removed and stored at -20°C until analysis for
hormone content.
When a series of samples was required the same procedure was followed with
the exception of blood being removed via an indwelling jugular cannula. 
Catheterisation was carried out at least one hour before the commencement of 
sampling; a short length of sterile medical grade polyethylene tubing (id 1.0mm, od 
1.5mm; Dural Plastics and Engineering Pty Ltd, Auburn, NSW, Australia) was
introduced into a jugular vein using an intravenous catheterisation set (Medicut 14g;
Sherwood Medical, Tullamore, Ireland) and sealed with a 3-way tap. After each
withdrawal of blood, an approximately equal volume of sterile saline solution (0.9%
NaCl) containing heparin (1000IU/100ml) was used to flush the cannula.
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3. HORMONE DETERMINATIONS
Heterologous double-antibody radio-immunoassays (antibodies raised against 
ovine hormones) were used for the quantification of caprine prolactin and growth 
hormone based on the method described by Vernon et al (1981).
3.1 Hormone standards
Ovine prolactin (AFP-9221A) and growth hormone (AFP-9220A) for biological 
studies (donated by the National Institute of Health, Bethesda, Maryland, USA) were 
used to prepare hormone standard solutions of 10/ig/ml in radio-immunoassay (RIA) 
buffer and stored at -20°C until use. Where undiluted plasma samples were assayed 
these standards were prepared in human low activity plasma (donated by the West of 
Scotland Blood Transfusion Service, Carluke, UK), otherwise RIA buffer was used. 
Standard curves were prepared by serial dilution of the highest standard in plasma or 
buffer, as appropriate, with concentrations typically ranging from 1.56-200 ng/ml for 
prolactin and 0.62-40 ng/ml for growth hormone.
3.2 Radio-immunoassay buffer
RIA buffer (pH 7.4) containing 0.05M sodium phosphate, 0.15M sodium 
chloride, 0.5% w/v bovine serum albumin (fraction V, RIA grade) and 0.05% w/v 
sodium azide was prepared for use in RIAs.
3.3 First antibody
Anti-ovine prolactin (AFP-C358109611 and AFP-973260) and anti-ovine growth 
hormone (AFP-C0123080) for radio-immunoassay (donated by NIH) were stored at 
1:100 dilution in 7.5% sodium bicarbonate solution and diluted in RIA buffer 
immediately before use. An effective concentration was determined by experimentation 
and optimally bound 30% of the total added radio-labelled hormone. Typical antibody 
dilutions of 1:60,000-75,000 for prolactin and 1:15,000-25,000 for growth hormone 
were used, 100/d contributing to a total assay volume of 300/d.
3.4 Second antibody
49.57% v/v RIA buffer, 49.57% v/v polyethylene glycol (using 16% PEG 
solution) and 0.012M ethylenediamine tetraacetic acid were mixed and pH adjusted to 
7.4. Then 0.83% v/v anti-rabbit (donkey) antibody and 0.03% v/v normal rabbit serum 
were added (both donated by the Scottish Antibody Production Unit, Carluke, UK).
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3.5 Radiolabelling of hormone
Radiolabelling was carried out using a method based on that described by 
Fraker and Speck (1978). Radioactive iodine (125I in sodium iodide) was incorporated 
into ovine prolactin (AFP-7150B), growth hormone (AFP-8758C) (both NIH) for 
iodination or bovine recombinant growth hormone (bST, Ml 1505178; Monsanto, St 
Louis, Missouri, USA) by use of IodogenTm (Pierce Europe BV, Oud-Beijerland, 
Netherlands). Approximately 5/ig protein (10/*1 at 0.5mg/ml in 7.5% sodium 
bicarbonate), 10/d phosphate buffer (0.5M, pH7.4) and 500 /xCi 125I were placed in an 
iodogen-coated microtube (30/d iodogen in 5 % w/v chloroform, evaporated to dryness) 
and incubated for 20 minutes. 100/d phosphate buffer was added and the mixture 
transferred to the top of a gel filtration column (Sephadex G-10 pre-soaked in RIA 
buffer; Pharmacia, Uppsala, Sweden). 200/d potassium iodide solution (2% w/v) was 
washed through the microtube and added to the column.
Iodinated hormone was eluted by addition of RIA buffer and the eluate 
fractionally collected. The radioactivity of each fraction was determined by monitoring 
with a Geiger counter (Mini-Instruments Ltd, Essex, UK). Percentage incorporation 
of 125I into prolactin or growth hormone was determined by precipitation with 
trichloroacetic acid solution (10%) of a fraction of known radioactivity as follows: 
acid precipitable radioactivity (protein-associated 125I)
= [pellet counts/initial counts] x 100
Fractions were pooled if necessary and diluted in RIA buffer until stock 
solutions varied from 100 000 to 300 000 cps per 100/d volume. Aliquots were stored 
at -20°C, behind lead, until use.
3.6 Radio-immunoassay of prolactin and growth hormone
Samples or standards (100/d) were incubated with first antibody (1st Ab, 100/d) 
for a minimum of 4 hours when assaying for prolactin and for approximately 24 hours 
when assaying for growth hormone. A tube containing no sample (B0) or 1st Ab (to 
determine non-specific binding), one containing only 125I-oPrl (’total counts’) and a 
’zero’ which contained no hormone were included in every assay. 100/d 125I-oPrl 
containing approximately 500cps/100/d, or 125I-oGH of approximately 300cps/100/d in 
RIA buffer were added, mixed and incubated overnight at room temperature. Second 
antibody was added (300/d), mixed, and further incubated for a minimum of 2 hours. 
All tubes were centrifuged (1800g, 30 minutes, room temperature) and the resulting
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supernatant decanted prior to counting (Gamma counter, 74% efficiency; Packard, 
Meriden, USA).
Inter-assay coefficients of variation were typically 10.3% for prolactin, and 
8.7% for growth hormone.
4. MILK COMPOSITIONAL ANALYSIS
4.1 Total solids
The solid content of a milk sample was determined by taking duplicate aliquots 
of freshly collected milk of known weight (approximately 1ml) and drying at 70°C until 
reaching a constant weight (after approximately 36 hours). The resulting milk solids 
were weighed, the difference representing the amount of liquid which had evaporated. 
Total solids content was calculated by dividing the total weight of the milk sample by 
the weight of solids present after drying, meaning duplicate samples, and multiplying 
by 100 to express total solids as a percentage of the whole milk sample.
4.2 Fat
The assay was carried out using the rapid fat method of Fleet and Linzell (1964) 
based on the separation of whole milk into a cream layer (white) and a serum layer 
(opaque) by centrifugation. The length of the cream fraction was expressed as a 
percentage of the total sample length and a correction factor applied to determine fat 
content as only 75 % of the cream layer was attributable to fat.
Freshly collected samples were incubated at 37°C for a minimum of 30 minutes 
and thoroughly mixed before drawing into duplicate capillary tubes (Hawksley, UK) 
and sealing with wax (Radiometer, Denmark). Tubes were centrifuged (lOOOOg, 15 
minutes, room temperature) and read within 15 minutes (Microhaematocrit centrifuge 
and reader, Hawksley). Duplicate measurements were made for every sample, 
readings averaged, and corrected by multiplying by 0.75 to determine percentage fat 
content.
4.3 Bradford protein
The method of Bradford (1976) was used to determine protein content by 
measuring the change in absorbance produced by a dye binding to protein. A protein 
standard curve was obtained by dilution of stock bovine serum albumin solution 
(containing 0.1 mg protein/ml) to give standards ranging from 1 to 10/xg protein.
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Freshly collected milk samples were diluted so that their protein concentrations could 
be determined from the standard curve. Dilutions of 1:350, 1:700 or 1:1400 milk in 
distilled water were used. The assay was carried out in 96-well micro-titration plates 
(Dynatec, Billinghurst, UK).
50/d aliquots of standards and samples were placed in duplicate wells, 240/d 
Bradford reagent added (20%, Bio-Rad Laboratories Ltd, Hemel Hempstead, UK) and 
incubated at room temperature for between 5 and 15 minutes. Absorbance of the 
coloured complex formed was monitored at 620nm (Titertek Multiskan MCC340 Mkll 
type 347, Labsystems, Basingstoke, UK) and protein concentration expressed as 
grammes of protein per 100ml milk.
4.4 Lactose
Lactose determinations were carried out using a Sigma diagnostic kit (510A) for 
measuring glucose. Milk samples were pre-incubated with /3-galactosidase, degrading 
lactose into glucose and galactose, allowing glucose to be assayed (see Figure 2.1).
Lactose standard solution (lOmM a-lactose in 0.1M sodium phosphate buffer, 
pH 7.3) was used to prepare a standard curve with concentrations ranging from 1 to 
5mM. Quality controls containing 0.5, 2,5 and 5mM lactose were prepared, 
subaliquotted and stored at -20°C until use, and run in every assay. Milk samples were 
diluted 1:40 in 0.1M sodium phosphate buffer.
The following were placed in a microtube, vortexed and incubated in the dark 
at 37°C for exactly 30 minutes:
400/il diluted milk sample, lactose standard or quality control 
70/d 0.1M Potassium phosphate buffer (pH 7.3)
20/d 0.1M Magnesium sulphate 
10/d /3-galactosidase
The reaction was stopped by addition of perchloric acid (100/d 4.2% v/v). 10/d 
aliquots of reaction mixture were placed in a 96-well micro-titration plate, 300/d 
Peroxidase/glucose oxidase/o-dianisidine solution added to each well and incubated for 
10 minutes at 37°C. Absorbances were read at 450nm and lactose content determined 
by reading from the standard curve after correction for dilution of the original milk 
sample.
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5. PHYSIOLOGICAL MEASUREMENTS
5.1 Total udder volume determination
Udder volumes were determined by water displacement based on the method 
of Linzell (1966). Goats were given exogenous oxytocin (400mU Oxytocin-S, Intervet, 
Cambridge, UK) by intravenous injection and immediately milked. They were then 
stood with their front legs elevated while the whole udder was gently immersed in a 
bucket of luke-warm water of known weight. The bucket was reweighed after this 
procedure, the weight of water displaced representing the udder’s volume. This was 
repeated (usually three times) until replicates were within lOOg of each other.
A second method of udder ’casting’ was also used (Dewhurst et al, 1993). 
Udders were shaved to remove excess hair, udder cream (’Starcare’, Lever Industrial, 
Runcorn, UK) applied liberally and the midline between the glands marked (Sprayline 
stock marker, Ritchley Tagg Ltd, Masham, UK). The udder was emptied by milking 
with oxytocin as before and was immediately casted in quick-set foam (Froth-PakR, 
Foampax Scotland, Newmilns, UK). Gross udder volumes were determined with 
material of known specific gravity by filling the cast to the position of the body wall. 
Individual gland volumes were measured by splitting the cast along the midline and 
remeasuring.
5.2 Cisternal and alveolar storage capacities
Cisternal milk volume was determined first (by catheter drainage), followed by 
alveolar milk volume, measured using the method described by Knight et al (1994). 
Teats were swabbed with 70% alcohol-2 % hibitane solution and locally anaesthetised 
(xylocaine gel 2%, Astra Pharmaceuticals, Kings Langley, UK). A sterile sheath from 
an intravenous cannulation set (Medicut 14g; Sherwood Medical, Tullamore, Ireland) 
was carefully introduced into the teat duct and canal until approximately 10mm of the 
cannula protruded. This allowed milk to flow freely from the gland without any further 
teat contact. Milk was collected and weighed to determine the volume removed. This 
procedure was carried out in a quiet environment and glands drained simultaneously, 
when possible, to minimise the chance of milk ejection. The milk flowing from the 
cannula was visually monitored for signs of milk ejection, characterised by a transient 
increase in flow rate and volume. Alveolar milk volume was determined immediately 
after cisternal drainage by administering iv oxytocin (400mU), hand-milking to remove 
the remaining milk and weighing the amount obtained. Cisternal percentage was 
calculated by dividing cisternal volume by the total amount of milk collected from the 
gland and multiplying xlOO.
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CHAPTER 3 
STIMULATION OF MAMMARY GROWTH IN  
PREGNANT AND LACTATING GOATS
1. INTRODUCTION
The mammary gland grows during pregnancy, exponentially so during late 
gestation, in preparation for the demands of the newborn. However mammary growth 
continues during early lactation, albeit at a slower rate (Knight et al, 1987). If this 
growth process could be enhanced either during pregnancy or early lactation then it 
might be possible to improve the production potential of an animal by increasing 
secretory cell numbers and their differentiation, resulting in a greater capacity for milk 
secretion.
The factors controlling and restricting mammary growth have not yet been fully 
elucidated; systemic hormones can be modulated by factors such as receptor numbers, 
the production of variants and the presence of circulatory binding proteins. Mediators 
of somatotrophic factors, for example, IGF, IGF-binding proteins and growth factors 
(eg. EGF, TGF and fibroblast GF) exert local paracrine and autocrine mitogenic effects 
(Collier et al, 1993). However other growth factors such as interferons and TGF-/3 
exert negative influences. Chalones were identified as cell cycle inhibitors in the 1960s 
but specific negative regulators have only recently been identified (for review see 
Johnson, 1994). Mammastatin, found in the cytoplasm, inhibits mammary cell 
proliferation (Ervin et al, 1989) but many inhibitors are present at the cell surface and 
may respond to cell-cell contact, including mammary-derived growth inhibitor and 
sialoglycopeptide inhibitor.
Nutrition of the animal, not only during pregnancy and lactation, but throughout 
life, especially around puberty, will also influence subsequent mammary development 
(Sejrsen, 1994). Genetic inheritance also plays a role- identical twins had similar rate 
constants for mammary growth although the stage of gestation had the greatest 
influence on mammary development (Swanson & Poffenbarger, 1979). So there are 
many factors which are acting to determine mammary size. The gland’s functional 
capacity can be estimated by determining the size and differentiative state of the cell 
population (by measuring DNA and specific enzyme activities, respectively). 
Incorporation of a thymidine analogue into DNA allows measurement of cell 
proliferation to be made and the monitoring of milk yields also indicates the extent of 
mammary function.
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The normal pattern for mammary growth in goats during pregnancy is one of 
an exponential increase in parenchymal volume which slows post-partum, then drops, 
while differentiation increases around parturition and remains at a higher level during 
lactation (Knight & Wilde, 1993). Stimulation of mammary growth has been achieved 
using growth hormone; in pre-pubertal heifers 15 weeks of treatment resulted in a 46% 
increase in parenchymal volume (Sejrsen et al, 1986). However growth hormone 
administered during late gestation to goats did not give a growth response or increased 
milk yield during the subsequent lactation (Lee & Forsyth, 1988). This contrasts with 
treatment during lactation when parenchymal volumes were increased over control 
glands (probably due to hypertrophy as 3H-TdR incorporation did not increase) and 
milk yields increased by 23% (Knight et al, 1990). It is still not clear whether these 
observations are due to hypertrophy, hyperplasia, or some combination of them both, 
and metabolic state also influences the effect of treatment.
The ’yield response’ to exogenous growth hormone is well known in lactating 
ruminants with increases of up to 30% in cows and goats (Bauman et al, 1985; Knight 
et al, 1990). This has been ascribed to increased blood flow reducing the restriction 
of substrate supply to the mammary gland in goats (Mepham et al, 1984), to alteration 
of IGF-I levels (Davis et al, 1989) and to the mobilisation of tissue reserves towards 
milk production (’nutrient partitioning’), among others. However these effects of 
growth hormone are limited to the period of treatment with little or no carry-over 
(Knight, 1992) and a detailed investigation of its effects on mammary cell proliferation 
and differentiation has not been conducted in goats.
It had been recognised by Turner et al (1963) that gross udder size was not as 
good a measure for ’glandular tissue’ as the determination of DNA content of the 
gland. They designed an experiment in which a cow udder half was removed before 
a 6 month treatment period, to serve as a control, and the remaining half removed post­
treatment. In all animals tissue weights increased (130-347%) as did total DNA (113- 
376%), suggesting that the removal of glands might be having an effect on the 
remaining ones. Linzell (1963) transplanted mammary glands in lactating Saanen goats 
and found that if the transplanted gland failed, the remaining gland showed increased 
growth (up to 62%) and in virgin goats which subsequently lactated, as much milk was 
produced from one gland as control animals did from both glands. It was hypothesised 
that the loss of a gland was detected by interruption of major blood vessels and nerves 
and there was a rapid compensatory response. However, others (Benson et al, 1965;
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Cowie et al, 1965) have argued that during lactation any ’compensatory growth’ 
reflects the release of lactogenic and steroid hormones rather than a growth stimulus 
per se.
This study compared the potential growth stimuli of hemimastectomy and 
exogenous growth hormone using goats in two reproductive states- late gestation and 
early lactation.
2. ANIMALS
British Saanen goats from the Institute herd were used. Hay and water were 
available ad libitum and animals were offered 1.0kg (when pregnant) or 1.5kg (when 
lactating) of a proprietary concentrated feed (Goat mix no.l, Edinburgh School of 
Agriculture, Edinburgh, UK) per day.
3. EXPERIMENTAL DESIGN
3.1 Experimental groups
Eighteen primiparous goats were selected on the basis of the time of mating and 
confirmed pregnancy and were randomly assigned to six groups containing three 
animals in each. Kidding dates ranged from 18th March-lOth April 1993.
3.2 Treatments
The experiment employed a 2x3 factorial design with factors of reproductive 
state (pregnant or lactating) and experimental treatment, namely growth hormone or 
hemimastectomy or no treatment (control). Treatment groups were abbreviated to PGH, 
PHX, LGH & LHX while two control groups were described as PC & LC.
Growth hormone (12 mg BST in sterile saline solution, gift of Monsanto, St 
Louis, USA) was given by subcutaneous injection every second day for 6 weeks, 
commencing 6 weeks before anticipated parturition in the PGH group, and immediately 
after parturition in the LGH group (referred to as the (GH) treatment period).
Hemimastectomies were performed 6 weeks pre-partum in the PHX group and 
within 4 days of parturition in lactating animals (LHX).
Bromodeoxyuridine (BrdU) (200mg in sterile saline) was given intravenously 
once every four days (a total of 7 doses) to all animals during the last 4 weeks of the 
treatment period to facilitate the measurement of cell proliferation.
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3.3 Measurements
Mammary gland biopsies were taken within 4 days of parturition in pregnant 
groups, and during lactation week 7 (within 4 days of the end of the treatment period) 
in lactating groups. During lactation week 5 (pregnant groups) or week 11 (lactating 
groups) ie. four weeks after the end of the treatment period, animals were euthanised 
and mammary glands removed for the collection of tissue and the measurement of 
gross and parenchymal tissue weights.
When lactating, all groups were milked twice daily at 0800 and 1600h and milk 
yields from individual glands were recorded.
4. METHODS
4.1 Surgical procedures
On the afternoon prior to surgery hay and concentrates were withdrawn from 
animals and only water was available {ad libitum) until after the procedure was 
completed. Immediately before surgery animals received oxytocin (lOOmU i.v.) and 
milk removed from mammary glands by hand milking.
Mammary gland biopsies and hemimastectomies were performed as described 
by Knight & Peaker (1984) and Knight (1987), respectively. Briefly, anaesthesia was 
induced with sodium pentobarbitone (Sagatal, May & Baker, Dagenham, UK) and 
animals were maintained on this during biopsy; secretory tissue was exposed by 
incision and blunt dissection and a small portion removed by electrocautery. For 
hemimastectomy, anaesthesia was maintained by administration of halothane in oxygen 
for the duration of the procedure. Mammary glands were separated along the mid-line 
by an initial incision and blunt dissection to the body wall. A second incision was made 
to include the teat and some skin of the gland to be removed, and then blunt dissection 
was used to separate it from the body wall. Blood vessels were ligated or cauterised 
until the gland could be completely removed. The space remaining after biopsy or 
hemimastectomy was filled by layering surrounding tissue into it and closing by the 
application of sutures. External sutures were removed between 10 and 14 days post- 
operatively. Penicillin was applied locally at the time of skin closure and flunixin 
meglumine and oxytetracycline (Finabiotic, Schering-Plough, Mildenhall, UK) was 
given by daily i.m. injection for three days after surgery.
47
4.2 Preparation of tissue
Biopsy samples were trimmed until only secretory tissue unaffected by 
electrocautery was present. Hemimastectomised glands were weighed, dissected until 
only parenchymal tissue remained, then reweighed. Samples of secretory tissue 
obtained by both procedures were wrapped in silver foil, stored in liquid nitrogen as 
quickly as possible after removal and later assayed for enzyme activities and DNA 
content. A further portion was placed in fixative (4% paraformaldehyde solution diluted 
1:1 with 0 .1M phosphate buffer, pH 7.4) and subsequently processed for measurement 
of BrdU incorporation.
4.3 Determination of enzyme activities
Preparation o f assay samples
Tissue samples were ground to a fine powder under liquid nitrogen and two 
portions accurately weighed out. Samples for galactosyl transferase assay were placed 
in 0.25M sucrose solution (1 part in 25) and homogenised (Polytron, 70% of maximum 
speed, 15 seconds). For other determinations, samples were placed in iso-osmotic Tris- 
sucrose buffer (1 part in 10) (containing 300mM sucrose, 30mM Tris-HCl, ImM 
EDTA and ImM reduced glutathione (GSH); pH 7.4), homogenised (45 seconds) and 
particle-free supernatant (PFS) prepared by centrifugation (1 lOOOrpm, 60 seconds). The 
homogenate was retained and frozen at -20°C without loss of activity (CJ Wilde, 
personal communication) for measurement of aryl esterase activity and DNA content 
and PFS was used for acetyl CoA carboxylase and fatty acid synthetase determinations 
(adapted from Wilde et al, 1986).
Details of the reactions catalysed by these enzymes are illustrated in Figure 3.1. 
Acetvl CoA carboxylase (ACC)
The process of fatty acid synthesis starts with a ’committed step’ reaction 
catalysed by acetyl CoA carboxylase [EC 6.4.1.2] (Scott & Eagleson, 1988). The 
enzyme’s activity was determined by addition of a radioactively labelled precursor to 
a reaction mixture and measuring its incorporation over a fixed incubation time using 
a modified version of the method described by Ingle et al (1973). Its activity was 
expressed as the number of nanomoles of bicarbonate incorporated per minute per gram 
of tissue.
Samples of PFS (150^1) were preincubated (30 minutes, 37°C) in 0.02ml 
distilled water and 0.33ml stock solution (200mM Tris/HCl, lOOmM MgCl2, 200mM
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Acetyl CoA carboxylase
Acetyl-CoA Malonlyl-CoA
BiotinCarboxy-biotin
ATP + bicarbonateADP + Pi
A
ACC
Malonlyl-CoAAcetyl-CoA
malonyl-ACP + CoAacetyl-ACP + CoA
acetoacetyl-ACP 
+ ACP + water
NADPH + H
Fatty acid synthetase
NADP
D-3 -hydroxybutyryl-ACP
B
galactosyl
UDP-galactose -
transferase —► galactose-P-(l—>4)-
-N-acetylglucosamine
N-acetylglucosamine UDP
C
a phenyl acetate + water aryl esterase ^ a phenol + acetate
(3-acetoxyindole) (indoxyl)
D
Figure 3.1 Summary of reactions catalysed by the enzymes: 
(A) Acetyl CoA carboxylase (B) Fatty acid synthetase 
(C) Galactosyl transferase & (D) Aryl esterase.
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citrate, ImM EDTA, 50 mg/ml BSA, lOOmM GSH; pH 7.3) in sealed vials. Assay 
solution (0.33ml) containing acetyl CoA (0.05ml of 4.45mM acetyl CoA), ATP (0.1ml 
of 50mM ATP; pH 7.5) and sodium bicarbonate (1.35/^Ci NaH14C 03 made to 25/xl 
with distilled water; specific activity 0.1-0.5 mCi/ml, ICN Flow, High Wycombe, UK) 
was warmed to 37°C with acetyl CoA omitted from blank reactions. The reaction was 
initiated by addition of 0.5ml assay solution to the pre-incubation solution, the mixture 
incubated (90 seconds, 37°C) and 5M HC1 (0.2ml) added to stop the reaction.
Unreacted sodium bicarbonate was removed by evaporation; samples were 
warmed (60 minutes, 55°C), ground dry ice added and mixed in tubes, and further dry 
ice added. Finally, scintillation fluid (10ml Emulsifier Safe, Packard, Meriden, USA) 
was added, the mixture thoroughly shaken and counted for 14C content (14C 4 minute 
counts; Packard 1600TR liquid scintillation analyser).
Fattv acid synthetase (FAS)
Fatty acid synthetase is a complex multifunctional protein and carries out 
elongation of fatty acid chains in the process of fat synthesis (Speake et al, 1975; Scott 
& Eagleson, 1988). The first reduction step catalysed by the enzyme produces NADP+ 
whose production can be monitored spectrophotometrically, giving a direct 
measurement of enzyme activity. However this reaction depends on the second 
reduction in the pathway being prevented by the absence of flavin. FAS activity was 
determined using a method based on that described by Speake et al (1975) and activity 
expressed as the number of micromoles of NADPH which were incorporated into 
product per minute per gram of tissue.
A solution containing PFS (25fj\ of PFS diluted 1 part in 5 with iso-osmotic 
Tris-sucrose buffer), NADPH (0.1ml of ImM NADPH, Boehringer Mannheim, Lewes, 
UK) and phosphate buffer (0.795ml of 0.25M KH2P04 containing 1.5mM EDTA and 
1.5mM GSH; pH 6.6) was pre-incubated for 5 to 10 minutes at 30°C and monitored 
by measuring absorbance at 340nm (Cecil CE5501 double beam UV 
spectrophotometer, Ambridge, UK). Once a stable baseline was obtained acetyl CoA 
was added (50/xl of 0.6mM acetyl CoA) and the reaction rate monitored. Once a steady 
rate was achieved, malonyl CoA was added (30^ ul of 1.3mM malonyl CoA) and 
absorbance measured.
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Galactosyl transferase (GT)
Galactosyl transferase [EC 2.4.1.22] is composed of catalytic and modifier 
subunits, the latter being the whey protein a-lactalbumin, and it catalyses the 
production of lactose. However, in the absence of the modifier subunit GT adds 
carbohydrate to glycoproteins. Disruption of the Golgi membranes allows free access 
of substrates to the enzyme complex and its activity can be determined by incorporation 
of a radiolabelled precursor into the end-product (Kuhn & White, 1977; Stryer, 1988). 
GT activity was assayed using the method of Kuhn & White (1977) and expressed as 
the number of micromoles of galactose incorporated per minute per gram of tissue.
Reaction mixture (25/d of 2:2:1 ratio of 0.2M TES, 150mM MnCl2 and 5 % v/v 
Triton X-100), UDP-[14C]-galactose (5/d of 5mM UDP-gal. containing approximately 
25000dpm, DuPont Ltd, Stevenage, UK) and N-acetyl glucosamine (10/d of 0.1M 
NAG) were added together and incubated for 10 minutes at 37°C. The latter was 
omitted from reaction blanks. The reaction was initiated by the addition of sample 
(10/d homogenate), incubated (10 minutes, 37°C) and stopped by placing tubes in a 
boiling water bath for 90 seconds. The resulting solutions were placed on ice, distilled 
water added (50/d) and transferred to the top of a DOWEX resin column (formate 
form, 400 mesh, 4% crosslinking) with reaction tubes washed twice with further 
distilled water (2 x 100/d), the washings also being transferred to the column. Reaction 
product was eluted with 1ml distilled water, the eluate collected, 10 ml scintillation 
fluid added and the resulting solution counted for 14C content.
Aryl Esterase (AE)
Aryl esterase [EC 3.1.1.2] is not involved in lactational metabolism (Knight et 
al, 1992) and originates from the rough endoplasmic reticulum of a cell. It is found in 
microsomal cell fractions and can be used as a specific marker for microsomes. 
Addition of substrate to the enzyme forms a product which can be measured 
spectophotometrically and hence enzyme activity determined. The method used was 
described by Shephard & Hubscher (1969) and AE activity expressed as the number 
of micromoles of indoxyl produced per minute per gram of tissue.
Homogenate (40/d), phosphate buffer (1.0ml of 0.1M KH2P 04; pH 6.8) and 
distilled water (120/d) were pre-incubated for 5-10 minutes at 37°C and absorbances 
measured at 386nm. Once a steady baseline was obtained 40/d indoxyl acetate was 
added (25mM in 50% ethanol) and the resulting change in absorbance measured.
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4.4 Determination of DNA content
DNA was assayed using the method of Labarca and Paigen (1980) with 
concentrations determined from a standard curve and the DNA in samples expressed 
as milligrams per gram of tissue.
Homogenates in iso-osmotic Tris-sucrose buffer were further sonicated (20KHz 
Kontes microultrasonic cell disrupter, Burkard Scientific, Uxbridge, UK) in 20 second 
blocks, with cooling, for a total of one minute. Samples were diluted appropriately 
with assay buffer (2M NaCl, 0.1M NaH2P04; pH 7.4, buffer filtered through 2pm 
membrane). DNA standards in assay buffer were prepared from bovine thymus DNA 
(1 mg/ml in dH20 , diluted to lO^g/ml with assay buffer). 1ml aliquots of sample or 
standard were taken in duplicate, 0.5ml fluor solution added (lmg/ml bisbenzimide in 
water, diluted to 3/ig/ml with assay buffer) and incubated for 15-20 minutes at room 
temperature before determination of fluorescence (Fluorometer, Hoefer Scientific, San 
Fransisco, USA).
4.5 Determination of BrdU incorporation
Preparation o f  tissue
Tissue was fixed for a minimum of 2 hours in fixative then dehydrated in a 
graded series of ethanol and cleared using histoclear (National Diagnostics, Atlanta, 
USA). Samples were mounted in moulds using four changes of wax (RA Lamb, 
London, UK) and after solidifying they were removed from the moulds, cut and 
mounted on embedding stubs (Agar Scientific Ltd, Stansted, UK). Subsequent 
sectioning was carried out using a 2040 autocut microtome (Cambridge Instruments 
GmbH, Nussloch, Germany) and glass cutting blades (histology grade, Agar Scientific).
Visualisation o f BrdU
The protocol used to measure BrdU incorporation was that recommended by 
DAKO a/s (Glostrup, Denmark) for fixation and staining of tissue, and detecting with 
monoclonal mouse anti-bromodeoxyuridine (clone Bu20a).
Poly-L-lysine-coated microscope slides were prepared by cleaning in acid 
solution (10% w/v potassium chromate, 10% concentrated sulphuric acid v/v) 
overnight, rinsing thoroughly in water and incubating in poly-L-lysine solution (10%).
Tissue sections were placed on poly-L-lysine-coated slides, pre-incubated (60°C) 
and circled with a ’PAP pen’ (Agar Scientific Ltd). Samples were rehydrated by
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incubation in histoclear followed by a graded series of ethanol.
Endogenous peroxidase activity was quenched (1% hydrogen peroxide in 
methanol) and the DNA present partially denatured with 2M HC1 to facilitate antibody 
binding. The reaction was stopped by addition of sodium borate solution (0.1M, pH 
8.5) and sections incubated with protease (0.25 mg/ml in TBS) to unmask antigenic 
binding sites by proteolysis. Incubation in avidin (0.05 mg/ml in 0.05M Tris/HCl, pH 
7.4) followed by biotin (0.05 mg/ml in 0.05M Tris/HCl, pH 7.4) was carried out to 
block endogenous avidin-binding activity. A further incubation in normal rabbit serum 
(10% in 0.05M Tris/HCl, pH 7.2) was used to block any non-specific background 
binding.
BrdU incorporation was detected and visualised by sequential incubation, and 
TBS rinsing, in the following: mouse anti-BrdU antibody (2.5% in Tris/HCl, pH 7.2), 
biotinylated rabbit anti-mouse immunoglobulin (0.1 % in 0.05M Tris/HCl, pH 7.2) and 
avidin-biotin-peroxidase DAKO ABComplex/HRP kit). Staining was carried out by 
application of 3,3-diaminobenzidine tetrahydrochloride (0.5mg/ml DAB in TBS 
containing 0.03% H20 2 v/v) followed by Mayer’s hematoxylin. Tissue was destained 
(1 % HC1 in 95% ethanol), dehydrated through a graded series of ethanol then mounted 
with coverslips using DPX mounting medium and allowed to dry overnight before 
photographing under magnification (x660).
4.6 Statistical analysis
Data were analysed using the General Linear Model ANOVAR procedure 
(SASS). Factors in the model were liveweight, stage (pregnant or lactating) and 
treatment (control, hemimastectomy and growth hormone).
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5. RESULTS
5.1 Milk yields
Average daily gland yields for pregnant (Figure 3.2) and lactating (Figure 3.3) 
treatment groups were determined during lactation until the end of the experiment. 
Both hemimastectomised groups increased gland yields to above 1.7 1/d post partum, 
in contrast to control and growth hormone groups which achieved a peak yield of 1.40 
1/d. There was no difference between left and right glands of the latter groups so the 
average yield of both glands was calculated and used in statistical analyses. In lactating 
groups the analysis was based on yields obtained in the last 15 days of the treatment 
phase as earlier yields were compounded by the effect of surgery (LHX group).
There was a significant effect of treatment of milk yield but no effect of 
liveweight or stage, and no significant interaction between treatment and stage (Table 
3.1). Hemimastectomy increased milk yields whether the gland was removed during 
pregnancy or lactation, with a peak yield of 1.71 1/d achieved in PHX compared to
1.05 1/d in controls. There was no apparent effect of growth hormone treatment on 
yield, which was contrary to our expectations. Examination of milk yields (Figure 3.2) 
indicated a decrease in the yield of LGH goats following the cessation of treatment. 
When this post-treatment yield difference between PC and PGH was included as a 
covariate in the analysis, the corrected mean yields were 1.23 (LC) and 1.42 (LGH) 
1/d, indicating a yield response to treatment. This difference, although numerically 
greater than uncorrected yields, did not achieve statistical significance.
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Figure 3.2 Average daily milk yields from individual glands in 
pregnant control (PC), pregnant hemimastectomised (PHX) and pregnant 
growth hormone-treated (PGH) groups. The GH treatment phase lasted 
from 42 days (6 weeks) pre-partum until parturition. Biopsies o f mammary 
tissue were obtained within 4 days of parturition and final samples were 
obtained during lactation week 5, a minimum of 4 weeks post-treatment.
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Figure 3.3 Average daily milk yields from glands in lactating control 
(LC), lactating hemimastectomised (LHX) and lactating growth hormone- 
treated (LGH) groups. The GH treatment phase lasted from parturition for 
42 days (6 weeks o f lactation). Biopsies o f mammary tissue were obtained 
within 7 days of the cessation o f treatment and final samples were obtained 
in lactation week 11 (a minimum of 4 weeks post-treatment).
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Milk yield (1/d/gland)
Source Stage Treatment
Factor Pregnant Lactating Control HX GH
mean
(SEM)
1.32
(0.10)
1.27
(0.10)
1.13
(0.12)
1.56
(0.11)
1.19
(0.11)
P n.s. - 0.022 n.s.
PC PHX PGH LC LHX LGH
1.05
(0.15)
1.71
(0.16)
1.19
(0.17)
1.21
(0.18)
1.41
(0.16)
1.20
(0.16)
- 0.012 n.s. - n.s. n.s.
Table 3.1 Milk yields during lactation for control goats (PC/LC), for
goats hemimastectomised during pregnancy (PHX) or during lactation 
(LHX), and for goats treated with growth hormone during pregnancy 
(PGH) or lactation (LGH). Values are least squares means and sems were 
calculated from pooled data. Significance levels are comparisons relative to 
the appropriate control group.
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5.2 Liveweight
Gross body weights were measured at the end of the experimental period and 
meaned for each treatment group. Control goats had the highest weights (PC 40.2 ±  
3.7, LC 46.0 ± 2.1 kg) when compared to the other treatment groups with 
hemimastectomised animals being of intermediate weight (PHX 38.8 ±  2.0, LHX 43.0 
± 2 . 3  kg). Growth hormone-treated groups had the lowest mean weights (PGH 37.2 
±  2.0, LGH 39.7 ±  0.4 kg) but none of these differences were statistically significant. 
The higher weights in the lactating groups compared to the equivalent pregnant groups 
reflects that their liveweight measurements were made 6 weeks later than the pregnant 
groups (in lactation weeks 11 & 5 respectively).
5.3 Mammary gland weight
Total gland weight and parenchymal tissue weight were determined in all 6 
groups four weeks after the end of the treatment phase (Figure 3.4) and statistical 
analysis conducted (Table 3.2). Estimates of parenchymal DNA were also made (Table 
3.2B).
Total gland weight was related to liveweight (p< 0.002), confirming previous 
observations (Sejrsen, 1994). Effects of treatment on parenchymal tissue and 
parenchymal DNA were also found (p<0.01). Hemimastectomy provided the most 
potent stimulus for mammary growth with total gland, parenchymal tissue and DNA 
significantly increased over controls (p< 0.004). The largest difference was seen during 
pregnancy, supporting the increased milk yield at this time, but there was no 
statistically significant interaction of treatment*stage indicating that surgery could be 
performed pre- or post-partum and elicit a similar effect.
Growth hormone during pregnancy stimulated parenchymal tissue growth and 
a positive effect of treatment was seen on parenchymal DNA levels (p<0.05). 
However this was not apparent when individual pregnant and lactating groups were 
compared. Growth hormone administered during lactation had little effect on the 
amount of mammary tissue with values similar to controls. It appeared to be having a 
limited effect on the secretory cells of the mammary gland, but there was a small 
stimulation during pregnancy, confirming the measurements of milk yield. However 
these changes were small in comparison to the stimulation achieved by 
hemimastectomy.
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Figure 3.4 Least square mean values for gross gland weights (open 
bars) and parenchymal tissue weights (hatched bars). Goats were either 
controls, hemimastectomised or given growth hormone during pregnancy 
(PC,PHX, PGH) or during lactation (LC, LHX, LGH). Error bars indicate 
standard errors for each group. These measurements were made four weeks 
after the end of the treatment phase (10 weeks after hemimastectomy). 
Statistical analysis of this data is illustrated in Table 3 .2 A.
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A
Significance levels 
Gross gland weight (g)
Source Stage Treatment
Factor Pregnant Lactating Control HX GH
P n.s. - 0.0002 n.s.
PC PHX PGH LC LHX LGH
- 0.0003 n.s. ~ 0.012 n.s.
Parenchymal tissue weight (g)
Source Stage Treatment
Factor Pregnant Lactating Control HX GH
P n.s. - 0.0002 n.s.
PC PHX PGH LC LHX LGH
- 0.0001 0.022 - n.s. n.s.
B
Parenchymal DNA (mg)
Source Stage Treatment
Factor Pregnant Lactating Control HX GH
mean
(SEM)
1716.8
(156.1)
1972.1
(156.1)
1286.6
(189.0)
2236.4
(175.0)
2010.4
(190.4)
P n.s. - 0.004 0.029
PC PHX PGH LC LHX LGH
1417.6
(248.0)
2295.5
(271.5)
2203.1
(271.5)
1155.5
(295.0)
2177.3
(256.2)
1817.8
(250.4)
- 0.030 n.s. - 0.017 n.s.
Table 3.2 Statistical analysis of total gland and parenchymal tissue
weights (A) and parenchymal DNA (B) in control (PC/LC), hemimastectomised 
or growth hormone during pregnancy (PHX, PGH) or lactation (LHX, LGH). 
Significance levels quoted are relative to the appropriate controls.
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5.4 Cell proliferation
Cell number (per mm2) was used as an estimate of cell size while the number 
of labelled cells (stained with BrdU, see Plate 3.1) and the percentage of labelled cells 
were used as markers for cellular proliferation. Measurements were made in samples 
obtained at biopsy (6 weeks after hemimastectomy / immediately after the cessation of 
GH treatment) and at the end of the experiment (final sample), 4 weeks after biopsies 
were taken . The results are shown in Tables 3.3 and 3.4.
There was a significant interaction between biopsy, biopsy *treatment and 
biopsy*stage (p<0.01) on total and labelled cell number.
The percentage of labelled cells was also affected by biopsy (p=0.001), stage 
(p=0.001) and biopsy*stage (p < 0.005). The ’biopsy effect’ reflected a general loss 
of cells (both unlabelled and BrdU labelled) in the period between biopsy and final 
samples while the stage interaction indicated a significant and positive effect of 
pregnancy on the degree of cellular proliferation compared to lactating tissue.
There was no apparent proliferative response to hemimastectomy with values 
similar to controls, surprising as there was a clear increase in mammary gland size and 
parenchymal tissue. This apparent discrepancy could be explained if there was an early 
proliferative response soon after the removal of the gland which occurred in the period 
before BrdU was administered. Growth hormone treatment increased total cell number 
(p=0.059), significantly so when PGH and PC biopsy samples were compared 
(p=0.013), but little effect was seen when it was administered during lactation. This 
again supports our measurements of gland size and milk yield.
5.5 Cell differentiation
Assessment of cellular differentiation was made by determining DNA 
concentrations in biopsy and final samples (Table 3.5), and measuring the enzyme 
activities of three ’key milk enzymes’- acetyl Co A carboxylase (ACC), fatty acid 
synthetase (FAS) (Table 3.6) and galactosyl transferase (GT), and one ’control’ enzyme 
(aryl esterase, AE) (Table 3.7).
DNA concentrations were significantly affected by an interaction with biopsy 
(p=0.005)- higher concentrations being associated with final samples. An interaction 
with stage was also found for FAS (p=0.03) although there were no other significant 
interactions for the other enzymes.
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Total cell number (per mm )
Source: Time Stage Treatment
Factor: Sample Pregnant Lactating Control HX GH
Biopsy 417.6 478.0 357.2 415.9 321.4 515.4
Final 326.6 292.6 360.6 325.3 335.2 319.2
(SEM) (19.5) (27.6) (33.8)
p biopsy - 0.009 - n.s. n.s.
final n.s. - n.s. n.s.
Group: PC PHX PGH LC LHX LGH
Biopsy 452.8 331.8 649.3 379.0 311.0 381.5
Final 284.7 295.0 298.2 366.0 375.5 340.5
(SEM) (47.8)
p biopsy - n.s. 0.013 - n.s. n.s.
final - n.s. n.s. - n.s. n.s.
B
BrdU-labelled cell number (per mm2)
Source: Time Stage Treatment
Factor: Sample Pregnant Lactating Control HX GH
Biopsy 28.08 48.89 7.28 24.42 22.17 37.67
Final 8.56 14.50 2.61 7.75 9.83 8.08
(SEM) (0.92) (1.6) (1.60)
p biopsy - 0.0001 - n.s. n.s.
final 0.0001 - n.s. n.s.
Group: PC PHX PGH LC LHX LGH
Biopsy 42.50 34.17 70.00 6.33 10.17 5.33
Final 11.83 18.67 13.00 3.67 1.00 3.17
(SEM) (2.20)
p biopsy - 0.0225 0.0001 - n.s. n.s.
final - n.s. n.s. - n.s. n.s.
Table 3.3 Total number of cells (A) and BrdU-labelled cells (B) in control
(PC/LC), hemimastectomised or growth hormone groups during pregnancy (PHX, 
PGH) or lactation (LHX, LGH). Values are least square means and sems are for pooled 
data. Significance levels are comparisons relative to the appropriate control group.
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Percentage labelled cells (%)
Source: Time Stage Treatment
Factor: Sample Pregnant Lactating Control HX GH
Biopsy 6.44 10.54 2.34 5.69 7.00 6.63
Final 2.94 5.06 0.82 2.64 3.48 2.72
(SEM) (0.40) (0.60) (0.69)
p biopsy - 0.0001 - n.s. n.s.
final 0.0002 - n.s. n.s.
Group: PC PHX PGH LC LH X LGH
Biopsy 9.68 10.40 11.52 1.71 3.59 1.73
Final 4.10 6.67 4.43 1.18 0.29 1.00
(SEM) (0.98)
p biopsy - n.s. n.s. - n.s. n.s.
final n.s. n.s. n.s. n.s.
Table 3.4 Percentage of BrdU-labelled cells in control goats 
(PC/LC), and those hemimastectomised or given growth hormone during 
pregnancy (PHX, PGH) or lactation (LHX, LGH). Values are least square 
means and sem’s quoted are for pooled data. Significance levels are relative 
to the appropriate control groups.
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DNA concentration (mg/g)
Source: Time Stage Treatment
Factor: Sample Pregnant Lactating Control HX GH
Biopsy 3.48 3.37 3.60 3.10 3.28 4.07
Final 4.91 4.81 5.01 4.33 5.05 5.35
(SEM) (0.29) (0.41) (0.51)
p biopsy - n.s. - n.s. n.s.
final n.s. - n.s. n.s.
Group: PC PHX PGH LC LHX LGH
Biopsy 2.13 2.97 5.00 4.07 3.60 3.13
Final 4.63 4.50 5.30 4.03 5.60 5.40
(SEM) (0.72)
p biopsy - n.s. 0.015 - n.s. n.s.
final - n.s. n.s. - n.s. n.s.
Table 3.5 DNA concentrations for control (PC/LC) goats, those 
hemimastectomised during pregnancy (PHX) or lactation (LHX), or given 
growth hormone during pregnancy (PGH) or lactation (LGH). Values are 
least square means and sem’s for pooled data. Significance levels are 
comparisons to the appropriate sample of the control group
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A
Acetyl CoA carboxylase activity (nmol/mg DNA)
Source: Time Stage Treatment
Factor: Sample Pregnant Lactating Control HX GH
Biopsy 11.83 11.68 11.98 12.63 15.02 7.85
Final 11.42 13.73 9.10 9.87 13.87 10.52
(SEM) (1.40) (1.97) (2.42)
p biopsy - n.s. - n.s. n.s.
final n.s. - n.s. n.s.
Group: PC PHX PGH LC LH X LGH
Biopsy 16.87 15.40 2.80 8.40 14.63 12.90
Final 11.33 17.63 12.23 8.40 10.10 8.80
(SEM) (3.42)
p biopsy - n.s. 0.013 - n.s. n.s.
final - n.s. n.s. - n.s. n.s.
B
Fatty acid synthetase activity (pmol/mg DNA)
Source: Time Stage Treatment
Factor: Sample Pregnant Lactating Control HX GH
Biopsy 0.86 1.05 0.67 0.92 1.04 0.63
Final 0.98 1.35 0.62 0.95 1.06 0.94
(SEM) (0.11) (0.15) (0.18)
p biopsy - n.s. - n.s. n.s.
final
Group: PC PHX PGH LC LHX LGH
Biopsy 1.36 1.45 0.35 0.47 0.64 0.91
Final 1.25 1.60 1.20 0.65 0.52 0.68
(SEM) (0.26)
p biopsy - n.s. 0.018 - n.s. n.s.
final n.s. n.s. n.s. n.s.
Table 3.6 ACC (A) and FAS (B) enzyme activities for control goats (PC/LC) or those 
hemimastectomised or given growth hormone during pregnancy (PHX, PGH) or during 
lactation (LHX, LGH). Values are least square means. Significance levels are relative to 
the appropriate controls.
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A
Galactosyl transferase activity (p mol/mg DNA)
Source: Time Stage Treatment
Factor: Sample Pregnant Lactating Control HX GH
Biopsy 021 0.28 0.26 0.28 0.32 0.20
Final 0.33 0.37 0.28 0.34 0.32 0.31
(SEM) (0.02) (0.03) (0.04)
p biopsy - n.s. - n.s. n.s.
final n.s. - n.s. n.s.
Group: PC PHX PGH LC LH X LGH
Biopsy 0.39 0.33 0.11 0.18 0.31 0.28
Final 0.36 0.42 0.34 0.32 0.22 0.28
(SEM) (0.06)
p biopsy - n.s. 0.006 - n.s. n.s.
final - n.s. n.s. - n.s. n.s.
B
Aryl esterase activity (pmol/mg DNA)
Source: Time Stage Treatment
Factor: Sample Pregnant Lactating Control HX GH
Biopsy 0.73 0.97 0.49 1.06 0.63 0.50
Final 0.45 0.46 0.44 0.58 0.35 0.43
(SEM) (0.10) (0.14) (0.18)
p biopsy - 0.038 - n.s. 0.045
final n.s. - n.s. n.s.
Group: PC PHX PGH LC LHX LGH
Biopsy 1.60 0.82 0.50 0.53 0.44 0.51
Final 0.56 0.39 0.43 0.59 0.31 0.42
(SEM) (0.25)
p biopsy - 0.048 0.009 - n.s. n.s.
final - n.s. n.s. - n.s. n.s.
Table 3.7 GT (A) and AE (B) enzyme activities for control goats (PC/LC) or
those hemimastectomised or given growth hormone during pregnancy (PHX, PGH) or 
during lactation (LHX, LGH). Values are least square means and sem’s were calculated 
from pooled data. Significance levels are relative to the appropriate controls.
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Hemimastectomy had no apparent effect on the level of differentiation with 
values similar to controls throughout. The single exception was aryl esterase (which 
is not involved in milk synthesis) in the biopsy sample of the PHX group when it was 
lower than controls (p=0.048), this was also seen in PGH (p=0.009) so probably did 
not reflect a treatment effect per se. The similarity in results to control groups shows 
that the cell population in hemimastectomised animals was well differentiated and 
suggested that there had been no measurable proliferative response during the 
measurement period which would have resulted in new and relatively undifferentiated 
cells.
DNA concentrations increased when growth hormone was given during 
pregnancy (p=0.015) but this was only apparent in biopsy samples and no effect was 
seen during lactation. Enzyme activities were significantly lower in PGH compared to 
PC groups (p< 0.018), but these subsequently increased and were not significantly 
different to control levels in final samples, collected 4 weeks later. This suggested that 
there was a population of relatively undifferentiated cells present at biopsy 
(immediately after the cessation of treatment), also detected by the increased DNA 
concentration, and that the secretory cell population became more mature over the next 
four weeks, achieving a level of differentiation similar to those of the other groups.
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6. DISCUSSION
Hemimastectomy in late pregnancy had a significant stimulatory effect on milk 
yield post partum with a peak yield of 1.96 1/d compared to 1.23 1/d in controls and 
1.40 1/d in growth hormone-treated groups. When hemimastectomised shortly post 
partum yields again increased to a peak of 1.711/d while control and growth hormone 
groups achieved 1.50 and 1.40 1/d, respectively. This increased milk production was 
supported by increased mammary size and parenchymal tissue weight in both 
reproductive states although the effects were more pronounced during pregnancy, and 
consequently these groups had the highest gland DNA contents. HMX was associated 
with the lowest cell numbers per mm2 in biopsy samples, indicating that cells tended 
to be larger in size and the percentage incorporation of BrdU was above that of 
controls showing that there had been a proliferative response. It must be borne in mind 
that in this group the biopsy sample was taken 6 weeks, and final samples 10 weeks, 
after surgery was performed, giving ample time for both proliferation and subsequent 
differentiation of cells to occur. These observations were supported by the 
measurements of enzyme activity; milk enzyme activities in PHX were higher than PC 
in final samples and LHX were also higher than controls in biopsy samples, indicating 
that cellular differentiation had indeed occurred. So hemimastectomy was successful 
in stimulating a ’compensatory growth’ response, particularly so during late gestation, 
indicating a considerable plasticity in the growth pattern of the mammary gland. 
Restrictions on mammary size include the level of gland development during puberty, 
gross body weight, partly limited by the size of the mammary fat pad, by steroid 
hormones (particularly oestradiol) and modulated by tissue sensitivity (via receptors) 
to a variety of factors, among others (Sejrsen, 1994). The results presented here 
support the phenomenon of compensatory growth when the animal ’senses’ damage or 
loss of the mammary gland, allowing lactation to proceed with a reduced but adequate 
supply of milk available for the new bom, improving their chances of survival.
Growth hormone increased yields only during the treatment period in lactating 
goats, but when given during gestation there was a carryover effect of increased yield 
in the post-treatment period. The latter observation corresponded with increased 
mammary gland, parenchymal tissue weights, and therefore total DNA content (also 
confirmed by significantly increased DNA concentration in biopsy samples). BrdU 
incorporation and the percentage of labelled cells were also elevated showing that there 
had been a marked proliferative response. However these cells were relatively
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undifferentiated in terms of milk synthesis, shown by depressed enzyme activities. 
However in final samples these had increased to control levels showing that there was 
a differentiative response, albeit delayed.
When growth hormone was given during lactation there were no significant 
stimulatory effects on mammary growth, either gross or on cell numbers, supporting 
the observation that the alteration in milk yield was short-term and restricted to the 
treatment period. However this raises the question of how the increase in milk yield 
during treatment was possible? Measurements of milk enzyme activity at biopsy 
showed an increase compared to controls, an effect absent in final samples- 4 weeks 
after treatment had stopped, suggesting that improved production was due to increased 
enzyme activity and cellular differentiation.
Growth hormone is mammogenic in pregnant goats and this is supported by in 
vitro observations of GH and somatomedins stimulating proliferation and 
differentiation, respectively, of certain cell types. The latter synergise with PDGF and 
EGF to promote fibroblast cell division and other cell types probably require other 
combinations of growth factors for mitogenesis (Wallis, 1985). The lactation response 
was not mammogenic and apparently reflected improved milk secretion in the existing 
cell population. This may have, in turn, be supported by improved substrate supply and 
nutrient partitioning towards the mammary gland but we have no evidence to support 
this hypothesis, although the general effect has been well documented (Bauman & 
Currie, 1980).
There was a clear difference in response to treatment in the two reproductive 
states investigated- late gestation and early lactation, most probably influenced by 
hormonal changes. One important hormonal difference is the presence of placental 
lactogen during pregnancy. This hormone is mammogenic in cows (Byatt et al, 1994) 
and sensitive to the requirements of the foetus (Hayden et al, 1979) and could 
synergise with other hormones and factors to enhance mammary growth, however it 
is absent during lactation. The rapid drop in progesterone at parturition and parturition 
itself, may also signal a change in mammary gland responsiveness to various hormones 
and factors and lactation is associated with the regular release of lactogenic hormones 
and oxytocin when suckling or milking occurs. A further factor in the different 
’reproductive responses’ will be the increasingly high level of foetal demand for 
nutrients in late gestation while in early lactation these are redirected towards the 
mother, facilitating lactogenesis.
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Bines & Hart (1981) said that the "potential of the (bovine) mammary gland to 
synthesise milk probably is determined fully at parturition" and to an extent this is true 
for growth hormone. When given during lactation it improved the ’efficiency’ of milk 
production rather than increasing the cell population so that could be seen as fulfilling 
the potential of the gland. However hemimastectomy shortly after parturition showed 
that the mammary gland still retains the capacity for growth and so application of 
appropriate stimuli could further enhance milk production post partum.
The long term effects of these treatments were not investigated in this study but 
effects on lactation persistency could be postulated, especially if the pattern of 
mammary growth has been altered, as seen with hemimasectomy and to a lesser extent 
with growth hormone during pregnancy. Growth hormone and IGF-1 suppress plasmin 
activity in milk, and the elevation of circulating IGF-1 by exogenous bST and IGF-1 
reduces plasminogen activator secretion in bovine mammary cells (Turner, 1991). This 
suggests that there might be reduced proteolysis and remodelling of the mammary 
gland which in turn could maintain secretory function during declining lactation.
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CHAPTER 4
THE INFLUENCE OF PROLACTIN ON LACTATION PERSISTENCY
1. INTRODUCTION
In ruminants, prolactin concentrations are high during early and peak lactation 
but subsequently decline over the remainder of lactation. This pattern correlates 
temporally with milk production peaking and gradually dropping as lactation progresses 
(Hart, 1975b). This raises the question of whether or not the association between the 
hormone and milk production is purely temporal, or if there is a closer, physiological 
link between high prolactin and high milk production. If they are indeed related then 
could maintaining prolactin at a high level throughout lactation also keep milk 
production near maximal levels?
Evidence to support the hypothesis of a role for prolactin during established 
lactation has been seen in some species. In goats, correlations are found between 
average (monthly) prolactin concentrations and milk yield (Hart, 1975a) but studies 
using bromocriptine to decrease endogenous prolactin dispute the relevance of this 
since this treatment has little effect on yield (Forsyth & Lee, 1993). In rats, lactation 
could be extended by maintaining the suckling stimulus, and therefore prolactin, by 
regularly swapping an older litter with a younger set (Flint et al, 1984). A variety of 
pharmacological agents which stimulate prolactin release have also been used in vivo 
to investigate their effects on milk production and mammary development. One agent, 
perphenazine (PZ), proved to be effective in inducing prolactin release in sheep and 
had positive mammogenic effects (Morag et al, 1971) although there was no apparent 
effect on milk production when given to sheep in mid-lactation (Bass et al, 1974). This 
drug has also been implanted in the brain median eminence of goats and had a 
significant and positive effect on prolactin levels and maintained milk production, ie. 
improved lactation persistency. However, this administration route required the use of 
a specialised surgical procedure and there were some negative post-operative side- 
effects (Vandeputte-Van Messom & Peeters, 1982). So there is some evidence to 
support the hypothesis that prolactin is not only involved in the establishment, but also 
in the subsequent maintenance of lactation postpartum, and that the decreased prolactin 
concentrations observed as lactation progresses can contribute to the general decline in 
milk production in ruminants.
Unfortunately there are some side-effects associated with perphenazine treatment
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but these vary between species, depending on dose level and the delivery route used. 
In general, ruminants are less amenable to intramuscular or interperitoneal injections 
with side effects of pain and tenderness at the injection site, behavioural problems 
(generally lethargy) and weight loss (Shani et al, 1975), and a bolus injection limits the 
longevity of the drug administered. Oral dosing has been used successfully without 
side-effects in rats (by doping drinking water and thereby facilitating small but frequent 
PZ dosing) (Stringer et al, 1990) and horses (Ireland et al, 1991) but has not been 
attempted in ruminants. Although surgical implantation of perphenazine is clearly 
successful in goats, it is a complex procedure to carry out and has inherent 
disadvantages. The development of a delivery route which did not cause significant 
side-effects and was relatively straightforward to administer would be desirable for 
further investigations in this area.
The overall aim of this work was to clarify the role of circulating prolactin on 
milk production by elevating and maintaining prolactin concentrations using 
perphenazine. An initial experiment was designed to determine a minimum effective 
perphenazine dose when administered by intravenous infusion. The second experiment 
attempted to maintain high prolactin concentrations over a lactation and monitor the 
effects of this on lactation persistency and a variety of other parameters. A change in 
milking frequency was incorporated into this experiment in an attempt to elucidate 
whether or not prolactin was acting locally or systemically on the mammary gland; one 
gland was switched to once-daily milking (IX) while the contralateral gland continued 
on routine twice-daily (2X) milking so both glands experienced similar systemic but 
different local endocrine environments.
2. ANIMALS
British Saanen goats from the Institute herd were used. Hay and water were 
available ad libitum and, in addition, a proprietary concentrate feed was offered twice 
daily, dependent on physiological state, as follows: non-pregnant 0.5 kg/d, pregnant
1.0 kg/d and lactating goats 1.5 kg/d.
3. EXPERIMENTAL DESIGN
Two experiments were carried out consecutively. Firstly, goats in various 
physiological states were infused for up to 4 days with varying doses of PZ and the 
effects on prolactin secretion were studied. In the second experiment lactating goats
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were treated with PZ orally or by injection and were studied over 26 weeks during 
which time a variety of physiological parameters were measured.
3.1 Experimental groups
The first experiment utilised three groups of four goats which were (i) non­
pregnant and non-lactating (December 1991- January 1992), (ii) pregnant with stages 
of gestation ranging from weeks 14 to 18 (February 1992) and (iii) lactating in lactation 
weeks 1-3 (March 1992); three goats appeared in both latter groups.
Two groups of four lactating goats matched for parity and body weight, with 
kidding dates ranging from 8th-24th March 1992, were used in the second experiment 
of treatment throughout lactation.
3.2 Treatments
For infusions, animals were housed singly in metabolic crates within sight and 
sound of other goats, and lactating animals were temporarily disconnected from the 
infusion apparatus when milked twice daily at 0800 and 1600h. PZ was dissolved in 
a minimal volume of 0.2N HC1 and added to sterile 0.9% w/v sodium chloride solution 
to yield final concentrations of 82- 552mg PZ/1, depending on the rate of infusion, the 
weight of the animal, the dose level and duration of infusion required. Vehicle or PZ- 
containing solutions were infused through polyethylene tubing (Dural SP70/102 tubing, 
Critchley Electrical Products Pty Ltd, Auburn, Australia) at a constant rate via an 
indwelling jugular vein cannula using a peristaltic rocking pump (Frost Instruments 
Ltd, Cambridge, UK). Flow rates were constant during each infusion (range 5.1- 7.2 
ml/h) while two of the non-pregnant, non-lactating group received infusate at rates of 
17 and 19 ml/h due to the inner diameter of the peristaltic tubing used.
Vehicle alone was infused for a 24 hour pre-treatment period followed by PZ 
given at doses as follows: non-pregnant, non-lactating animals received 0.47mg 
PZ/kg/d for 48h, pregnant goats received l.Olmg PZ/kg/d for 96h while lactating 
animals were given 0.26mg PZ/kg/d for 56h followed by 0.44mg PZ/kg/d then 1. lOmg 
PZ/kg/d for 24h each. PZ infusions were followed by a post-treatment infusion of 
vehicle alone for 8  or 8.5h. The amount of infusate administered was determined by 
weight difference at regular and noted times, allowing the exact dose to be calculated 
for each animal. In all groups, the switch between vehicle alone and PZ-containing 
infusions and changes in PZ dose were made between 0900 and 1000 hours.
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In experiment 2, treatment through lactation, PZ was given as follows: 
lactation week 13-15: oral dose of 25mg/goat/d
16-20: oral dose of 50mg/goat/d
2 1 -2 2 : daily s.c. injection of 25mg/goat/d 
23-28: daily s.c. injection of 50mg/goat/d 
For oral dosing, PZ was suspended in distilled water at a concentration of
5mg/ml and administered as a single bolus between 0900 and lOOOh daily, using a
commercial dosing gun. For injection, PZ was dissolved in a minimal volume of 0.2N 
HC1, added to 30% polyvinylpyrrolidone solution, pH adjusted to 7.0 and administered 
daily at 1400h.
Lactating goats in experiment 2 were milked twice daily at 0800 and 1600h 
from parturition until lactation week 25. From week 26 onwards, right glands were 
switched onto a regime of once-daily milking at 0800h only (IX), while left glands 
continued to be milked twice daily (2X).
3.3 Measurements
In experiment 1, during infusions, regular blood samples were collected from 
indwelling jugular vein catheters, plasma prepared and analysed for prolactin content. 
Sampling frequencies varied between groups: at hourly intervals between 0900 and 
1700, and at 2000 and 2200 in the non-pregnant, non-lactating goats and at two hourly 
intervals from 0900-1700 and at 1945 and 2145 hours in the pregnant and lactating 
groups. All goats were monitored over an 8  or 8.5 hour period (0900-1700/1730h) 
following the cessation of PZ treatment.
In the second experiment milk yields obtained at each milking were recorded 
throughout. Mixed samples of bulk milk (the whole flow) were collected from both 
glands in weeks 11, 12, 13, 16, 18, 20, 22, 25, 28, 32 and 37 and analysed for 
protein, total solids, rapid fat and lactose contents. Additional samples were collected 
for casein analysis (see Chapter 7).
Blood samples were obtained twice weekly by jugular venepuncture at 1400h 
while more frequent profile sampling was carried out in weeks 11, 13, 16, 20, 25, 28, 
32 and 37. For this, catheterisation of the jugular vein was carried out at approximately 
1600h on the day preceding sampling. Samples were collected from indwelling cannula 
immediately before, and 2 0  minutes after, morning and afternoon milkings, and at 
1000, 1200 and 1400h. Plasma was prepared and subsequently analysed for
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prolactin and growth hormone content.
Empty udder volume was measured by water displacement in weeks 11, 12, 13, 
16, 20, 25, 30, 32 and 37 of lactation. Alveolar and cisternal storage volumes were 
determined by catheter drainage 5 hours after a normal morning milking in weeks 13, 
25 and 37.
General nutritional status was monitored by measuring body weights once- 
weekly and additional measurement of food refusals (uneaten concentrate feed) were 
made on weekdays by weighing the amount remaining prior to each milking.
4. RESULTS
4.1 Perphenazine infusions
Typical profiles for prolactin concentrations before, during and after PZ 
infusion from a representative individual in each group are illustrated in Figure 4.1. 
Concentrations for each animal were averaged over each treatment period and group 
means calculated (Figure 4.2). Comparisons between groups were made using Student’s 
unpaired t-test.
Significant differences in plasma prolactin concentrations were found between 
non-pregnant/non-lactating, pregnant and lactating groups, during the pre-treatment 
infusion periods (9.6+2.0; 49.6±7.9 and 566+129 ng/ml prolactin, respectively, 
p < 0.001). PZ infusion significantly increased prolactin concentrations in all three 
groups; non-pregnant, non-lactating goats showed the greatest incremental response 
(from 9.6 ng/ml to 74.6 ng/ml during treatment, p<  0.0001). Prolactin concentrations 
fluctuated over the day, and in response to treatment, with concentrations of up to 78 
ng/ml pre-treatment, 300 ng/ml during PZ and to 8 8  ng/ml post-treatment.
Pregnant animals had an intermediate increase during treatment (49.6 to 293 
ng/ml, p < 0.0001) and there was some carryover of PZ’s effect into the post-treatment 
period: prolactin dropped from 293 to 184 ng/ml (p=0.014) but this was still above 
pre-treatment levels (p=0.0014). Again there was variability across the day with 
concentrations of up to 134 ng/ml prolactin being seen pre-treatment, 1395 ng/ml 
during PZ and 48-701 ng/ml post-treatment.
Lactating goats approximately doubled their prolactin concentrations (556 to 
1070 ng/ml) in response to the first dose of PZ (p=0.0023) but the next highest dose 
(0.44mg PZ/kg/d) was associated with a drop in prolactin (p=0.011) although 
Concentrations remained above pre-treatment levels (p=0.53). When the dose was
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further increased to 1.1 Omg PZ/kg/d, 24 hours later, prolactin was again increased, 
relative to pre-treatment levels (p=0.047). This group showed the widest variation in 
prolactin concentrations (ng/ml); pre-treatment 46-1165, P Z ^  588-2005, PZ044 482- 
1002, PZj 10 231-1438 and post-treatment 84-2005. Samples were collected one hour 
after milking (morning and afternoon) in this group to avoid the transient prolactin 
surge associated with milking itself, to make conditions between the groups as similar 
as possible. The range in prolactin concentrations during each treatment phase are 
reflected in the standard errors calculated in Figure 4.2 for all groups.
4.2 Long-term perphenazine treatment
Milk yields and lactation persistency
Lactation curves showing the average daily yields for each group were plotted 
(Figure 4.3 A). Perphenazine was administered orally from weeks 13-20, by injection 
on weeks 21-27 and treatment was discontinued in week 28. Milk yields declined 
gradually but there was a more rapid decrease in the perphenazine group apparently 
associated with PZ injections. When single gland milk yields were compared between 
weeks 20 (last week of oral PZ dose) and 27 (last week of injections), a significant 
drop was found in both glands of the PZ group (2X: 0.58 ±  0.15 kg/d; IX: 0.65 +
0.08 kg/d, p <  0.033), and this drop was greater than that seen in controls over the 
same period (2X: 0.38 ±  0.12 kg/d; IX: 0.42 ±  0.09 kg/d, p < 0.051). The rapid 
decline in yield in the PZ group corresponded temporally with decreased food intake 
and fluctuations in body weight (Figure 4.4). Treatment was stopped during week 28, 
resulting in a temporary recovery in yields, followed by a gradual decline. Statistical 
analysis of yields (ANOVA) indicated that there was no effect of treatment on yields 
(p=0.266) but the change in milking frequency and lactation period both affected yield 
(p< 0 .0 0 1 ).
There was no apparent effect of PZ treatment on lactation persistency, 
determined by regression analysis of individual yield profiles (Figure 4.3 B) and 
subsequent ANOVA, although again lactation period had a significant negative effect 
on persistency (p=0.018). There was a slight trend towards slightly improved 
persistency of glands which were milked once-daily in late lactation, compared to 
contralateral 2X milked glands (Table 4.1). This was observed in 5 out of 8  animals, 
independently of treatment, but differences between glands were not significant 
(p=0.41, paired t-test).
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Figure 4.3 (A) Average daily milk yield from control 2X ( • )  and IX
(Q) glands and perphenazine 2X (A) and IX (A) glands. Vertical lines 
represent changes in PZ treatment- orally on weeks 13-20 and by subcutaneous 
injection until week 28. (B) Regression analysis of milk yields was conducted 
(full analysis in Table 4.1), means obtained for each group in weeks 13-25 and 
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Figure 4.4 Measurements of nutritional status in experiment 2.
(A) Average daily concentrate refusals from weeks 24-29 in control (open 
bars) and PZ (hatched bars) groups when PZ was given by injection at a 
dose of 25mg PZ/d in week 23 and at 50mg PZ/d during weeks 24 to 28. 
Treatment was discontinued in week 28.
(B) Average body weights for control ( • )  and PZ (A) groups.
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Group Milked Treatment only
m (weeks 13-25)
Treatment + IX
m (weeks 29-37)
Control 2X -47.7 -48.5
1 0 . 8 -98.1
-18.9 3.3
-2 1 . 2 - 1 0 1 . 0
mean -19.2 -61.1
r2 46.8%, p=0.050 r2 67.8%, p=0.159
Control IX -46.4 -38.3
13.9 -83.3
-17.0 -19.0
-30.6 -83.6
mean -2 0 . 0 -56.0
r2 49.6%, p=0.029 r2 82.6%, p=0.047
Perphenazine 2X -6.5 -83.0
-12.4 -20.3
-17.9 -80.1
-31.6 2 0 . 8
mean -17.1 -40.6
r2 40.0, p=0.073 r2 52.9, p=0.072
Perphenazine IX -13.7 -59.7
-3.8 -23.5
-29.2 -87.5
-33.2 25.2
mean -2 0 . 0 -36.4
r2 36.0%, p=0.170 r2 53.0, p=0.063
Table 4.1 Summary of regression lines fitted to individual milk yield
profiles for each animal’s glands. m=change in average daily yield, ml/week. 
r2 and p indicate the accuracy and probability of the best line being fitted to 
the data.
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Nutritional status
Orally administered PZ (given during weeks 13-20) had no apparent effect on 
appetite, in week 20 mean refusals were 26.2 ± 19 g/d in the control group and 43.1 
+ 15 g/d in PZ-treated animals (p=0.52). However, within 2 to 3 weeks of PZ 
injections commencing, concentrate feed refusals began to steadily increase (Figure 
4.4A) with all treatment animals refusing food (albeit to variable levels) during weeks
26 and 27. The highest levels of refusals in the PZ group were obtained during week
27 with control animals refusing 558 ± 239 g/d while PZ animals refused 4852 g/d 
(p=0.12). The increase in refusals over this period (week 20 compared to week 27) 
did not achieve significance in either group (p=0.12 and p =0.073 in controls and PZ, 
respectively, paired t-test), reflecting the variability between individuals. Appetites 
were rapidly regained when injections were stopped during week 28. Goat weights 
were determined weekly (Figure 4.4B) and the rate of weight gain between the groups 
was similar during the period of oral PZ dosing (CON: +0.549 kg/wk; PZ +0.518 
kg/wk). From the cessation of treatment to the end of the study (weeks 28-37) the PZ 
group had a much higher rate of weight gain than controls (+0.889 & +0.227 
kg/week, respectively).
Milk composition
There were general trends of increased protein, fat and solids content from 
lactation week 20 onwards. Lactose showed a different pattern with concentrations 
initially high then dropping to a lower level for the remainder of lactation (Figure 4.5). 
There were no significant differences in milk protein, lactose, fat or solids content 
either between glands within individuals, or between the experimental groups over the 
period studied.
Hormone concentrations
Lactational profiles for prolactin and growth hormone obtained from routine 
blood sampling are shown in Figures 4.6 and 4.7, respectively. Weekly concentrations 
were averaged over each treatment phase for each group and compared using Student’s 
unpaired t-test. Prolactin levels were not significantly different between the groups 
except in the last phase of IX milking (after PZ treatment was discontinued) when 
prolactin was lower in the control group. Growth hormone concentrations were similar 
during the pre-treatment phase but became lower in PZ-treated animals once treatment
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commenced. This became significant in later lactation even though treatment had been 
discontinued.
More frequent profile sampling was also conducted and mean prolactin and 
growth hormone concentrations were calculated for each group at each timepoint for 
every sampling week (Figures 4.8 & 4.9 respectively). Pre-treatment (week 13) 
prolactin concentrations were very similar between the groups and subsequent treatment 
had no significant effect on plasma prolactin. There was, however, a trend towards 
prolactin being slightly higher in the PZ group after treatment finished (weeks 28, 32 
and 37), confirming the observations made in the routinely collected samples.
Growth hormone profiles showed a reduction in concentrations in PZ-treated 
animals from week 25 onwards. When hormone concentrations were averaged over the 
day for each group, and lactation weeks compared, the decrease in the PZ group was 
statistically significant (p < 0.001) in weeks 25, 32 and 37 (CON: 4.0, 4.0 and 3.7 
ng/ml GH; PZ: 2.4, 1.5 and 1.7 ng/ml GH, respectively), again confirming the trends 
seen in the routinely collected samples.
Udder characteristics
Treatment itself had no significant effect on gross udder volume with both 
groups showing an initial decrease in volume between pre-treatment and treatment 
phases (CON: p =0.002, PZ p =0.056), and subsequent maintainance at a lower level 
for the remainder of lactation (Table 4.2 & Figure 4.10).
The sites of milk storage were also determined in weeks 13 and 25 (Figure 
4.11) and there were no significant differences between the groups in week 25 
(p>0.36). Alveolar capacity was initially higher in the PZ group compared to controls 
(p=0.009) but the former lost capacity by week 25 (p=0.014), in contrast to controls 
which increased volumes over the same period (p=0.098). Cistern volumes were 
similar between groups in week 13 (p=0.71) and both showed a decrease in volume 
over time (CON: p=0.051, PZ p=0.036). Cistern percentage was significantly higher 
in controls in week 13 (p=0.013), reflecting the disparate alveolar capacities of the 
groups, but percentages dropped significantly in both groups by week 25 (p<0.018).
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Phase: Pre­
treatment
PZ treatment IX  milking only
Lactation
week:
1 1  + 1 2 13 2 0 25 30 32 37
Control 1542 1525 1185 1085 1182 989 953
s.e. 1 0 2 1 1 2 160 96 96 137 32
PZ 1558 1362 1 1 2 0 1082 996 1060 862
s.e. 1 1 1 106 56 150 8 6 81 93
Table 4.2 Udder volumes (ml) measured in experiment 2.
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Figure 4.10 Statistical analysis of udder volume measurements in 
control (open bars) and PZ (hatched bars) groups. Volumes were averaged 
over each treatment phase and expressed as a percentage of the pre­
treatment level.
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5. DISCUSSION
The main question addressed in this work was can increased prolactin 
concentrations improve lactation persistency? The first experiment tested the effects of 
perphenazine infusion, at a variety of doses, on prolactin concentrations in goats in 
various physiological states. PZ significantly increased prolactin with one exception- 
in lactating goats receiving 0.44mg PZ/kg over a 24h period. Close examination of 
individual prolactin profiles indicated a trend towards decreasing concentrations as time 
of infusion increased. This could reflect a decrease in sensitivity to PZ or a pituitary 
restriction on prolactin release. The subsequent elevation of prolactin with an increased 
dose may have overcome any desensitisation or there may have been sufficient 
synthesis and restoration of the pituitary stores of prolactin. PZ did elevate prolactin 
but it is not known whether absolute prolactin concentrations or the magnitude of the 
increase are physiologically relevant to the animal. Changes in prolactin concentrations 
with physiological state, determined before treatment, were consistent with those found 
in previous studies and reflected the increasing requirement for prolactin in pregnancy 
and lactation. Lactating goats have higher prolactin levels for up to 16h a day 
compared to non-lactating ones (Hart, 1974) and the mammary gland has an elevated 
prolactin binding capacity, supporting milk synthesis (Beck etal, 1979). Environmental 
influences of daylength and temperature will also modify prolactin levels; daylength 
and circulating prolactin are positively correlated (Hart, 1975a). Non-pregnant, non- 
lactating goats were studied between December and January, while the remainder 
(pregnant and lactating) were observed during February and March with daylight 
increasing from about 8  hours to 1 2  hours over this period.
The infusion method used in experiment 1 was not suitable for long-term PZ 
treatment due to welfare considerations- animals were housed in metabolic crates to 
restrict their movement, but they could still be quickly and easily disconnected from 
the apparatus for milking or other procedures. It had been envisaged that for the second 
experiment osmotic minipumps (Alza Corporation, Palo Alto, USA) would be used as 
a means of extended PZ administration. Two of these pumps could administer a total 
volume of 4ml solution over a period of 1 to 4 weeks, as appropriate. However, it was 
subsequently found that the minipump was incompatible with the solvent concentrations 
which could successfully dissolve the PZ dose required. PZ has a maximum solubility 
of 153 mg/ml in ethanol (ABPI data compendium, 1990) but the minipump could only 
tolerate ethanol to 5%, too dilute to dissolve PZ to 31 mg/ml, the required dose for an
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average 70kg goat given 0.25mg PZ/kg/d over a one week period. Unfortunately the 
determination of a suitable PZ dose for lactating goats coincided with seasonal kidding 
and as the long-term experiment had to commence near peak lactation an alternative 
administration route had to be found quickly.
Consequently in experiment 2, PZ was initially given orally in the light of 
reports in rats (Stringer et al, 1990) and horses (Ireland et al, 1991). But after several 
weeks of treatment and having increased the daily dose from 25 to 50 mg PZ there was 
no still no apparent effect on prolactin concentrations. So why was PZ ineffective in 
lactating goats? Stringer et al used young, non-pregnant, non-lactating rats and gave 
them a syrupy form of PZ dissolved in drinking water, made fresh every 48 hours, 
elevating prolactin about 5-fold. Goats in a comparable physiological state responded 
to equivalent PZ infusions (8 -fold increase in experiment 1) but a similar dose given 
orally had no effect. PZ was made fresh every day, so one would not predict 
inactivation prior to administration. Ireland et al (1991) gave PZ to late pregnant mares 
in combination with bromocriptine (to reduce prolactin). PZ prevented part of the 
prolactin decrease and the dose used was within the range used in these experiments. 
So could it be due to the administration route rather than the dose level used? The lack 
of effect in goats may reflect species variation in the digestive system; rats and horses 
have ’simple’ stomachs which, in the latter, have adapted to cope with the digestion 
of fibre (horses have an enlarged caecum) while goats, and other ruminants, have an 
additional stomach, the rumen, which relies on a large microbial population of bacteria, 
fungi and protozoa to degrade cellulose and facilitates extended periods of regurgitation 
and chewing to improve digestion (Czerkawski, 1986). It could well be that PZ was 
inactivated and degraded in the rumen before it could be absorbed and exert its effects 
in the goat.
PZ administration was then switched to intramuscular injection but prolactin still 
remained lower in treated animals. This depression may be partly explained by 
decreased food intake, and increased lethargy which may have given them a measure 
of ’resistance’ to stress, both factors which can increase prolactin (Hart, 1973b). The 
lack of response and side-effects observed supported previously published observations 
(Shani et al, 1975) and it appears to be a problem specific to localisation of PZ in body 
tissues. It is perhaps surprising that brain implantation of PZ (localising PZ in the brain 
over a prolonged period) proved successful, but it may have caused less tissue irritation 
in this region. Unfortunately this technique involves difficult surgery, more intensive
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husbandry of animals due to post-operative weakness, and causes an initial reduction 
in milk yield (Vandeputte-Van Messom & Peeters, 1976 & 1982). Despite this, it 
appears to be the best approach towards long-term alteration of prolactin in goats by 
pharmacological means. A more direct approach may, however, now be possible. A 
recent abstract has reported that recombinant prolactin has been given to goats and milk 
yields were increased by 1% (Knight et al, 1995). Unfortunately the experiment was 
conducted over a short time period and there was no data provided to verify that the 
treatment elevated systemic levels of prolactin, but the increased yield indicates that 
there a stimulation of milk secretion, probably due to the increased availability of 
prolactin in the mammary gland. If recombinant prolactin could be used in conjunction 
with a subcutaneous osmotic minipump then it could be given over periods of several 
weeks. Alternatively it could be administered by injection, like BST, possibly in a 
delayed release vehicle which could increase the interval between injections up to 
fortnightly. The stability of prolactin given by this route has been verified (Hebert et 
al, 1991). Use of these methods could facilitate a long-term study on the effects of 
maintaining prolactin concentrations over a lactation.
Lactation persistency was altered in late lactation not by PZ treatment but by 
the change in milking frequency; IX milking tended to improve persistency. The 
change from twice- to once-daily milking was predicted to decrease persistency as milk 
accumulated over a single 24 hour period rather than over 8  and 16h intervals, 
decreasing the period of maximal milk secretion (Peaker & Blatchford, 1988). 
Endocrine environments were similar in both glands as the milking-induced release of 
hormones continued twice-daily, although the IX gland was only emptied at every 
second milking, suggesting that another local factor, other than hormones, was 
modulating the effect. Udder anatomy can influence milk production; cows with greater 
cisternal storage of milk had higher rates of milk secretion (Dewhurst & Knight, 1993), 
an effect thought to be modulated by FIL. This protein acts as an autocrine inhibitor 
of milk secretion and as such requires to be in contact with the secretory cells 
themselves. Once it leaves the alveolar areas of the gland it effectively becomes 
inactive and therefore a greater movement of milk from this area to the cistern would 
minimise its inhibitory effects on the secretory cells, partly relieving the local inhibition 
on secretion. Measurements of milk compartmentation in the udder were made at the 
start and near the end of PZ treatment but both glands were being milked twice-daily 
during this time. Further measurements were made in week 37 but measurable milk
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was obtained from one animal in each group so the data proved inconclusive as to 
whether or not changes in the partitioning of milk stored in the udder could be the 
explanation for our observations. More frequent measurement of cisternal and alveolar 
ratios would be required for a closer study of this phenomenon.
The lactation curve showed a double peak at approximately weeks 8  and 16, the 
former as expected. The latter peak was not predicted and did not coincide with any 
change in treatment and the suppression of milk yields between the two was possibly 
due to a nutritional constraint such as the quality of the hay available to the goats.
Another observation made in experiment 2 was that the PZ group had generally 
lower growth hormone concentrations, becoming more marked later in lactation, 
despite discontinuation of treatment. This initial depression coincided with decreasing 
concentrate intake, however, when animals are in negative energy balance growth 
hormone levels increase, inhibiting proteolysis and stimulating incorporation of amino 
acids into muscle (Bauman & Currie, 1980). Simultaneously other metabolites are 
diverted away from storage by tissue deposition (Hart, 1983) and redirected towards 
energy utilisation. This allows protein reserves to be retained during times of high 
metabolic stress. So instead of the predicted increase in growth hormone as animals 
decreased their food intake (Breier & Gluckman, 1991), we saw a decrease in growth 
hormone. PZ could be having a direct or indirect effect, for example, growth hormone 
decreases when there is a restriction on growth hormone-releasing factor. In the latter 
case, IGF-I concentrations also drop, detectable in serum samples (Moore et al, 1992) 
but we did not assay samples for IGF. Alternatively, growth hormone could have 
directed these changes, and it was impossible to separate cause and effect in this case. 
Growth hormone remained at low levels while animals regained their appetites, the 
rapid rate of weigh gain supporting the measurement of low growth hormone, directing 
metabolites towards tissue deposition. Milk yields may also have reflected this- there 
were initially small but rapid recoveries in production which soon tailed off.
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CHAPTER 5
THE INFLUENCE OF OXYTOCIN ON LACTATION PERSISTENCY
1. INTRODUCTION
The classical role of oxytocin is to promote the emptying of milk from the 
alveolar areas of mammary glands by facilitating the milk ejection reflex during 
suckling or milking. It can be used therapeutically to enable milk removal in animals 
with compromised milk ejection, but will also improve milk removal in those with 
normal milk ejection. Typically milk left in the udder goat or cow udder after a normal 
milking might constitute some 1 0 % of the volume of the milk removed and this 
’residual fraction’ can be obtained by administering exogenous oxytocin (Bruckmaier 
et al, 1993; Sagi et al, 1980). This procedure can also be used to reduce yield losses 
when milking regimes are changed to ones of less frequent milking (Carruthers et al, 
1993), attributed to the improved removal of the residual milk fraction. Similar positive 
effects have been seen in other studies (see Ballou et al, 1993; Sprain et al, 1954) but 
treatment periods have been generally quite short-term (up to 14 days). The immediate 
and short-term effect of oxytocin is to physically improve the removal of residual milk 
and therefore increased yield is not, in itself, evidence of increased milk secretion. 
However, other effects have been reported: oxytocin administered to rats has extended 
lactation by up to 10 days after litters have been removed (Benson & Folley, 1957) and 
some recent work has suggested that oxytocin can also have long term effects on 
lactation persistency in ruminants: Nostrand et al (1991) gave oxytocin to cows 
immediately before milking (twice-daily) over 305 days and found that oxytocin 
improved milk production by 11.6%, an average of 2.78 kg/d. The treatment had the 
greatest effect during declining lactation but there was a wide range in response within 
the treatment group (6.3 to 22.7%) and complex statistical evaluation of the data was 
required. Indeed some animals were excluded as their milk production was not 
adequate to fit the analysis. Consequently the positive effect of oxytocin on lactation 
persistency requires further investigation.
If we assume that oxytocin is indeed having a long-term effect, then how could 
it be acting? It could be either a direct metabolic action of oxytocin on the mammary 
gland or an indirect effect of milk removal. Support for the former hypothesis was 
produced when oxytocin was given to cows either before or after milking: milk yields 
were increased slightly irrespective of whether treatment was given before milking
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(explicable by improved milk removal) or after milking, the latter clearly not an effect 
of milk removal as milking had already finished (Ballou et al, 1993). However absolute 
differences in yield between treatment animals were very small compared to controls 
(<  lkg/d) and p-values of <0.08 were quoted (significance is usually assumed to be 
reached when p<0.05) and further work carried out by Knight (1994) has not 
substantiated the initial findings. By milking the two halves of the same udder at 
different times and administering oxytocin at only one of these times it was shown that 
milk removal immediately after oxytocin administration was essential for enhanced milk 
production. Although the group size used was small, the effect was clearly significant 
(p<o .0 0 1 ), since each animal served as its own control rather than comparing groups 
of individuals.
So could oxytocin be affecting milk production via milk removal? If so, its 
positive effect could be explained by a reduction in the concentration, or amount, of 
FIL around the secretory cells, allowing maximal rates of milk secretion to continue 
for longer periods (Wilde & Knight, 1990). Conversely, infrequent or incomplete 
milking during later lactation speeds up the process of involution (Wilde et al, 1989) 
which may reflect the lack of milk removal from the alveolar areas of the gland where 
FIL exerts its action. It would be therefore predicted that less frequent milking would 
reduce lactation persistency and oxytocin should help to minimise, or negate, this effect 
as it improves milk removal from these areas (Carruthers et aly 1993), although the 
results from the previous chapter suggest that once-daily milking can have a positive 
effect most probably due to alteration of milk storage characteristics.
The aim of this work was to determine the long-term effect of oxytocin 
treatment on lactation persistency and the experiments were designed to incorporate a 
change in milking regime while oxytocin treatment continued, to test whether or not 
oxytocin was acting directly (’metabolically’) or indirectly (via milk removal). 
Consequently, treatment animals received oxytocin at both milkings throughout 
lactation and during the initial treatment phase both glands were milked twice-daily. 
Later in lactation one gland was switched to once-daily milking (IX) while the 
contralateral gland continued on twice-daily milking (2X), hence both glands continued 
to be subjected to oxytocin but IX glands were emptied every second dose, while 2X 
ones were emptied every time a dose was given. If milk removal was required for 
oxytocin to exert an effect then a difference in lactation persistency between glands 
would be predicted during the second phase when milking frequencies were altered.
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However, if oxytocin was having a general metabolic effect then there should be little 
difference between the glands’ persistencies when milking frequencies were changed.
2. ANIMALS
British Saanen goats from the Institute herd were used. Hay and water were 
available ad libitum and, twice daily, animals were offered a total of 1.5kg of a 
proprietary concentrate feed.
3. EXPERIMENTAL DESIGN
Two long-term experiments were conducted over successive years in which 
treated animals received oxytocin prior to every milking while control animals were 
milked normally. All animals were initially milked twice-daily then, in later lactation, 
one gland was switched to once-daily milking. Various parameters were measured 
during the experiments including hormone concentrations, milk yield and composition, 
and udder capacities.
3.1 Experimental groups
The first experiment utilised lactating goats kidding between 8th-24th March,
1992. They were randomly divided into control and treatment groups (n=4, 3 
primiparous & 1 multiparous, 3rd lactation). The control group was the same as that 
described in Chapter 4 (PZ treatment), and consequently vehicle alone was not given.
The second experiment used lactating goats kidding between 4th-15th May,
1993. These had been used in a study conducted between parturition and lactation week 
8  (detailed in Chapter 6 ), consequently animals were assigned to oxytocin (n=5, all 
multiparous, 2-4th lactation) or control (n=4, all multiparous, 2nd lactation) groups 
on the basis of the treatment given in the previous study. Frequently milked and 
suckled animals were evenly divided between control and oxytocin groups, one drained 
animal was placed in the control group and the remaining two were assigned to the 
oxytocin group.
3.2 Treatments
Oxytocin (5 IU; Oxytocin-S, Intervet, Cambridge, UK) was administered 
intramuscularly immediately before milking at 0800 and 1600h every day from 
lactation week 12 (experiment 1) or week 13 (experiment 2) onwards. The oxytocin 
dose used was that recommended by the manufacturer. To minimise tissue 
inflammation and tenderness due to repeated injections, the site of injection was
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swapped from left to right flanks on alternate weeks. After 12 or 13 weeks of twice- 
daily milking and oxytocin treatment, one gland was switched to once-daily milking 
(1600h) while milking of the contralateral gland and oxytocin treatment continued as 
before. Hence, in the first experiment oxytocin was administered during lactation 
weeks 13-37 and unilateral once-daily milking conducted on weeks 26-37. In 
experiment 2 , treatments were given on weeks 12-31 and in conjunction with once- 
daily milking during weeks 24-31.
In experiment 1, all animals received intravaginal Chronogest sponges (30mg 
fluorogestone acetate, Intervet), changed every 10-14 days from lactation week 26 until 
the end of the experiment, to prevent the resumption of seasonal oestrus. In the second 
experiment the goats commenced natural oestrus cycles in the second week of October, 
lactation weeks 23-24.
3.3 Measurements
Blood samples were collected by jugular venepuncture twice-weekly at 1400h 
and analysed for prolactin (routine samples). In experiment 1, additional measurements 
of growth hormone and prolactin were made in blood samples taken at frequent 
intervals through a day, at timings detailed in Chapter 4, in lactation weeks 11, 13, 16, 
20, 25, 28, 32 and 37.
Mammary gland cisternal and alveolar storage capacities were determined after 
5 hours milk accumulation in both experiments: in weeks 13, 25 and 37 in experiment 
1, and weeks 11, 14, 19, 23, 27 and 30 in experiment 2. Gross udder volumes were 
determined at the same time in experiment 1 only.
Mixed samples of bulk milk were collected for compositional analysis of 
protein, lactose, fat and solids content in weeks 11, 12, 13, 16, 18, 20, 22, 25, 28, 32 
and 37 in experiment 1 and in weeks 14, 18, 21, 25, 29 and 31 in experiment 2.
4. RESULTS
4.1 Milk yields
Milk yields were calculated by determining average daily gland yields over one 
week periods for each goat and meaning according to treatment group (Figure 5.1). 
Statistical analysis of yields obtained during each treatment phase was performed 
(Figure 5.2). Left and right glands were evenly balanced in terms of milk production 
with the exception of control animals in experiment 1 whose 2X glands produced more
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milk than IX glands (determined by Student’s paired t-test, p<0.02) throughout the 
experiment. Statistical analysis of changes over time (ANOVA) found that in 
experiment 1 the pre-treatment period the oxytocin group were producing less milk 
than controls (p=0.077) but during treatment yields increased to above controls 
(p< 0.001). The switch to IX milking also led to a loss of yield (p=0.001) in these 
glands. In experiment 2, milk yields were not significantly different between groups 
either before or during treatment (p >0.092) and there was little effect on yields after 
the switch to IX milking (p=0.795).
4.2 Lactation persistency
To obtain a measurement of lactation persistency regression lines were fitted to 
milk yield curves (average daily gland yields) for individual animals in each treatment 
phase in experiments 1 (Table 5.1) and 2 (Table 5.2). In experiment 1, regression lines 
over the treatment phase (weeks 13-25) gave an average r2 of 22.7%. This was 
increased to 64.7% when weeks 16-25 were analysed, due to fluctuations in yields over 
the intervening period, so the latter period was used in subsequent calculations. Group 
means were calculated (Figure 5.3) and statistical analysis by ANOVA conducted. 
Oxytocin treatment and milking frequency had no significant effect on lactation 
persistency (p< 0.842) but there was a difference between the two measurement periods 
with the second period having reduced persistency (p< 0.056).
4.3 Milk composition
Similar trends were apparent in both experiments (Figures 5.4 & 5.5), 
with all components showing an increase over lactation, with the exception of lactose. 
Lactose concentrations showed a large increase shortly before the start of oxytocin 
treatment in experiment 1 but this was not seen in the second experiment, and the 
biological significance of the initial observation is not known.
Statistical analyses for each milk component were carried out using Student’s 
paired or unpaired t-test to compare glands within animals, and treatment groups, 
respectively over each treatment phase. Within individual goats, the two glands 
exhibited similar compositions throughout the experiment. There were no significant
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Group Milked Treatment only
m (weeks 16-25)
Treatment + IX
m (weeks 26-37)
Control 2X -86.5 -57.6
-8.5 - 1 2 0 . 0
-34.2 3.5
-40.6 -71.8
mean -42.4 -61.5
r2 72.2%, p=0.092 r2 75.3%, p=0.037
Control IX -82.4 -44.8
-2 1 . 2 - 1 1 2 . 0
-32.3 -10.4
-47.8 -56.9
mean -45.9 -56.0
r2 81.0%, p=0 . 0 0 2 r2 79.6%, p=0.006
Oxytocin 2X -38.3 23.9
-19.8 -104.0
-13.0 -87.1
1 2 . 6 -6 6 . 1
mean -14.6 -58.3
r2 49.8, p=0.050 r2 8 6 .6 , p<0 . 0 0 1
Oxytocin IX -43.9 1 .1
-27.8 -69.3
-23.8 -81.2
27.2 -41.9
mean -17.1 -47.8
r2 55.8%, p=0.022 r2 69.0, p=0.205
Table 5.1 Summary of regression lines fitted to individual
milk yield profiles for each animal’s glands in experiment 1 . m is 
the change in average daily yield, ml/week, r2 and p indicate the 
accuracy and probability of the best line being fitted to the data.
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Group Milked Treatment only
m (weeks 12-23)
Treatment + IX
m (weeks 24-30)
Control 2X -87.1 -36.9
-14.3 -16.8
-18.0 -156.0
-38.8 -113.0
mean -39.6 -80.7
r2 79.2%, p=0.002 r2 53.4%, p=0.116
Control IX -62.6 -137.0
-28.4 -147.0
-78.3 -3.7
-60.9 -43.5
mean -18.4 -82.8
r2 81.2%, p<0 . 0 0 1 r2 63.6%, p=0.052
Oxytocin 2X -63.0 65.1
-41.9 -104.0
-45.6 -165.0
-23.3 -169.0
-16.9 -4.6
mean -38.1 -101.5
r2 72.4, p=0.003 r2 55.0, p=0.160
Oxytocin IX -47.6 -118.0
-51.4 -2 0 . 0
-142.0 -30.2
-33.4 -6 6 . 2
- 1 2 . 2 -113.0
mean -57.3 -69.5
r2 76.0%, p=0.003 r2 46.0, p=0.133
Table 5.2 Summary of regression lines fitted to individual
milk yield profiles for each animal’s glands in experiment 2 . m is 
the change in average daily yield, ml/week, r and p indicate the 
accuracy and probability of the best line being fitted to the data.
104
Experiment 1
3 3
Q>
’>»
T3
0)
’>N
O x y t o c i n  
( b o t h  g l a n d s  2 X )
O x y t o c i n  
+  1X m i l k in g
C o n t r o l
2 X
O x y t o c i n
2 X
Experiment 2
C o n t r o l
O x y t o c i n
2 X
Figure 5.3 Summary of regression analysis for control and treatment 
groups in both experiments. In experiment 1 (A) both glands were milked 
2X in weeks 16-25 and switched to unilateral IX milking in weeks 26-37. 
In experiment 2 (B) these milking frequencies were applied in weeks 12-23 
and 24-30, respectively. Lines have been plotted with displacement for 
clarity. Full analysis of this data is illustrated in (A) Tables 5.1 & (B) 5.2
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Figure 5.4 Milk compositional analysis determined in Experiment 1 
in control 2X ( • )  and IX (O) glands, and in oxytocin 2X (A) and IX (A) 
glands. Pooled sems were 0.06 g/lOOml protein, 3.35mM lactose, 0.09 and 
0.17% for fat and solids, respectively.
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Figure 5.5 Milk compositional analysis determined in Experiment 2 
in control 2X ( • )  and IX (Q) glands, and in oxytocin 2X (A) and IX (A) 
glands. Pooled sems were 0.06g/100ml protein, 2.26mM lactose, 0.10 and
0.14% fat and solids, respectively.
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effects of oxytocin or of milking frequency on milk protein, lactose or solids content 
in either experiment. However, some differences in milk fat content apparent during 
the treatment phase of experiment 2. Higher fat percentages were obtained in oxytocin- 
treated animals, 2X glands being significantly higher than control 2X glands
(p= 0 .0 2 1 ).
4.4 Udder characteristics
In experiment 1 milk storage capacities and distributions were measured 5 hours 
after milking at 3 timepoints. In the final week, measurable milk was obtained from 
only one control and three oxytocin goats (albeit from both glands) so statistical 
comparisons between groups were not possible. The frequency of measurements was 
increased in Experiment 2 in an attempt to monitor more closely any changes that 
occurred, and again milk storage was measured 5 hours post-milking.
Gross udder volumes
Changes in udder volumes were determined in experiment 1 only; the data is 
illustrated in Table 5.3. There was a significant reduction in gland size (p<0.05) 
between each phase (ANOVA), but no significant differences between the groups at 
any stage of lactation (Figure 5.6). There was, however, a trend towards oxytocin 
animals maintaining their udder volumes in late lactation: in weeks 32 and 37 volumes 
(as a proportion of that measured pre-treatment) were 14% and 11% higher than 
controls.
Sites o f milk storage
The initial experiment indicated that oxytocin treatment could alter milk storage 
characteristics (Table 5.4). Alveolar volumes increased significantly between weeks 13 
and 25 in oxytocin-treated animals (p=0.0017) and were higher than controls in week 
25 (p=0.0012), resulting in a lower cistern proportion than controls (p=0.055). By 
lactation week 37, 3/4 oxytocin animals and 1/4 control animals were measurable 5 
hours post-milking so statistical comparisons were not possible. However this again 
suggested that oxytocin was having a positive effect on milk production and the second 
experiment aimed to extend these findings.
The results for experiment 2 are illustrated in Figure 5.7 and statistical 
comparisons using ANOVA were conducted. There was a significant and positive effect 
of oxytocin treatment on alveolar storage of milk (p=0.013), pre-treatment the
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Phase: Pre­
treatment
Oxytocin treatment Oxytocin 
+ IX  milking
Lactation
week:
11 + 12 13 20 25 30 32 37
Control 1542 1525 1185 1085 1182 989 953
s.e. 102 112 160 96 96 137 32
Oxytocin 1508 1263 1174 940 1145 1174 1106
s.e. 90 116 105 80 67 69 163
Table 5.3 Udder volumes (ml) measured in Experiment 1
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Figure 5.6 Statistical analysis of udder volume measurements in
control (open bars) and oxytocin (hatched bars) groups in Experiment 1. 
Volumes were averaged over each treatment phase and expressed as a 
percentage of the pre-treatment level.
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Treatment phase:
(lactation week)
Pre-treatment
(week 13)
Oxytocin treatment
(week 25)
Oxytocin + IX 
milking (week 37)
Alveolar volume (ml)
Control 46.2 (7.1) 72.5 (10.8) 55.0 *
Oxytocin 52.5 (10.4) 145.0(13.9) 109.2 (24.2) +
Cisternal volume (ml)
Control 276.9 (36.6) 225.6 (50.0) 87.5 *
Oxytocin 244.4(10.5) 173.7 (25.9) 97.6(21.8) +
Cistern proportion (%)
Control 84.1 (3.6) 69.4 (6.2) 61.4 *
Oxytocin 83.4 (2.6) 53.0(4.6) 47.8 (2.8) +
Table 5.4 Effect of oxytocin treatment on milk storage
characteristics in experiment 1. Each dataset represents n= 8  with the 
following exceptions where * n= 2  and + n=6 .
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Figure 5.7 Changes in (A) alveolar volume, (B) cisternal volume and 
(C) cistern proportion in Experiment 2. Control glands were milked 2X ( • )  
or IX (Q), as were oxytocin glands (2X A; IX A).
Il l
oxytocin group had much lower capacities than controls but they steadily increased 
during the first treatment phase, then declined in the last period (+  IX milking). All 
components (alveolar and cisternal volumes and cistern percent) were significantly 
affected by period with the lowest values being obtained in the last phase (p< 0 .0 0 1 ). 
There was no apparent effect of milking frequency on any of the milk storage 
characteristics measured (p> 0.845) and within goats, glands had similar alveolar and 
cisternal volumes.
4.5 Prolactin
Overall, prolactin levels determined by routine sampling showed a general 
decline as lactation progressed (Figure 5.8). Oxytocin-treated animals were found to 
have lower mean prolactin concentrations in experiment 2 , becoming significant during 
the last phase of treatment with IX milking (Figure 5.9). However, there was no 
apparent difference detectable between the groups in the first experiment.
More frequent samples were also collected and prolactin concentration profiles 
were obtained for each group at stages of lactation (Figure 5.10). Student’s unpaired 
t-test was used to determine any treatment effects but again both groups had very 
similar prolactin concentrations.
4.6 Growth hormone
Routinely collected blood samples were analysed for growth hormone content 
during experiment 1. There were indications of a slight downward trend as lactation 
progressed but concentrations were variable (Figure 5.11) and no significant differences 
were detected between treatment groups or in response to changed milking frequency. 
Frequently collected blood samples (Figure 5.12) also showed no differences between 
groups over time. Consequently, samples were not analysed for growth hormone 
content in the second experiment.
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Figure 5.8 Prolactin concentrations in control ( • )  and oxytocin (A) 
groups determined by routine blood sampling in (A) Experiment 1 and 
(B) Experiment 2.
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Figure 5.9 Statistical analysis o f prolactin concentrations in 
experiments 1 (A) and 2 (B), divided into treatment phases in control (open 
bars) and oxytocin treated (hatched bars) groups. Differences between 
groups were tested by Student’s unpaired t-test. n=4 for control groups and 
oxytocin in experiment 1, and n=5 in experiment 2.
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Treatments phases were as follows: pre-treatment - week 11, oxytocin 
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Figure 5.11 Effect o f treatment on growth hormone levels
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Figure 5.12 Growth hormone concentrations determined by frequent 
sampling in experiment 1 in control ( • )  and oxytocin (A) groups. 
Treatments phases were as follows: pre-treatment - week 11, oxytocin 
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5. DISCUSSION
The initial results of the effect of oxytocin on lactation persistency and milk 
production were encouraging; milk yields were maintained above controls during late 
lactation and lactation persistency was also positively affected. However the second 
experiment gave little response to treatment, confirming the observations of Nostrand 
et al (1991) of variable responses to treatment between animals. So how can this be 
explained? The main difference between the two experiments was that in the second 
the animals had been used for another study during the first six weeks of lactation and 
although these previous treatments were taken into account when control and oxytocin 
groups were assigned in this work, there may have been a general carry-over effect 
which reduced or prevented the possibility of an ’oxytocin response’. However, 
persistencies were generally similar in the control groups in both experiments 
suggesting that it did reflect a genuine difference in response to treatment. Another 
point to note is that both groups in the first experiment had a late peak in milk yields 
(around lactation weeks 17-20) which may indicate that they were subject to some 
nutritional constraint sometime after the initial peak in lactation, but again the 
similarity between the two control groups must be borne in mind. Parity might also 
have an effect; in experiment 1 3/4 primiparous animals were in each group while in 
experiment 2, 6 / 8  animals were on their 2nd lactation. If the main effect of oxytocin 
is to relieve the local inhibition of milk secretion then this would be expected to have 
more of an effect in animals with smaller cisterns and more alveolar storage of milk 
(Blatchford & Peaker, 1982), characteristics of primiparous animals.
To what extent could hormonal factors be responsible for influencing milk 
production? Prolactin is a lactogenic hormone and correlations have been derived 
between its release at milking and average monthly milk yields (Hart, 1974) but this 
is of debatable physiological significance because, in ruminants, artificial depression 
of circulating prolactin concentrations has little effect on milk yield during established 
lactation (Hart, 1974). It is possible that there is some interaction between oxytocin and 
prolactin beyond their temporal relationship (release at milking). However, a closer 
involvement is subject to debate; when suckling was studied in detail in rats it was 
found that prolactin release was pulsatile and that peak oxytocin concentrations 
occurred during prolactin minima (Higuchi et al, 1983). However, the magnitude and 
duration of prolactin peaks can be reduced by oxytocin antagonists and anti-oxytocin 
antibodies (Samson et al, 1986; Johnson & Negro-Villar, 1988). Anterior pituitary cells
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in culture specifically release prolactin on the addition of exogenous oxytocin (Samson 
et al, 1986) but no such response has been seen in vivo and any association between 
the two is probably at a neuroendocrine level (Higuchi et al, 1983). The observations 
presented here do not support the hypothesis of a link between circulating prolactin and 
milk yield, or between prolactin and oxytocin in general. Prolactin profiles were 
similar for both experiments although gross milk yields were different, and oxytocin- 
treated animals had variable prolactin levels although in the second experiment 
prolactin was lower than controls. More detailed sampling at various stages of lactation 
with samples around milking times were also collected but no differences were found 
between groups. Overall this suggests that the reduction in prolactin in the second 
experiment was probably not a side-effect of oxytocin treatment. Indeed, giving 
oxytocin by repeated injection would be predicted to have increased the stress on the 
animal, and in retrospect comparison with control groups would have been improved 
if vehicle-alone injections had been given. However, an elevation in prolactin with 
treatment would be predicted if there was stress (Hart, 1973a) but this was not seen. 
It could also affect appetites but the rate of weight gain was similar in all groups.
Another question addressed was how could oxytocin elicit a long-term effect? 
If it was acting metabolically one would expect both 2X and IX glands to have similar 
persistencies in the last treatment phase but if it was dependent on milk removal then 
poorer persistency would be predicted in IX milked glands. Oxytocin increased yields 
in the first experiment but little change was seen the the second, but the switch to IX 
milking did not cause a significant drop in yield in the latter. Regression analysis of 
yields indicated that IX milking did not decrease persistency as predicted. When 
oxytocin-treated glands were switched to IX milking they showed an improvement in 
persistency over contralateral 2X glands in 7 out of 9 animals. Of the remaining 2, one 
regression line gave a poor fit for the IX gland so was not a good comparison for the 
2X gland. A similar but less marked trend was also seen in the control group, 
suggesting that the observation might be ascribed to a change in milking frequency 
rather than an oxytocin effect per se. Due to this compounding factor the importance 
of removing milk at the time of oxytocin treatment could not be unequivocally 
determined, and the ’metabolic hypothesis’ could not be confirmed or refuted.
So how can this tolerance for reduced milking frequency and less rapid loss of 
milk production in late lactation be explained? Oxytocin seemed to enhance the 
persistency effect and it altered some milk storage characteristics in the udder.
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Treatment initially increased alveolar capacities, then maintained them, but trends were 
less clearly defined in the second experiment, probably reflecting the increased 
frequency of observations over a shorter time span. The observation of an increasing 
correlation between alveolar volume and milk secretion with lactation could indicate 
that absolute secretory tissue mass becomes more important as lactation progresses and 
as milk yields decline. If secretory cell number was maintained or improved in early 
lactation then there could be a carry-over into later lactation, potentially improving 
overall milk production without necessarily changing persistency. The oxytocin group 
did maintain their gross udder volumes above controls in late lactation, indicating a 
higher tissue mass although the increase could be attributed to, for example, thicker 
skin or more fat on the udder. Cisternal volumes were also higher in oxytocin animals 
in late lactation and this may partly explain their tolerance for infrequent milking. 
Local control of milk secretion is modulated through FIL but it must be in contact with 
secretory cells for autocrine inhibition to occur. If milk moves more readily into the 
cistern, then FIL essentially becomes inactive as it is distant from the secretory cells 
(Dewhurst & Knight, 1992). A change in milk storage dynamics due to, for example, 
a larger cistern, might promote or restrict the flow of milk away from its site of 
production, and could therefore alter milk yields via FIL action.
A further investigation of the influence of milking frequency on lactation 
persistency could be worthwhile as milking once a day would save on farming labour 
costs, although savings would be partly offset by increased milking times. Further 
experimental investigation could use three groups of animals which were milked twice 
a day until a specified time point and then either continued on twice-daily milking, 
switched to once-daily milking, or, as in this experiment, one gland switched to once- 
daily milking while the contralateral one continued on twice-daily milking. Comparison 
of milk yields could then indicate if it would be worthwhile reducing milking 
frequencies at this stage. Whether or not the regular use of oxytocin at milking is 
viable is questionable. The improvements in yield were at best variable and the 
administration route not suitable for widespread commercial use. However it may well 
be worth identifying animals which have poor persistency records and give them 
oxytocin at milkings. Sprain et al (1954) found that these animals responded well to 
treatment although there was no evidence for a persistency effect. Oxytocin may well 
work best with these animals whereas those which are already producing near their 
maximum potential will show little improvement in response to treatment. Further
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investigation of the influence on parity on the response to treatment could also be 
conducted. Selective oxytocin treatment in combination with altered milking frequency 
may well be the best solution for improving production and lactation persistency.
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CHAPTER 6
VARYING MODES OF MILK REMOVAL IN EARLY LACTATION AND THEIR 
EFFECTS ON LACTATION PERSISTENCY
1. INTRODUCTION
Mammary secretory tissue grows exponentially during late pregnancy and 
slower growth continues for several weeks after kidding, at least in primiparous goats 
(Knight, 1993) so if this growth pattern could be altered then it could affect overall 
milk production since this is dependent on secretory cell numbers and their activity. An 
alteration in growth could be stimulated by altering the method or frequency of milk 
removal post partum, for example, milking goats thrice-daily stimulated further growth 
and differentiation of the mammary glands (Wilde et al, 1987). So it might be expected 
that a short period of frequent milking in early lactation would have a long-term 
positive effect and conversely that infrequent milking early in lactation might have an 
unfavourable effect on development of the gland and on milk yields. Bar-Peled et al 
(1995) have provided some evidence for the former hypothesis in cows: increasing 
milking frequency from thrice- to six-times daily or milking with additional thrice-daily 
suckling, for six weeks post partum increased yields not only during treatment but 
significantly increased milk production when measured over an 18 week period.
The most natural method of increasing the frequency of milk removal is to keep 
goats with their kids after parturition, but there have been only a few reports on its 
long-term effects on gross milk production. Milk removal by suckling appears to be 
less efficient than machine milking as the latter can remove approximately 90% of the 
milk in the gland (Linzell & Peaker, 1971a) while two Damascus goat kids suckling 
thrice-daily (restricted to 15 minute intervals) for 38 days post partum removed, on 
average, 6 8 % of the available milk (Louca et al, 1975). However, it must be 
remembered that the ’efficiency’ of removal by kids will be restricted by their appetites 
and also by the time allowed for suckling, while there are no such constraints on 
machine milking. A more recent study, also in Damascus goats, found that kids 
allowed to suckle ad lib removed an average of 76% of the available milk over 
lactation days 3 to 38 and this regime had a significant and positive effect on lactational 
performance during the treatment period compared to goats milked twice daily 
(Hadjipanayiotou, 1986). In both studies no post-weaning carryover effect was found.
So why should there be differences in total milk yields between milked and
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suckled animals? Machine milking removes most of the milk in the gland but the 
physical stimulus is confined to the area where the teat is within the machine’s teat 
cup. This contrasts with suckling kids which vigorously push against and pummel the 
udder as well as sucking the teat. Both methods stimulate an acute reflexive release of 
prolactin (Johke, 1970) but cows can release significantly more prolactin and oxytocin 
in response to suckling and hand-milking rather than machine-milking; the magnitude 
and duration of peak hormone concentrations increases. So different methods of milk 
removal might result in subtly different hormone release profiles which, in turn, could 
influence the level of milk production. It has been suggested that the differential 
responses obtained by milking or suckling may be mediated through activation of 
specific sensory nerves in the teat involved in the neuroendocrine reflex (Svennerston, 
1990a,b) which modify the response to the stimulus applied. Goat kids would also be 
expected to remove milk more frequently than that of the standard milking practice 
(twice-daily) but even when suckling was restricted to the same times as milking an 
increase in yield was seen (Hadjipanayiotou, 1986).
Udder anatomy can influence the response of an animal to an alteration in 
milking frequency: goats with relatively small cisterns have lower rates of milk 
secretion per gram of secretory tissue than those with larger cisterns who store 
proportionately more milk there (Peaker & Blatchford, 1988). These observations are 
probably due to the increased inhibition of milk secretion by FIL which occurs when 
milk is directly in contact with secretory cells (Wilde et al, 1995). If milk moves away 
from these areas into cisternal regions then FIL effectively becomes inactive (Dewhurst 
& Knight, 1993). Animals which store a greater proportion of their milk in alveolar 
areas would therefore be expected to respond well to increases in milking frequency 
as this would relieve the local inhibition of secretion at a milking. Udder anatomy, sites 
of milk storage and milk production of cows is also influenced by parity (Dewhurst & 
Knight, 1993) while in goats it can affect the plane of production (Peris, 1994) so one 
would predict that there could also be differences between primiparous and multiparous 
animals in response to different milking regimes.
The primary aim of this work was to manipulate the mammary gland during 
early lactation by applying various milking frequencies and methods of milk removal. 
The short- and long-term effects of treatment were investigated with the hypothesis that 
increased milk removal would increase yield and possibly udder size, and that this 
may, in turn, be modulated by milk storage characteristics of the udder and hormone
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levels. Two studies were carried out over successive lactations to investigate the effects 
of once- and thrice-daily milking, suckling by kids, and continuous draining. All 
treatments in both experiments (with one exception) were unilateral (’treatment’ 
compared to IX milking) and this allowed a closer study of the local effects of milk 
removal as both glands experienced similar endocrine environments. The draining 
method was developed to examine the effect of allowing milk to continuously drain 
from the gland without accumulating in the udder and avoided the teat stimulation 
associated with conventional methods of milk removal. In the first experiment the 
groups were of mixed parity but in the second the response of primiparous and 
multiparous animals to unilateral once- and thrice-daily milking was tested while a third 
group (predominantly primiparous) were suckled bilaterally.
Prolactin and oxytocin responses to milking or suckling were measured and in 
the second experiment the suckling group were examined in more detail to investigate 
the influence of the presence of kids combined with the method of milk removal on 
prolactin profiles. The importance of the sites of milk storage within the udder in 
modifying responses to treatment was also considered. The majority of the observations 
were conducted during the treatment period (early lactation) however milk yields were 
recorded throughout lactation in both experiments. This allowed lactation persistency, 
that is the rate of decline in milk yields with time after peak lactation, to be measured 
and the long-term effects of early lactation treatments on milk production to be 
elucidated.
2. ANIMALS
British Saanen goats from the Institute herd were used and experiments 
commenced immediately post-partum. Animals had access to hay and water ad libitum 
and were offered 1.5kg of concentrated feed per day.
3. EXPERIMENTAL DESIGN
Two experiments were carried out over successive years with animals being 
selected on the basis of kidding date and parity (both the number of kids born and the 
number of previous lactations experienced). Treatments were milk removal by 
suckling, by milking thrice-daily (3X) or by continuous drainage. Animals giving birth 
to twins were preferentially assigned to suckled groups to ensure that suckled glands 
were adequately emptied during treatment. In the first experiment assignment to the
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remaining treatment groups was random. In the second experiment animals were 
selected for inclusion in parity-based 3/IX milking or bilateral suckling groups. With 
the exception of the latter, all treatments were based on a within-animal design 
whereby comparison was made with the contralateral gland milked once-daily (IX). 
Treatments were applied during the first 6 - 8  weeks of lactation and for the remainder 
of lactation all glands were milked twice-daily.
3.1 Experimental groups
Experiment 1
Kidding dates ranged from 4th-15th May, 1993. Three goats were assigned to 
the suckled group (all twins), three to the drained group ( 2  singles, 1 triplet) and four 
to the thrice-daily milking (3X) group (all singles). All mothers were multiparous (2-4 
lactations) with one exception in the suckle group (primiparous). Due to circumstances 
outwith the experiment the suckled group was reduced to 2  animals in the post­
treatment period. From week 13 onwards these animals were used in the oxytocin study 
detailed in Chapter 5, experiment 2.
Experiment 2
Six goats were assigned to the suckled group (all twins; mothers- 5 primiparous, 
1 multiparous), 6  primiparous goats were placed in the primiparous 3/IX group (3 
singles, 3 twins) and kidding dates ranged from l-13th March 1994. The first 6  
multiparous animals to kid after this period were assigned to the multiparous 3/IX 
group (kidding dates ranged from 15th March-1st April, 1994; 4 singles, 2 twins).
3.2 Treatments
Kids were removed from goats within 24 hours of birth with the 
exception of the suckled group’s kids who remained with their mothers throughout the 
treatment period. In the first experiment treatments commenced within 9 days of 
parturition and in the intervening period goats were milked twice-daily on both glands 
at 0800 and 1600h, allowing pre-treatment yields to be calculated for individual glands. 
In the second experiment treatments commenced within 24 hours of parturition so pre- 
treatment yields were not obtained.
Treatments were carried out for 6  weeks (Expt 1) or 6 - 8  weeks (Expt 2) and 
consisted of unilateral thrice-daily milking at 0 0 0 0 , 0800 and 1600h, suckling by kids 
(both experiments) or passive drainage (Expt 1 only). In the latter two groups treated
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glands were hand- or machine-milked at 1600h to remove any remaining milk, allowing 
estimation of the effectiveness of the treatment. All contralateral glands were milked 
once-daily at 1600h (IX) with the exception of the suckled group in the second 
experiment when both glands were suckled. In experiment 1 this protocol was followed 
6  days per week while the 7th day was designated as a ’measurement day’ (see p. 129). 
In experiment 2, the treatments were applied as detailed above for all but 3 days when 
additional measurements were made in the suckled group (weigh-suckle-weigh) (see 
p. 129).
Post-treatment all goats were milked on both glands twice-daily at 0800 and 1600h.
Methods used to apply treatments 
Suckled group
During the pre-treatment period in experiment 1 kids were kept with their 
mothers and a device designed to cover the goat’s udder to prevent them suckling. This 
was further modified once treatments commenced to allow unilateral suckling. The 
’unilateral suckling device’ (Plate 6.1) was composed of a length of Tubigrip (Seton 
Healthcare Group, Oldham, UK) sewn into a bag and shaped to fit the udder. A small 
hole was formed and reinforced to allow protrusion of one teat, giving kids access to 
that teat only. An adjustable elastic band was sewn into the top of the device and fitted 
around the base of the udder against the body wall. A further piece of elastic formed 
a brace over the hips of the animal and led to the collar to prevent the device slipping 
or being pulled off the udder by the kids.
In the second experiment the treatment was modified to a bilateral one (allowing 
kids access to both teats) so the udder was not covered during the experiment. 
Drained group
The drained group were housed in single pens with sawdust bedding changed 
on alternate days to ensure cleanliness. A sterilised teat cannula (Boviplug, Veterinary 
Drug Co, York, UK) was carefully inserted into the teat canal, allowing milk to drain 
continuously from the gland (Plate 6.2). Patency was checked regularly and teats 
cleaned frequently with a sterilising solution (2% hibitane in 70% alcohol) to reduce 
contamination and the risk of mastitis. The small but fairly constant flow of milk from 
the gland, seen especially when goats were standing up, also helped to minimise 
infection in the teat.
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mjfeQSHr*ment yM d in treated elands
In the first experiment, one day per week was designated as a ’measurement 
^ y ’ on which the milk yield of treated glands was determined by milking at 1600, 
0000 and 0800h with exogenous oxytocin (0.4IU i.v.) to ensure complete milk 
rernoval. In the suckled group, kids were separated from their mothers, and the drained 
group had their teat cannulas either removed or closed during this period. Contralateral 
IX glands were milked at the normal time of 1600h.
In the second experiment the suckled group were subjected to three periods of 
weigh-suckle-weigh measurements (adapted from the method described by Louca et al, 
1975) made in weeks 1, 3 and 6 in which milk yields were estimated by measuring the 
amount of milk removed by kids. This improved the continuity of treatment but gave 
a gross yield for each animal rather than an individual gland yield. The technique used 
was as follows: kids were separated from their mothers after milking at 1600h and 
were weighed immediately prior to suckling bouts, each of which lasted for a 
maximum of 15 minutes, carried out at 0000, 0800 and 1600h. Once satiated, kids 
were reweighed, the weight difference representing their milk intake. While suckling 
they were carefully watched for signs of urination as this would cause underestimation 
of suckled milk. After each suckling bout mother and kids were again separated. After 
the 1600h measurement, goats were given oxytocin (0.4IU) and hand-milked to allow 
estimation of the efficiency of milk removal by the kids.
Both suckling and draining proved effective in keeping the gland relatively 
empty with approximately 250ml milk being removed each day by hand milking in 
experiment 1. Bilateral suckling in experiment 2 was also effective with an average of 
190ml/d being obtained from each gland by hand-milking.
3*3 Measurements
A variety of measurements were made, summarised in Table 6.1. Briefly, 
^dividual gland milk yields were recorded throughout lactation and milk samples 
collected periodically for gross compositional analysis. Cisternal and alveolar milk 
borage characteristics were measured at the times indicated after 5 hours milk 
Cumulation. An additional measurement of gross gland volume was made in 
exPeriment 2 immediately after milk storage measurements. A casting method was 
Used, as described in Chapter 2, udder mid-lines were marked (Sprayline stock marker, 
Ritchey Tagg, Masham, UK) and some of this dye was transferred from the udder onto
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Group/
Measurement
Experiment 1 
all groups Primiparous
Experiment 2 
Multiparous Suckled
Commencement 
o f treatment
within 9 days 
post-partum
within 24h post-partum
weigh-suckle-
weigh
- - - d5-9, d20-28 & 
d35-43
milk
composition
weeks 1, 3 & 6 d6-9 & d38-42 d6-9 & d32-40 d6-10 & d36-43
milk storage weeks 0 & 5 d2-7 & d39-41 d3-7 & d40-49 d2-5 & C39-43
blood samples 
routine
collected twice-weekly at 1400h
blood samples 
frequents
weeks 0, 3-4 & 6 d26-35 - d29-39
gross weights once weekly
biopsies week 7 dl3-15 - dl2-16
termination o f 
treatment
week 7 d40-51 d43-60 d45-52
Table 6 . 1  Summary of measurements made and scheduling during
experiments 1 and 2. Note that in the former measurements were based on 
experimental week (week 0 = pre-treatment) whilst in the latter 
measurements were conducted with respect to lactation day.
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the cast during casting. This allowed identification and measurement of individual gland 
volumes by extrapolation, assuming a vertical midline.
Routine blood samples were collected twice weekly at 1400h for the 
determination of prolactin by RIA (Chapter 2). More frequent blood sampling was also 
conducted in both experiments and prolactin measured, but the aims and timings of the 
frequent sampling varied slightly between the two experiments. Measurement of 
oxytocin concentrations (by RIA) in experiment 2 were kindly performed by Berit 
Samuelsson and Kerstin Svennersten, Sveriges Lantbruksuniversitet, Uppsala, Sweden.
In experiment 1 animals were cannulated at 0900 on the sampling day, or 
between 1600 and 1700 on the preceeding day, and hourly blood samples collected 
from 0900 until 1300h. This was followed by two windows of more frequent sampling 
at -30, -15, -10, -4, -2, zero, 2, 4, 6 , 8 , 10, 15, 30 and 60 minute intervals. At time 
zero (1400h) the suckled group’s kids were allowed to suckle for several minutes, for 
the other groups this was a control sampling window with no teat stimulation. The 
sequence was repeated but at the second time zero (1600h) all goats were machine 
milked. A maximum of three goats were measured on any one day and suckled animals 
were separated from their kids between 1600 and 1700h on the preceeding day and 
reunited once the sampling day was completed. This design allowed a comparison 
within the suckle group of their responses to suckling and milking, and between them 
and the drain and 3X groups in their responses to machine milking, over the 
experimental period.
In experiment 2 the aim was to investigate in detail the response of suckled 
animals to the presence or absence of kids, in combination with the application of 
suckling or milking stimuli. The group was arbitrarily divided into two subgroups of 
3 which were randomly tested with the following four combinations conducted out on 
successive days: (a) kids present throughout the day, suckling stimulus, (b) kids 
present, milking stimulus, (c) kids removed, replaced briefly for suckling stimulus and 
(d) kids removed, milking stimulus. As an additional comparison the 3/IX primiparous 
group was subdivided into two groups which were used as controls when the no kids, 
milking combination (d) was tested in the suckled group. Animals were cannulated at 
0900 on the first day of the investigation. Samples were collected hourly from 0900- 
1300 then a single frequent sampling window was carried out at -60, -30, -20, -12, -8 , 
-4, zero, 4, 8 , 12, 20, 30 and 60 minute intervals. At time zero (1500h) goats were 
either suckled or machine milked for approximately 4 minutes. If kids were present
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during the day they were removed one hour prior to time zero, if not they were 
removed at 1700h on the day preceeding the measurement. A maximum of nine goats 
were sampled on any one day.
Biopsies were carried out in both experiments using the method of Knight & 
Peaker (1984), providing samples for other experiments performed by colleagues 
(results not shown).
3.4 Calculation of relative milk yield quotients
Relative milk yield quotients (RMYQ) were used to measure the effect of 
treatment on opposing glands within animals (Linzell & Peaker, 1971). The following 
equation was used:
RMYQ = (Tt . Cc) / (Tc. Q)
T = treatment gland 
C = control gland 
t = treatment period 
c = control period
A value greater than 1.00 indicates an increase in the yield of the treated 
gland relative to the control, while a RMYQ of less than 1.00 indicates a decrease 
relative to the control gland. In experiment 1, period 1 was before treatment 
commenced, in experiment 2  it was shortly after the start of treatment since treatment 
commenced at parturition. For both experiments period 2 was week 6  of treatment.
3.5 Statistical comparisons
Unless stated otherwise, statistical analysis was conducted using Student’s paired 
or unpaired t-test, as appropriate, to compare between glands or between groups.
4. RESULTS
4.1 Milk yields
In experiment 1, treated glands were subjected to unilateral suckling, 3X 
milking or draining, while contralateral glands were milked IX. Milk yields from 
treated glands were compared on measurement days and expressed as a percentage of 
the average daily yield obtained on 3 days immediately before treatment commenced 
(Figure 6.1). Lactational profiles of milk yields were also plotted (Figure 6.2) to 
illustrate the average daily yields obtained on both treatment and measurement days
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Figure 6.1 Milk yields determined on measurement days in 
Experiment 1, expressed as a percentage o f the pre-treatment yield, 
determined during twice-daily milking.. Treatment glands ( • )  were (A) 
milked thrice-daily, (B) drained or (C) suckled while contralateral glands 
(O ) were milked once-daily.
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Figure 6.2 Average daily milk yields measured in Experiment 1. 
Treatment glands ( • )  were (A) milked thrice-daily, (B) drained or 
(C) suckled while contralateral glands (O ) were milked once-daily.
On measurement days all treatment glands were milked thrice-daily, yields 
represented by (★). All glands were milked twice-daily from week 7 
onwards.
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during the treatment period, and during routine twice-daily milking after treatments had 
ceased. Finally the effectiveness of treatment within animals was assessed by 
calculation of relative milk yield quotients (RMYQ’s).
Suckling significantly increased yields over opposing IX glands when compared 
on measurement days both on a percentage basis, and on actual yields (p< 0 .0 1 ), 
confirmed by RMYQ values (1.611 ± 0.14, p=0.048). A similar pattern was seen in 
response to 3X milking (p< 0.004) although the treatment effect measured by RMYQ 
was not as marked (1.439 ±  0.13, p=0.074). Draining did not stimulate milk 
production with percentages and yields similar to those of contralateral IX glands and 
the RMYQ of 0.901 ±  0.18 (p=0.63) reflected this lack of response. There may have 
been some carryover of suckling and 3X milking onto contralateral IX glands during 
treatment as they increased their percentage yields above those of drained group’s IX 
glands (p<0.05), but this was not apparent when absolute yields were compared, 
suggesting that any overall effect was small. In the post-treatment period 3X glands 
consistently produced more milk than contralateral IX glands with an average 
difference of 0.265 ± 0.019 1/d (n = 15, p < 0.0001). This effect was reduced towards 
the end of the experimental period but this was after a prolonged period (16 weeks) of 
twice-daily milking. No significant effect of early lactation treatment on yield in the 
post-treatment period (weeks 7-22) was seen in the other groups; the improved yield 
in the suckled group IX glands provided insufficient data for analysis as there were 
only 2  animals available for measurement.
In experiment 2 milk yields were determined over the lactational period (Figure
6.3) and statistical analysis conducted (Figure 6.4). During the treatment phase, yields 
obtained by weigh-suckle-weigh measurements from bilaterally suckled animals were 
compared to those obtained of the other groups; suckled glands produced more milk 
than primiparous IX ones (p=0.01). In the post-treatment period a difference in yield 
between suckled glands was found (p= 0 .0 0 0 1 ), despite receiving identical treatments 
throughout. This may reflect an inherent imbalance between the glands due to 
circumstances outwith the experiment, not apparent during the treatment phase as yields 
were measured on a whole animal basis then divided by 2  to obtain an average gland 
yield.
3X milking increased yields above contralateral IX glands in the primiparous 
group (p=0.0001) and an RMYQ of 1.494 + 0.21 (p=0.062) was calculated, 
confirming the results obtained in experiment 1. There was some carryover of
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(A) During the treatment period both glands were suckled in the suckle 
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Figure 6.4 Statistical analysis o f milk yields in Experiment 2, n=6 for 
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bars represent 3X glands and diagonal-hatched bars represent IX glands.
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treatment apparent in weeks 7-9 (p=0.039) but not thereafter. 3/1X Multiparous 
animals also increased yields in response to 3X milking but proved remarkably tolerant 
of IX milking. Both glands had very similar yields during treatment, reflected in the 
RMYQ of 1.008 ±  0.14. Meaned data for this group (Figure 6.4) indicated that in the 
post-treatment period glands previously milked IX produced more milk than 
contralateral 3X glands. When the data was examined more closely and Student’s 
paired t-test used to calculate statistical significance, the average difference between IX 
and 3X glands of each animal over lactation weeks 7-24 was calculated to be 0.174 ±  
0.024 1/d. This was highly significant (p < 0.0001), indicating a carryover effect of 
early lactation IX milking on milk production in later lactation. This group also 
produced the largest volume of milk (an average of 3.691/d compared to 2.38 and 2.60 
1/d in suckled and 3/1X primiparous groups respectively, p<0.01).
4.2 Lactation persistency
Lactation persistency was measured over weeks 8  to 22 in experiment 1 and 
weeks 10-24 in experiment 2 when all glands were milked twice daily (Table 6.2). A 
general trend of improved persistency in IX glands was seen in all but the multiparous 
3 /IX group (15/20 IX glands had higher persistencies over contralateral IX glands), 
but the effect was significant only in the 3/1X group in experiment 1 (p=0.009). 
However it must be remembered that contralateral glands were being emptied 2X 
throughout this period so there was twice-daily milking-induced hormone release, 
which probably influenced persistency in IX glands. The bilaterally suckled and 
primiparous 3/IX groups had the highest persistencies, regardless of treatment; the 
former group contained 5/6 primiparous animals, suggesting that parity may also be 
a factor influencing persistency. When the regression lines for individual glands in 
experiment 2  were divided into whether animals were primi- or multi-parous, it was 
found that the former had significantly higher persistencies over the latter (an average 
drop of -17.3 ml/d for primiparous animals, -30.5 ml/d for multiparous, p=0.043).
4.3 Milk composition
Bulk milk samples were collected from all glands and all goats in both 
experiments. They were analysed for protein, lactose, fat and solids content but no 
significant effects of treatment within animals or between groups was found (Table
6.3).
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Treated gland Contralateral (IX) gland
Group m 2r P m
2r P
Mixed 3/IX -43.7 77.2 0 . 0 0 1 -27.6 63.5 0.033
(11.3) (14.4) (0 .0 0 1 ) (9.0) (2 2 .0 ) (0.033)
Primiparous - 1 1 .1 26.3 0 . 2 1 1 -4.5 12.3 0.500
3/1X (2.9) (9.5) (0.130) (2 .0 ) (6.9) (0.165)
Multiparous -28.8 51.1 0.026 -34.5 26.9 0.017
3/1X (6 .8 ) (11.4) (0.013) (3.8) ( 1 2 .8 ) (0 .0 1 2 )
Drained -48.9 63.6 0 . 0 0 0 -19.1 37.9 0 . 1 0 1
(28.7) (8.4) (0 .0 0 0 ) (7.6) (21.5) (0.062)
Suckled -75.0 84.5 0 . 0 0 0 -36.5 71.7 0 . 0 0 1
unilaterally (2 1 .0 ) (7.1) (0 .0 0 0 ) (16.6) ( 1 1 .6 ) (0 .0 0 1 )
Suckled -16.4 41.8 0 . 1 0 1 -6 . 0 43.2 0.303
bilaterally (4.4) (1 2 .0 ) (0.063) (9.6) (15.2) (0.189)
Table 6.2 Summary of regression lines (m) fitted to individual milk
yield curves for each animal’s glands in both experiments. The fit of the line 
(r2) and probability (p) are as indicated. Numbers in brackets represent the 
sem with the exception of the suckled unilaterally group when it represented 
the sd. Group sizes were as follows:
Mixed 3/1X n=4; drained n=3; suckled n=2 (all expt 1); primiparous3/lX, 
multiparous 3/1X & suckled bilaterally n= 6  (all expt 2).
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4.4 Udder characteristics
Sites o f milk storage
A summary of alveolar and cisternal storage volumes, and of cisternal 
percentages obtained in experiment 1 are shown in Figures 6.5 and 6 .6 . There were 
no statistically significant differences between groups in their alveolar and cisternal 
storage characteristics in week 0 (pre-treatment) or after 5 weeks of treatment, 
reflecting the variation between individuals. However, there were changes within 
glands, across time, in response to treatment. Alveolar volumes increased in suckled 
and 3X glands while cistern proportion dropped, suggesting a positive effect of 
treatment on the secretory cell population. Drained and IX glands increased or 
maintained cisternal volumes, decreased alveolar volumes and consequently IX milking 
increased cistern percentage in all three groups. The reduction in alveolar capacity 
suggests that this regime was not particularly effective in maintaining secretory cell 
function, most probably due to a lack of stimulation. Visual confirmation of the trend 
of cistern proportion increasing was obtained- after an identical period of milk 
accumulation more milk was seen in the cistern of IX glands than in contralateral 
treatment glands (Plate 6.3).
The results obtained in experiment 2 are summarised in Figures 6.7 and 6 .8 . 
At the start of treatment (week 1) there were some significant differences between the 
groups in their storage characteristics. The 3/IX multiparous group had the highest 
cisternal capacity (p<0.05), while the 3/1X primiparous group had the lowest alveolar 
capacities (p<0.05). These observations most probably reflect parity effects as 
measurements were made shortly post partum. In all 3 groups cisternal volumes and 
cistern proportion increased over the treatment period, while alveolar volumes dropped, 
significantly so in primiparous IX glands (p< 0.001), indicating a particular lack of 
tolerance for IX milking in this group. In contrast, multiparous animals had the highest 
alveolar volumes at the end of the treatment period (p < 0.05), corresponding with their 
high levels of milk production from both glands.
Gross udder volumes
In experiment 2, gross udder volumes were determined by casting, then the cast 
was cut along the midline and individual gland volumes estimated. The 3/IX 
multiparous group had the largest glands throughout (p < 0 .0 1 ), supporting their higher 
level of milk production, while 3/IX primiparous animals had the smallest (Figure 
6 .8 ). Treatment did not significantly affect gland volumes, all dropped over the six 
week period with the exception of IX glands in the 3/IX multiparous group.
141
3X group
5 00
_  4 0 0
(J
300
20 0
100
400
E 300
200
100
Drained group
50 0
<D
—b
4 0 0
30 0
200
100
40 0
^  300
200
100
Suckled group
5 0 0
_  4 0 0
E
O
30 0
200
1 0 0
0 L
I
JL
&
40 0
300
200
100
0
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bars represent IX glands, the others were treated as detailed.
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Plate 6.3 One o f the drained group just prior to the 1600h milking
on a measurement day. Both glands were emptied at the last milking 
(0800h) and the teat cannula in the right gland plugged. Note the 
distended appearance o f the left (once-daily milked) gland in the cisternal 
area, while the right gland appears more swollen in the alveolar area. After 
milking with oxytocin a similar yield was obtained from each gland.
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4.5 Hormone determinations
Routine sampling
Prolactin concentrations determined by routine sampling in both experiments are 
illustrated in Figure 6.9. During early lactation concentrations were particularly 
variable but both experiments showed a decline in prolactin concentrations after 
treatment stopped, consistent with observations of declining prolactin as lactation 
progresses (Hart, 1972). Statistical analysis was conducted on the basis of treatment 
phase (Figure 6.10). In experiment 1 the drained group had significantly lower 
prolactin levels than the suckled and 3X groups during treatment (p< 0.006), but no 
other statistical differences were found between groups in either experiment.
Frequent sampling
Frequent blood sampling allowed a more detailed profile of hormone 
concentrations to be determined both through the day and in response to milking or 
suckling stimuli (Figures 6.11, 6.12 and 6.13). The results obtained were analysed by 
calculating the total area under the hormone concentration profile curve (areas under 
the curve, AUC) (Table 6.4).
Experiment 1
Drained and 3X groups had higher prolactin concentrations in the first few 
samples collected in week 0 than was seen in subsequent weeks (Figure 6 .11), possibly 
reflecting increased levels of stress as this was the first time the animals had been 
subjected to the procedure. The drained group had the lowest prolactin levels during 
treatment (excluding the first 3 measurements in week 0), significantly lower than the 
other two groups by week 6  (p < 0 .0 1 ) and they showed a diminishing response to 
milking with time (p<0.01 by week 6 ). Their AUC was significantly less than that of 
the 3X group in week 3 (p=0.040) and these observations support the hypothesis that 
passive drainage allows milk removal but avoids the characteristic milking-induced 
hormone release. The suckled group increased their AUC between weeks 3 and 6  
(p=0.042) and comparison of actual prolactin concentrations supported this; increases 
were detected between each measurement week (p<0.05). However there was little 
response to either suckling or milking in weeks 3 and 6 . The 3X group also increased 
prolactin concentrations between weeks 3 and 6  (p< 0.001) but, in contrast to suckled 
animals, responded well to the milking stimulus throughout.
Oxytocin results are illustrated in Figure 6.12 and Table 6.4. Calculation of 
AUCs found no significant inter- or intra-group differences at any timepoint. Analysis
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Figure 6.9 Plasma prolactin concentrations determined by routine 
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drained and (A) suckled groups, and (B) Experiment 2  where ( • )  represents 
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Measurement/
Group
Area under the curve
week 0 week 3 week 6
Prolactin
Suckled 2323 (263) 4237 (364) 7689 (2110)
3X 4207 (568) 4232 (645) 6673 (2242)
Drained 7183 (1615) 2429 (371) 3845 (1750)
Oxytocin
Suckled 121 (54) 107(42) 197 (96)
3X 135 (14) 186 (30) 166 (43)
Drained 153 (63) 91 (29) 92(19)
Table 6.4 Analysis of prolactin and oxytocin ‘environments’
experienced by animals during the day as determined by frequent blood 
sampling in experiment 1. Numbers in brackets represent sems and n=3 for 
each measurement. Statistical significance is indicated in the text .
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of oxytocin concentrations found significant increases in the 3X group at each 
measurement week (p < 0.007), above that of the suckled group in week 0 (p < 0.009) 
and above suckled and drained groups in week 3 (p < 0.0001). However on week 6  
there were no significant differences between the groups. Comparison of oxytocin 
profiles found that in general there was a clear oxytocin response to machine milking 
in the 3X group which increased from week 0, a poor response in suckled animals and 
an improving response in the drained group.
The suckled group showed contrasting reactions to milking stimuli which varied 
between measurement weeks. When milked in week 0 they showed a characteristic 
prolactin peak, albeit of lesser magnitude than the other groups, but no detectable 
oxytocin release, by mid-treatment there was little response to either suckling or 
milking and by the end of treatment both stimuli elicited prolactin release. In both latter 
cases oxytocin release was greater in response to suckling than milking. It was 
therefore decided to look at this group in more detail in the follow-up work. 
Experiment 2
This aimed to clarify the prolactin response to suckling and milking stimuli in 
the suckled group with kids being present throughout the day or absent except for a 
brief suckling period (Figure 6.13). The primiparous group was used as a control 
comparison for the ’kids absent, milked’ combination. When AUC’s were compared 
over the whole day (Table 6.5) the only significant difference found was the kids 
present, suckled resulted in higher AUC than the kids absent, suckled combination 
(p=0.024) and neared significance when compared to kids present, milked (p=0.068). 
This pattern was reinforced when concentrations were compared- kids present, suckled 
resulted in higher prolactin than the other treatments (p < 0 .0 0 1 ).
The response to teat stimulation was varied. In the control animals there was 
no clear prolactin peak at milking, although a small and sustained rise was detected. 
A similar pattern was seen when kids were absent and milked in the suckled group- 
their response was greater but of similar duration. A very clear prolactin peak was 
obtained when these animals were suckled and levels remained elevated over a similar 
time. When kids were present there was a reduced response to milking- the peak was 
of similar magnitude but of shorter duration. The kids present, suckled combination 
gave a much higher basal prolactin level throughout the day, probably reflecting 
intermittent suckling by the kids, and the highest peak was obtained with suckling 
although levels rapidly fell after the stimulus.
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Suckled group kids Stimulus Area under curve
Present Suckling 5766 (571)
Milking 4357 (347)
Absent Suckling 3917 (344)
Milking 4312(843)
Primiparous group
Absent Milking 4185 (647)
Table 6.5 Analysis of the prolactin environment experienced in
specific conditions in experiment 2. Numbers in brackets represent sems and 
n= 6  for each measurement.
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5. DISCUSSION
The main aim of the experiment was to investigate the short- and long-term 
effects of different methods and frequencies of milk removal on milk yield and on 
lactation persistency. Suckling had a positive effect on milk yields compared to 
contralateral IX glands, milk yields of suckled glands being similar to that of 3X 
milked glands (compared on measurement days and by weigh-suckle-weighing). Milk 
removal by kids was relatively efficient with an average of approximately 2 0 0 ml 
remaining in the gland after a 24 hour suckling period (range 30-440ml). When 
residual milk was measured after 3 weigh-suckle-weigh episodes over 24 hours the 
efficiency of removal varied from 62 to 100% with an average of 91 %. This contrasts 
with previous work (Louca et al, 1975; Hadjipanayiotou, 1986) which found that 
suckling was not particularly efficient in removing milk (68-78% suckled). Suckling 
was restricted to twice-daily in these studies while in the experiments described here 
kids were allowed to suckle freely. However on measurement or weigh-suckle-weigh 
days when access was restricted to thrice-daily there was still relatively complete milk 
removal. It may well be that the differences reflect the appetites of the kids rather than 
the effectiveness of the stimulation; indeed close examination of the weigh-suckle-weigh 
data illustrated that the poorest ’removal percentages’ were associated with an 8  hour 
milk yield in excess of 1 0 0 0 ml and the converse was true for yields of under 1 0 0 0 ml. 
Combining milking with suckling will ensure regular emptying of glands and also 
provide the vigorous teat stimulation of suckling and this has resulted in an overall 
increase in production in cows, above that of those milked at identical intervals (Bar- 
Peled et al, 1995).
We found no long term positive effects of suckling on lactation persistency, 
confirming the results of Louca et al (1975) and Hadjipanayiotou (1986). Murciano- 
Granadina goats who suckled their kids for 7 weeks post partum, when switched to 
twice-daily milking also had very similar yields to those milked twice-daily throughout 
(Peris, 1994). In the first experiment the persistency profile was very poor for suckled 
glands but there were only 2  animals available for measurement in the post-treatment 
period and there may have been complications such as teat damage which contributed 
to the rate of decline. In the second experiment suckled group’s persistency was 
comparable to that of the 3/IX primiparous group, suggesting that the effect might also 
be attributable to an effect of parity, as well as a treatment effect. In both of these 
groups there was little decline in milk yield with a loss of approximately 125ml milk
156
over the 14 week post-treatment period. It may be that the continued growth of the 
mammary gland in early lactation (Knight & Wilde, 1993) and the effect of 
milking/suckling combine to maintain mammary function. The benefits of suckling 
remain variable as during treatment yields are enhanced but milk is lost to the kids; 
advantageous to those investing in and rearing kids, but not to those relying 
economically on milk production itself. Perhaps a compromise of both suckling and 
milking may provide the key in not only allowing the rearing of kids and collection of 
marketable milk, but also having a potential long-term positive effect on lactational 
performance as indicated in cows (Bar-Peled et al, 1995).
Hormone levels will play a role in the modulation of treatments on milk yield 
and lactation persistency; analysis of routinely collected samples showed that during 
the treatment phase the drained group had significantly lower prolactin concentrations 
than the other two groups and they responded poorly to treatment in terms of enhancing 
milk yield, but no significant differences were detected in experiment 2  or post­
treatment in either experiment. However it must be borne in mind that these samples 
provide a ’snapshot’ of the plasma concentration at that particular time. More frequent 
sampling attempted to elucidate group differences in more detail. Draining had the least 
effect in enhancing milk yields, the treatment avoided teat stimulation and milk ejection 
occurred only once every 24 hours when animals were machine milked. Basal hormone 
concentrations reflected the lack of stimuli but at milking oxytocin was released. The 
magnitude of the response was not restricted by the treatment, reflecting the level of 
stimulus that milking provides. 3X milked animals had, in general, the highest hormone 
levels and responded well to milking, especially by the end of the treatment phase. 
They had higher milk yields and this may reflect a combination of frequent milk 
removal and teat stimulation maintaining favourable hormonal conditions and reducing 
local inhibition of milk secretion. Suckled animals showed variable responses to 
suckling and milking. The follow-up in experiment 2 found a more distinct release of 
prolactin with suckling, rather than milking and higher overall levels associated with 
the presence of kids. However the elevated basal level seen when kids were present and 
suckling at time 0 , rather than milked, cannot be explained as one would predict 
similar levels for both stimuli. The response in the control group was also less than 
expected from the initial results and the overall differences may partly reflect the 
timing of frequent blood sampling which was carried out from week 3-4 onwards, a 
period in which hormonal fluctuations (determined in routine samples) were less
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marked.
So how can the teat stimulation of suckling or milking produce different 
hormonal release patterns? The physical stimulus of kids suckling as opposed to 
milking by machine affects the magnitude and pattern of hormone release (Svennersten, 
1990). Conditioned responses at milking will play a role in facilitating hormonal release 
and if animals are suckled when the environmental cues associated with milking are 
absent then this could alter the hormonal response. In experiment 1 prolactin release 
appeared to be inhibited by presence of kids, as has been seen in cows kept with their 
calves (Akers & Lefcourt, 1984). This restriction could be due to increased stimulation 
of the mammary gland due to intermittant suckling, increasing pituitary depletion of 
stored prolactin, or reducing the response to suckling by a process of down-regulation 
(Johke, 1970).
Increased milking frequency, to thrice-daily, improved milk yields during the 
treatment period in primiparous goats, but this response was lacking in multiparous 
animals receiving identical treatments. The response to increased milking frequency has 
been observed in Saanen goats by several authors; Henderson et al (1983) using 
animals on their 2nd to 5th lactations and Wilde et al (1987) whose group comprised 
of 6  primiparous and a multiparous (9th lactation) animal. So why did we find a lack 
of response in our multiparous group of goats on their 5th-7th lactations? One clear 
difference between our groups was that multiparous animals produced larger volumes 
of milk but showed poor lactation persistency. A similar effect has been seen in 
Murciano-Granadina goats; third lactation animals had significantly higher daily milk 
yields than primiparous ones, but reduced lactation persistency (Peris, 1994). Another 
difference between the groups was that multiparous animals had significantly larger 
udders than primiparous animals although cisternal and alveolar milk storage 
characteristics were not significantly different. This could reflect the short period 
allowed for milk accumulation before measurements of the sites of milk storage were 
made, and it is conceivable that differences were present but undetectable after five 
hours. This time period had been chosen to provide minimal interference to the 
treatments being applied in the experiments.
In experiment 1 a significant carryover effect of 3X milking on milk yields in 
the post-treatment period was found when compared to IX glands. This indicated a 
local and long-term effect which could reflect an increase in secretory tissue or its 
differentiation in the 3X gland, or a physical alteration of milk storage which improves
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the efficiency of milk production. The effect was not confirmed in the second 
experiment and our initial observations may reflect that the group were subsequently 
used in another experiment, while in experiment 2  animals received no additional 
treatments. It could also be due in part to parity effects as the 3/IX group in 
experiment 1 was of mixed parity.
A long-term carryover effect of IX milking in early lactation on subsequent 
milk yields was found in the 3/IX multiparous group. The effect was apparent 
throughout the post-treatment period although the level of persistency between IX and 
3X glands was similar. The effect could well be due to the physical effect of milk 
accumulating in the gland over a 24 hour period which would continue beyond the 
treatment period. If cistern capacity was increased then the local inhibitory effects of 
FIL in milk could be reduced as milk left the alveolar areas and entered the cistern, 
improving the efficiency of milk production.
It was hypothesised that drainage would improve milk yields over once-daily 
milking as milk would not accumulate in the gland and there would be reduced 
feedback inhibition of secretion. However drained glands showed no stimulation of 
yield even though milk removal was fairly continuous and there was virtually no 
accumulation of milk in the cistern. These observations could be explained by the 
requirement for milk to be removed specifically from secretory cells for FIL inhibition 
to be reduced. During draining milk was merely overspilling from the alveolar areas 
and draining away without stimulating the teat there would be no stimulation of 
hormone release and consequently no milk ejection. The secretory cell environment 
was probably comparable to the gland being milked once-daily, the similarities in yields 
between IX and drained glands suggested that this was indeed the case. All IX glands 
showed an increase in yield over the treatment period. Multiparous animals were most 
tolerant of this regime and post-treatment there was a distinct trend of improved 
persistency in IX glands, albeit not statistically significant.
So in conclusion, the sites of milk storage may also modulate the yield response 
of an animal to various modes of milk removal. Suckling was generally associated with 
increasing alveolar capacity and decreasing cisternal storage, resulting in a lower 
proportion of milk being stored in the cistern. These observations were consistent with 
frequent milk removal providing little opportunity for milk to accumulate and ’stretch’ 
the cistern. Secretory capacity was probably maintained by a combination of more 
frequent and complete milk removal minimising FIL inhibition of secretion, and as a
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response to the vigorous teat stimulation and massage of the udder by the kids. Once- 
daily milking in early lactation gave steady or slight increases in milk yield and was 
associated with increasing cisternal volumes, decreasing alveolar volumes and hence 
a greater proportion of milk was stored cistemally by the end of the treatment period. 
On the switch to twice-daily milking these glands showed greater lactation persistency 
than those on other treatments (with the exception of the 3/IX multiparous group) and 
was the most consistent effect seen in this work. The suggestion is that increased milk 
accumulation times caused a long-term alteration in milk storage sites, namely milk 
moving more readily into the cistern. However effects on udder storage were not as 
marked as the persistency profiles suggested. This may be due to the relatively short 
time after milking that the measurements were made (5 hours post-milking) and also 
that measurements were made during early lactation. Perhaps if measurements were 
made after 8  or even 1 2  hours milk accumulation and at various points in later lactation 
then more pronounced effects on the partitioning of milk in the udder could be 
detected.
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CHAPTER 7
CAN CASEINS IN MILK INDICATE LACTATION PERSISTENCY?
1. INTRODUCTION
Various physiological and cellular changes occur within the mammary gland to 
support the process of lactation. Milk yields are determined predominantly by the 
number and activity of the secretory cells in the gland (Oliver & Sordillo, 1989) and 
as yields fall after peak lactation the gland gradually involutes. In goats the decline in 
yield is accounted for by decreased cell number without a corresponding reduction in 
their secretory activity (Wilde & Knight, 1989) whilst in rats cellular activity alone, 
(Knight et al, 1984), and a combination of activity and cell number in mice (Shipman 
et al, 1987) determine yield. Most studies investigating involution have used the acute 
stimulus of stopping milk removal entirely and observing the consequences of this, for 
example after the cessation of milking in cows (Holst et al, 1987) or after litter 
removal in rodents (Walker et al, 1989). However this does not accurately mimic the 
gradual process of involution which occurs during declining lactation and can be spread 
over a period of months in ruminants.
During declining lactation the mammary tissue is gradually remodelled until 
milk production ceases and the gland is fully involuted. This process is modulated by 
plasminogen activator (PA) (which also operates in a variety of other tissues and 
physiological processes) which is responsive to changes in hormone concentrations 
(Ossowski et al, 1979). PA cleaves plasminogen to form an active alkaline protease, 
plasmin [E.C. 3.4.21.7] whose activity correlates positively with involution. Plasmin 
activity also correlates with increasing somatic cell counts, often an early sign of 
mastitis, in dairy cows (Politis et al, 1989a). Hence determination of PA and plasmin 
activity, or their ratio, could provide an index of the involution occurring in the gland, 
and could also, potentially, be related to lactation persistency as the rate of decline in 
milk production will reflect the extent of involution and loss of secretory capacity.
Plasmin also proteolyses proteins present in milk; caseins (cn) have variable 
resistances to its action (/?-cn < as-cn < /c-cn) (Eigel, 1977b). Indeed, plasmin 
proteolysis of /3-casein produces heterologous and distinct fragments of ’7 -casein’ 
(Eigel, 1977a). In vivo, plasmin activity negatively correlates with /3- and a sl+2-caseins 
and positively with 7 -caseins (Aaltonen et al, 1988; Politis & Ng Kwai Hung, 1989) 
supporting the in vitro work of Eigel (1977a,b).
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These observations led us to form the hypothesis that indirect measurement of 
involution could be made by measuring degradative casein products (ie 7 -caseins) in 
milk, reflecting the level of activation of the plasmin system. This hypothesis was 
tested in two experiments conducted over successive lactations. The first aimed to 
establish the methodology for longitudinal measurement of caseins in milk while the 
second experiment investigated the effect of treatments predicted to alter lactation 
persistency on 7 -casein production.
2. ANIMALS
British Saanen goats from the Institute herd were used. Hay and water were 
available ad libitum and, twice daily at milking, animals were offered a total of 1.5kg/d 
of a proprietary concentrated feed.
3. EXPERIMENTAL DESIGN
Two experiments were conducted over successive lactations and will be 
described separately.
3.1 Experiment 1
Five animals were milked twice-daily throughout lactation and milk yields from 
individual glands were recorded at each milking. Animals were not subject to any 
experimental treatments during this period. Bulk milk samples were collected once 
every two weeks from lactation weeks 2 to 18, at four-weekly intervals until week 34, 
and the final samples were collected in week 39.
Sample analysis was carried out using anion- and cation-exchange FPLC and 
on week 14 whole casein samples from each individual were subjected to SDS-, 
alkaline and acid PAGE. In addition, whole casein samples collected from one 
representative goat throughout lactation were separated by alkaline and SDS-PAGE.
3.2 Experiment 2
The methods developed in experiment 1 were subsequently applied to samples 
collected during the studies described in Chapters 4 and 5. In these, three groups of 
four animals received either no treatment, or perphenazine or oxytocin treatment, from 
lactation week 13 onwards, in an attempt to alter lactation persistency. All animals 
were milked twice-daily on both glands from parturition to lactation week 26, thereafter 
one gland was milked once-daily. Milk yields from individual glands were recorded
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throughout.
Milk samples were collected from both glands in lactation weeks 12, 16, 20, 
25, 28, 32 and 37 and all were separated by anion- and cation-exchange FPLC. In 
addition, samples of whole casein from one animal in the control group were separated 
by SDS- and alkaline PAGE.
4. METHODS
4.1 Casein preparation
Milk samples were collected at a morning milking (0800h, after 16 hours milk 
accumulation). In experiment 1 a bulk sample was obtained while in experiment 2 mid­
flow milk was collected; goats were machine milked until milk flow was established, 
the machine switched off and the goat’s teats swabbed with alcohol solution (70% 
alcohol-2 % hibitane). Approximately 20ml milk was collected by hand-milking into a 
sterile container, the goat was reconnected to the milking machine and milking 
continued as normal.
Milk samples were defatted by centrifugation (lOOOg, 30 minutes, 20°C) and 
filtering through glass wool. The filtrate was collected, diluted 1:1 with distilled water 
and pH adjusted to 4.6 (1M HC1). The resulting suspensions were throughly mixed, 
centrifuged (200g, 60 seconds, 20°C) and the supernatant (which contained whey 
proteins) tipped off. In experiment 1 this was retained and used for an investigation of 
lactational changes in whey proteins (Law & Brown, 1994). The casein pellets were 
washed with acidified distilled water (pH 4.6), recentrifuged, lyophilised and stored at 
-20°C.
4.2 Anion-exchange chromatography (Mono-Q)
All buffers used in both anion- and cation-exchange chromatography were 
filtered through 0.2^m filters (supor-200, 45mm, Gelman Sciences Inc, Michigan, 
USA), stored at 4°C and warmed to 20°C immediately before use. The method used 
was similar to that described by Law & Tziboula (1993).
Sample preparation
Lyophilised casein was dissolved to 8 mg/ml in sample buffer (3.3M urea 
containing 0.005M bis,tris-propane and 0.007M HC1), pH adjusted to 7.0 and 4^1/ml 
mercaptoethanol (50% in sample buffer) added. Samples were mixed (Variomag 
multipoint HP stirrer, Camlab, Cambridge, UK) for a minimum of one hour before
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filtering (Supor-200, 13mm, Gelman Sciences Inc, Michigan, USA).
Column separation
A minimum sample volume of 1ml was applied to a Mono-Q column (Mono-Q 
HR5/5 anion exchange column, Pharmacia, Uppsala, Sweden) for fractionation of 
casein types by fast protein liquid chromatography (Pharmacia). Elution buffer (1M 
NaCl in 3.3M urea, 0.005M bis,tris-propane and 0.008M HC1) was at a concentration 
of 0.0M after 1ml, 0.17M after 5.0ml, 0.23M after 17.5ml and 0.30M after 43.5ml. 
A flow rate of 1ml per minute was used. Absorbances were monitored at 280nm and 
analysis carried out on the basis of the area obtained beneath the sample’s absorbance 
curve.
4.3 Cation-exchange chromatography (Mono-S)
This was carried out using an adaptation of the method of Davies & Law 
(1987). Absorbance coefficients to determine the amounts of individual caseins as 
quoted by Law & Tziboula (1992) were used in calculations.
Sample preparation
Lyophilised casein was dissolved to 8 mg/ml in sample buffer (6 M urea 
containing 20mM acetate), pH adjusted to 7.0, 4jJ/ml mercaptoethanol (50% in sample 
buffer) added, mixed and left overnight at 5°C. Immediately before use the pH was 
adjusted to 5.0 and the solutions filtered.
Column separation
A minimum sample volume of 1ml was applied to a Mono-S column (Mono-S 
HR 5/5 cation exchange column, Pharmacia) for fractionation of casein types with 
elution buffer (6 M urea containing 20mM acetate and 1M sodium chloride) at a 
concentration of 0.0M after 1ml, 0.025M after 3.1ml, 0.075M after 17.5ml, 0.15M 
after 27.5ml and at 0.27M after 43.5ml. The flow rate was 1ml per minute and 
absorbances were monitored at 280nm.
Calculations
Results were analysed on the same basis as those separated by Mono-Q 
fractionation to obtain percentage areas for the different casein types. In addition, 
molar extinction coefficients at 280nm were used to calculate the relative amounts of 
casein present (ofsl- 9.9 ; a s2-  9.9 ; 0- 4.4 ; k -  8.2; y  (minor)- 8.2).
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4.4 SDS-PAGE analysis (Phast System)
Sample preparation
Microtubes containing 3mg or 6 mg/ml casein in sample solvent (12.5% SDS, 
5% mercaptoethanol, 6.25% bromophenol blue in lOmM tris/HCl buffer containing 
ImM EDTA) were placed in boiling water for 5 minutes and allowed to cool to room 
temperature.
Electrophoresis and resolution o f  caseins
Approximately 1/d of sample solutions were loaded onto a 20% homogenous 
media Phastgel and electrophoresed over a 40 minute period. The gel was stained with 
stain solution (0.1% Phastgel Blue R in 60% methanol) then washed in a 1:1 mixture 
of stain and destain (30% methanol, 10% acetic acid) containing 0.1% w/v copper 
sulphate. Finally gels were washed in destain solution, soaked in preservative (5% 
glycerol, 1 0 % acetic acid v/v) and photographed.
4.5 Alkaline PAGE analysis
The method used to separate whole casein was based on that described by 
Peterson & Kopfler (1966).
Sample preparation
Casein was dissolved to 40mg/ml casein in TEBarb buffer (0.025M tris/HCl, 
0.0032M EDTA, 0.027M barbitone, pH 8 ) containing 7M urea. 1/d mercaptoethanol 
per mg protein was added, the mixture vortexed and 5/d bromophenol blue in buffer 
(saturated solution) added. Samples were left for a minimum of one hour before 
applying to a pre-formed gel.
Gel preparation
150ml gel solution, pH 8  (4.5% monomers, 4% crosslinking; acrylamide/ N,N’- 
methylenebisacrylamide at 96:4 ratio in TEBarb buffer containing 4.5M urea) was 
warmed to 20°C, 300mg ammonium persulphate and 450/d dimethylaminopropionitrile 
added, mixed and poured immediately into a gel former.
Electrophoresis
The gel was polymerised for 30 minutes in darkness, pre-run for 30 minutes at 
300V and samples loaded (10/d per lane). They were electrophoresed in TEBarb buffer
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containing 7M urea for approximately six hours at 200V.
Resolution o f caseins
Gels were soaked in MWA solution (40% methanol, 8 % acetic acid v/v in 
distilled water) for 10 minutes then immersed in stain solution (MWA solution 
containing 1% w/v Naphthalene black 12B) for 20 minutes. They were rinsed in 
deionised water, destained with several washes of MWA solution over a 48-72 hour 
period, and recorded by photographing.
4.6 Acid PAGE analysis
Sample preparation
Casein (25mg/ml) was dissolved in sample buffer, pH 1.9 (8 .6 % acetic acid, 
2.25% formic acid v/v), 0.5/lcI mercaptoethanol per mg protein added, and vortexed 
together. 5/d methyl red in urea buffer (sample buffer containing 8 M urea) was added, 
mixed and samples left for a minimum of one hour before applying to the gel.
Gel preparation
150ml gel solution (10% monomers in sample buffer containing 4.5M urea) was 
warmed to 20°C, 350mg ammonium persulphate and 1ml TEMED were added, mixed 
and poured immediately. The gel was left to polymerise (2 hours, 30°C) before use.
Electrophoresis and resolution o f caseins
The gel was pre-run in electrophoresis buffer (7.7% glacial acetic acid v/v) for 
20 minutes at 200V before sample loading (10/d per lane) and running for 
approximately seven hours at 200V. Both electrophoretic steps were carried out with 
reversed polarity electrodes. Casein bands were resolved by staining (1% Coomassie 
brilliant blue R in MWA solution).
4.7 Acid PAGE analysis (Phast System)
A 20% homogenous gel (Pharmacia) was equilibrated in urea buffer, with two 
changes of buffer, for approximately one hour, then dried. Samples of whole casein 
were dissolved in urea buffer to 6 mg/ml and gel strips were prepared by mixing 2 % 
agarose w/v in sample buffer, cooling, pouring into moulds and allowing to solidify 
for a minimum of thirty minutes.
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Reverse-polarity electrophoresis was carried out using the Phast-System 
according to manufacturers instructions. The subsequent staining and preservation of 
the gel was carried out as detailed for SDS-PAGE analysis.
4.8 Photography
All gels were immersed in preservative, placed on a light box and photographed 
using a T2203 enlarger, black and white print film (type 665, Polaroid) and a Kodak 
wratten 15 filter (all supplied by Sigma Chemical Company Ltd). An aperture of f . 8  
and V8th second exposure time were used. Photographs were left intact for 30-35 
seconds, print and negative separated, and the latter incubated at 20°C in developer 
(22% w/v sodium sulphite solution) before washing thoroughly in cold water. Prints 
were dried at room temperature after coating with gloss.
4.9 Kjeldahl determination of total nitrogen
Casein precipitation was based on the original description of Rowland (1938). 
Colorimetrical determinations were made using the method of Reardon et al (1966) and 
protein content calculated using the method summarised by Barbano & Lynch (1992).
Casein preparation
Whole milk was skimmed, a standard volume diluted 1:1 with acetate buffer, 
pH 5.0 (2.5% w/v glacial acetic acid, 0.1M sodium acetate), mixed and casein 
precipitated by centrifugation at 200g for 15 minutes at 20°C. The supernatant was 
discarded, casein pellets washed and recentrifuged three times, then lyophilised.
Sample preparation
Casein samples were dissolved in distilled water, acidified (0.25M sodium 
hydroxide) and made to a standard volume with further distilled water. Portions of 
these test solutions were analysed for nitrogen content. Blanks and standards (0.005M 
ammonium sulphate solution of which 1ml contains 0.14mg nitrogen) were run in each 
assay.
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Measurement o f nitrogen content
Micro-kjeldahl flasks were prepared with boiling mixture (1:100 selenium: 
potassium sulphate mixture, ground to homogeneity) and 3:1 ratio of concentrated 
sulphuric acid to test solution added. Solutions were boiled until they became clear, 
cooled, and made to a standard volume with distilled water. They were analysed in 
triplicate as follows: Reagents A (0.75M sodium hydroxide), B (0.87xl0^M sodium 
nitroprusside, 0.23M sodium salicylate) and C (2.4xl0'3M sodium 
dichloroisocyanurate) were added stepwise in a ratio of 1 :2 : 1  to the test solution, mixed 
and incubated at room temperature for 30 minutes before absorbances were read at 
667nm.
Calculations
Mean absorbances were obtained for each unknown, the assay blank subtracted 
and converted to mg protein present as follows:
mg protein = (Ay / As). a. b. c
where:
Au= absorbance of the unknown sample at 667nm 
As= absorbance of the standard at 667nm 
a=  0.14; conversion factor for obtaining mg N/ml digest 
b=  6.38; conversion factor for N to protein 
c=  25; correction factor for dilution of milk
4.10 Expression of caseins in milk samples
The initial fractionation of whole casein by FPLC and conversion of areas under 
the curve using the appropriate absorbance coefficients (see 4.2/4.3) allowed caseins 
to be expressed as a fraction of the whole present (’relative amounts’, %). Kjeldahl 
determination of total protein measured total casein in the milk and subsequent 
multiplication by the appropriate relative amounts of each casein in the sample allowed 
the concentrations of individual caseins to be calculated (g/1). These two measures 
allowed comparisons between animals to be made who may, for example, have similar 
relative distributions of the caseins, but secreted total casein at a higher or lower 
concentration in the milk. Also, changes in the relative amount of casein can be a more 
sensitive indicator of casein degradation than expressing it as a change in total 
concentration- a drop from 58% to 56% could equate to only 0.4 g/1 in a total of 1 lg/1.
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5. RESULTS
5.1 Experiment 1
Whole casein samples were separated by anion- and cation-exchange 
chromatography and selected elution profiles from early and late lactation are illustrated 
in Figures 7.1 to 7.4. The separation is based on the different weights and charges on 
the molecules using a + /- charged column under pressure to which caseins with the 
opposite charge bind with varying affinity and are then removed (eluted) by an 
increasing salt gradient. The peaks produced by separating milk casein using this 
method are well characterised and identification was conducted with reference to Law 
& Tziboula (1992 & 1993) who separated goat casein by cation- and anion-exchange 
FPLC respectively. It became apparent that one animal (goat 41) had a much higher 
level of a sl-casein expression than other members of the group. Consequently, goat 
41’s results are presented separately from the remainder of the group whose data has 
been meaned (n=4).
Cation-exchange FPLC
The results obtained by this method were used to calculate the relative amounts 
of the caseins present and lactational changes in casein composition were observed; the 
proportion of a sl-cn gradually increased between weeks 10 and 39 while a^-cn levels 
peaked in week 18, then gradually decreased. /3-Casein increased slightly in the first 
4 weeks, then showed a gradual downward trend while k - cn increased over lactation, 
more rapidly so from week 18 onwards (Figure 7.5).
Casein concentrations
Determination of the total nitrogen present in whole casein samples allowed the 
relative amounts of the various caseins (determined by FPLC) to be converted into 
concentrations for each casein fraction (Figure 7.6). a s2-Casein was the only component 
not to be produced at a consistently higher level in goat 41, and showed the greatest 
fluctuation through lactation, y -  and k - C aseins increased from lactation week 18, as did 
asl- and /3-cn, but to a lesser extent.
Anion-exchange FPLC
This method was the most effective in separating 7 -cn from the other casein 
components and consequently calculation of the relative amount of 7 -cn was derived
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Figure 7.1 Elution profiles from anion-exchange fast protein liquid 
chromatography separation of whole casein collected from goat 227 
(producing low a sl-casein, representative of remainder of group) in lactation 
weeks 4 (A) and 39 (B). Casein fractions were identified as follows:
1. y-cn and other breakdown products 2. K-cn 3. |3-cn 4. (3- and a s2-cn 
5. a s2- and a s] -cn.
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Figure 7.2 Elution profiles from anion-exchange fast protein liquid 
chromatography separation of whole casein collected from goat 41 
(producing high a sl-casein) in lactation weeks 4 (A) and 39 (B). Casein 
fractions were identified as follows:
1. y-cn and other breakdown products 2 . K-cn 3. P-cn 
4. a sl - and a s2-cn with some P-cn.
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Figure 7.3 Elution profiles from cation-exchange fast protein liquid 
chromatography separation of whole casein collected from goat 227 
(producing low a sl-casein, representative of remainder of group) in 
lactation weeks 4 (A) and 39 (B). Casein fractions were identified as 
follows: 1. y-cn and other breakdown products 2 . P-cn 3. K-cn
4. a sl-cn 5. a s2-cn
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Figure 7.4 Elution profiles from cation-exchange fast protein liquid 
chromatography separation of whole casein collected from goat 41 
(producing high a sl-casein) in lactation weeks 4 (A) and 39 (B). Casein 
fractions were identified as follows:
1. y-cn and other breakdown products 2. 0-cn 3. K-cn 4. a sl-cn 5. a s2-cn
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Figure 7.5 Changes in the relative amounts of casein with stage of 
lactation in goat 4 1 ( G )  and the remainder of the group ( • )  (n=4).
(A) a sl -cn (B) a s2-cn (C) P-cn and (D) K-cn. Pooled sems for the latter 
were 0.12, 0.31, 0.24 & 0.30 % respectively. Units represent the percentage 
of total casein of which the particular casein comprises.
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Figure 7.6 Changes in casein concentrations (g/1) with lactation stage 
in goat 41 ( □  ) and the remainder of the group ( • )  (n=4).
(A) a sl -cn, (B) a s2-cn, (C) P-cn, (D) y-cn and (E) K-cn. Pooled sems 
were 0.05, 0.09, 0.30, 0.13 & 0.11 g/1, respectively.
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from this data. 7 -Casein was determined for each individual and, as no significant 
difference was detected between goat 41 and the other animals in the relative amount 
of 7 -cn present (Student’s unpaired t-test, p>0.25, data not shown), a group mean was 
calculated for each timepoint (Figure 7.7).
Relationship between y-casein, milk yield and lactation persistency
Lactation persistency was measured from week 12 onwards as this represented 
the period when yields were steady then began to decline. Regression analysis was 
carried out for individual glands and values meaned; a reduction in yield of 0.0397 ±  
0.004 litres/week (r2= 94.0 ± 2.1 %, p =0.000) was obtained. The Pearson correlation 
coefficient for milk yield against lactation stage was calculated to be -0.969 ±  0.011.
Similar calculations were carried out for changes in the relative amount of 7 -cn 
with time and it was found that 7 -cn increased by 0.258 ±  0.035 percent per week 
(r2=71.1 ±  4.5%, p=0.006 + 0.003) and a correlation of 0.841 ±  0.026 was 
calculated.
The relationship between 7 -cn and average daily milk yield was also determined 
for each goat at each sampling point by correlation. Over the whole experimental 
period (weeks 2-39) a correlation of -0.684 ±  0.064 was obtained (n=5). However, 
when the analysis was restricted to lactation week 1 2  onwards (when yields began to 
decline and 7 -cn to increase) the correlation coefficient improved to -0.824 ±  0.049. 
This was further increased to -0.940 when average milk yield was correlated with 
average 7 -cn percentage for the group.
PAGE separations o f caseins
Samples collected from goat 227 throughout lactation were separated by alkaline 
PAGE (Plate 7.1). The most notable change was a lactational decrease in a s2-cn while 
a sl- and /3-cn appeared to remain relatively steady. Acid PAGE separation of whole 
casein from each animal in mid-lactation (Plate 7.2) allowed a-cn variants to be 
determined. When taken in combination with results obtained from the other PAGE 
separations it was found that all animals in the group were heterozygous as2-CnAB. The 
substantially higher levels of a sl-cn in goat 41 were attributed to a genotype of a sl- 
CnAB. The remainder of the group had a much lower level of expression of this casein, 
had no bands corresponding to A, and were therefore most probably homozygous for 
a sl-CnE.
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Plate 7.1 Alkaline PAGE separation o f whole casein samples 
collected through lactation from goat 227 in Experiment 1 
1: as,-cn  2: a s 2-cn 3: P + K-cn 4: y- & minor cns 5: para-K-cn
a s2-cn
as,-cn
p-cn
y-cn,
K - c n
a n d
m in o r
caseins
G oat 30 41 226 227 229
number
Plate 7.2 Acid PAGE separation o f whole casein samples collected 
from each goat in lactation week 14 o f Experiment 1.
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5.2 Experiment 2
FPLC
Anion- and cation-exchange FPLC of whole casein samples was conducted and 
the results and profiles obtained were similar to those seen in experiment 1. The former 
method provided the best separation of 7 -cn and was used to calculate the relative 
amount of 7 -cn present. Cation-exchange profiles confirmed the observations of 
experiment 1 and again 7 -cn and casein breakdown products increased as lactation 
progressed (results not shown).
PAGE separation o f caseins
The samples collected from a control gland milked twice-daily throughout 
lactation were separated by alkaline PAGE (Plate 7.3). A marked decrease in a s2-cn 
was seen as lactation progressed while a sl- and /3-caseins appeared to remain relatively 
steady, again confirming the observations made in experiment 1 .
Relative amounts o f y-casein
7 -Casein percentages for each treatment group and for glands subjected to 
different milking frequencies are shown in Table 7.1. Student’s paired t-test was used 
to compare contralateral glands within treatment groups but no significant differences 
were found (p>0.47). Unpaired t-tests were conducted to compare treatment groups 
but again no significant differences were found (p>0.84 in 2X, p>0.68  in IX glands).
Relationship between 7-cn. milk yield and lactation persistency
Lactation persistency over the experimental period has been described and 
analysed in detail in Chapters 5 (4.2) & 6  (4.3) but, in summary, it was found that 
perphenazine and oxytocin treatments were not improving persistency in themselves and 
that once-daily milking in later lactation might be having small but positive effect on 
persistency regardless of treatment.
The calculations and statistical analysis of this data conducted in this chapter 
was derived from average daily milk yields obtained on the weeks that samples were 
collected and 7 -cn prepared. Regression lines were fitted to individual lactation curves 
and the results meaned (Table 7.2). No significant differences were found between 
contralateral glands within groups (p > 0.42, paired t-test) or between groups (p >  0.12, 
unpaired t-test) and an overall correlation of -0.840 ±  0.028 between yield and stage
1 7 9
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Lactation week 12 16 20 25 28 32 37
Plate 7.3 Alkaline PAGE separation o f whole casein samples
collected through lactation from a control animal in Experiment 2.
Group/
Lactation
week
Control
(% y-cn) 
2X IX
Oxytocin
(% y-cn) 
2X IX
Perphenazine
(% y-cn) 
2X IX
12 11.43
(1.73)
11 .02
(1.33)
9.12
(0.74)
9.35
(0.86)
10.80
(1.49)
11.15
(1.36)
16 17.95
(2.00)
18.55
(2.48)
19.22
(1.43)
19.98
(0.96)
13.98
(1.16)
17.02
(2.24)
20 27.85
(3.92)
32.62
(3.90)
27.55
(3.50)
28.50
(4.13)
23.22
(3.56)
24.70
(3.40)
25 28.22
(2.60)
27.50
(3.98)
28.50
(2.32)
27.58
(3.06)
24.52
(2.33)
27.35
(5.45)
28 29.68
(3.87)
29.90
(3.57)
28.68
(3.86)
28.20
(1.61)
25.15
(1.54)
2 1 .0 2
(1.84)
32 35.72
(4.98)
36.20
(3.07)
29.48
(3.29)
32.32
(2.94)
38.15
(5.74)
32.22
(1.33)
37 29.40
(5.94)
27.73
(5.05)
34.90
(1.98)
34.18
(1.54)
37.02
(8.91)
36.40
(3.19)
Table 7.1 The effect of treatment on y-casein percentage (%) in milk
samples, determined by anion-exchange chromatography in experiment 2. 
Values given are means with SEM in brackets, n=4 for each measurement.
1 8 1
Glands/ 2X glands ‘IX’ glands
Group m m
Control -62.0 -55.9
-40.9 -48.3
-11.3 -15.2
-34.5 -40.8
mean -32.7 -40.0
r2 73.4, p=0.031 r2 78.8, p=0.020
Oxytocin -17.8 -2 1 . 8
-44.6 -37.5
-36.4 -36.9
-16.9 - 1 1 . 8
mean -28.9 -27.0
r2 59.0, p=0.096 r2 62.2, p=0.086
Perphenazine -46.3 -50.8
-50.9 -40.5
-42.1 -55.6
-23.5 -27.4
mean -40.7 -43.6
r2 80.1, p=0.009 r2 80.6, p=0 . 0 1 2
Table 7.2 Summary of regression lines fitted to individual milk yield
profiles for each animal’s glands in experiment 2  where m is the change in 
average daily yield, ml/week. The analysis was on lactation weeks 12-37; 
IX milking commenced in week 26 until the end of the study, r and p 
indicate the accuracy and probability of the best line being fitted to the data.
182
of lactation was calculated.
Regression analysis of 7 -cn levels was also performed (Table 7.3) but again no 
significant differences were found either between glands (p>0.14) or groups 
(p>0.32). An overall correlation between 7 -cn and stage of lactation of 0.772 ±  0.031 
was calculated.
An overall comparison of the relationship between 7 -cn and milk yield was also 
made (Figure 7.8). Correlations between these parameters were calculated for each 
individual gland but no significant differences were found between glands (paired t-test, 
p>0.26) or groups (unpaired t-test, p>0.24) and the pooled correlation (both glands, 
all groups) between 7 -cn and milk yield was 0.869 ±  0.046.
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Glands/ 2X glands ‘IX’ glands
Group m (y-cn) m (y-cn)
Control 0.859 0.873
0.878 0.739
0.636 0.383
0.925 1.130
mean 0.825 0.781
r2 64.1, p=0.088 r2 53.8, p=0.161
Oxytocin 0.827 0.721
0.859 0.803
0.800 0.969
0.965 0.935
mean 0.863 0.857
r2 65.8, p=0.030 r2 67.4, p=0.033
Perphenazine 1.400 0 . 8 6 8
0.648 0.460
1 . 1 2 0 0.830
1.300 0.925
mean 1.117 0.771
r2 62.2, p=0.046 r2 58.2, p=0.054
Table 7.3 Summary of regression lines fitted to individual y-casein
results for each animal’s glands in experiment 2 . m is the change in y-casein, 
percent per week. The analysis was on lactation weeks 12-37; IX milking 
was applied in weeks 26 to 37. r and p indicate the accuracy and 
probability of the best line being fitted to the data.
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Figure 7.8 Changes in the relative amount of y-casein ( •  ) and in 
milk yields (A ) over lactation in Experiment 2 .
Values plotted are the meaned results from control, oxytocin and 
perphenazine groups and both 2X and IX glands. SEMs are illustrated and 
n=24 for each measurement.
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6 . DISCUSSION
Remodelling of the mouse mammary gland through proteolysis and activation 
of the plasmin system has been described by Ossowski et al (1979). Their experiments 
removed pups either at parturition or on lactation day 5 to cause a rapid cessation of 
lactation. This in turn caused a large but transient increase in plasminogen activator 
(PA) concentrations, mammary weights decreased and protein and DNA contents also 
dropped. If exogenous oxytocin and prolactin were administered after pups were 
removed a reduced response in PA activation was seen, illustrating PA’s responsiveness 
to changes in the hormonal environment. This suggests that it might therefore provide 
a marker for involution in the mammary gland.
Unfortunately different species respond to different lactogenic signals. In 
rodents the cessation of suckling-induced hormone release is the primary signal for 
involution while in ruminants the increase in intramammary pressure as less milk is 
removed is more important (Fleet & Peaker, 1978). Rodents lose large numbers of 
secretory epithelial cells during involution, in direct contrast to ruminants which appear 
to have minimal loss of cells and still maintain some secretory capacity even when the 
gland is fully involuted (Sordillo & Nickerson, 1988; Oliver & Sordillo, 1989). In 
cows extensive cytoskeletal reorganisation has been observed, organelles involved in 
secretory functions are retained, although histologically altered, and secretion can 
continue at a low rate (Holst et al, 1987).
However, in many of these studies the stimulus for involution is acute, an 
immediate cessation of milk removal, which does not mimic the chronic process of 
slow and gradual involution after peak lactation. Little evidence has been produced for 
the specific role of the plasmin system in ruminant lactation; PA content in bovine 
mammary tissue does increase within a few days of the cessation of milking in late 
lactation (Politis et al, 1992b) and plasmin and plasminogen-derived activity both 
increase in late lactation (Korycka-Dahl et al, 1983). However, this could be due to the 
increased permeability of blood vessels in the mammary gland allowing them access 
to the milk via leaky tight junctions. This is seen during mastitic infection of glands 
when the epithelium becomes ruptured, and increased plasmin and plasminogen 
concentrations are associated with increasing milk somatic cell counts (Politis et al, 
1989a). Determination of the ratio of plasmin to plasminogen, in combination with 
determination of sodium, potassium and serum albumin concentrations in milk, could 
indicate whether the increase was as a result of leakage from the blood or due
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specifically to increased activation of the plasmin system.
The results obtained in experiment 1 showed that the proportions of the caseins 
changed as lactation progressed and milk yields declined. The observations supported 
the model of as2- and (3-cn being most susceptible to proteolytic attack with 7 -cns and 
proteose-peptones being produced as breakdown products. Formation of the latter was 
most probably by the action of plasmin on /3-cn. Increased 7 -cn was seen using all 
separation methods, but the increase detected by alkaline PAGE was not as marked as 
expected. Gel separations conducted to specifically resolve 7 -cn were loaded with a 
double concentration of whole casein in an attempt to improve detection. It is possible 
that this contributed to obscure some changes, or that FPLC methods overestimated the 
size of the fraction by including other products which were not 7 -cns but eluted in a 
similar position. The relative amount of /3-cn decreased by approximately 4% over the 
lactation which appears quite a small drop, but it was the most abundant casein present, 
constituting almost half of the total casein, and hence a drop of a few percent was quite 
large in real terms.
The second experiment attempted to elucidate whether or not changes in 
lactation persistency, and hence involution, had an effect on casein composition, most 
especially 7 -cn. There were very small differences between the treatment groups and 
the general trends of changes in the relative amounts of the caseins confirmed the 
observations of experiment 1. So why were no changes detected? The treatments 
applied were not as successful in maintaining or improving persistency as had been 
hoped, indeed perphenazine treatment had a negative effect on milk yield. Oxytocin 
treatment was more successful but the alteration in persistency was small. In the light 
of this it was perhaps not surprising that no changes in 7 -cn were detected between the 
groups.
If an effective treatment which improved persistency could have been tested then 
there would have been the potential to find differences between test and control groups. 
Growth hormone has delayed mammary regression in goats (Knight et al, 1990) and 
when cows were treated with it there was a reduction in PA concentrations (Politis et 
al, 1990). It would have been interesting to give an additional group growth hormone 
treatment and to have determined the effect on lactation persistency and milk casein 
content over a lactation.
It is, however, also possible that the acute activation of the plasmin system 
when milking is stopped prematurely (eg by pup removal) reflects the rapidity of
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change in the mammary gland, in the usual situation there would be a more gradual 
weaning of the young and therefore the changes during slow involution may not 
activate the system to the same, or to an easily measurable, extent. It may also be the 
case that the changes in casein composition, although statistically correlated with 
lactation and the plasmin system, may not be directly related to each other. However, 
there is good evidence, already covered in the introduction, which shows that plasmin 
proteolytic action does indeed have an effect on caseins.
Experiment 1 produced an unexpected result in that one member of the group 
had a markedly different ’casein profile’ in both relative amounts and concentrations 
of the various casein components. This animal, goat 41, had high levels of a8l-cn and 
had higher individual casein production than the other members of the group, believed 
to be homozygous a sl-CnE. It was deduced from a variety of gel separations that this 
individual had the genotype a sl-CnAB. The a 8l-Cn gene locus exhibits a high degree of 
polymorphism and the relative amount of a 8l-cn is positively correlated with the total 
concentration of casein in milk (Remeuf & Lenoir, 1986). Goats with a sl-CnA, a sl-CnB 
and a 8l-Cnc alleles generally yield higher levels of a 8l-cn than those with o;8l-CnD, a 8l- 
CnE or a sl-CnF alleles (Grosclaude et al, 1987; Brignon et al, 1990). Therefore 
production of a 8l-cn (both relative amount and concentrations) will vary depending on 
the genotype of the animal (Martin & Grosclaude, 1993). Other differences in milk 
have been seen between groups of goats expressing high or low levels of a 8l-cn. The 
former produced milk with significantly lower pH and mean micellar size distribution, 
and had higher total solids, fat, nitrogen and calcium contents (Pirisi et al, 1994). It 
has been observed that for an individual the relative amounts of the secreted caseins 
did not vary with the total concentration of casein in the milk, although casein 
proportion could be changed by variations in whey proteins, specifically a-lactalbumin 
(Kroeker et al, 1985). Making cheese from milk containing high a 8l-cn produces firmer 
curds, improves cheese quality (higher solids, fat and casein contents) and yield. 
However it increases coagulation times and alters textures compared to cheese produced 
from low a 8l-cn milk (Ambrosoli et al, 1988; Pirisi et al, 1994). Selective breeding for 
particular genetic polymorphisms leading to increased casein could improve cheese 
yields (Marziali & Ng-Kwai-Hang, 1986), however it would probably alter the 
processing characteristics of the milk and would not necessarily be advantageous.
k - Casein increased with stage of lactation and increasing para-K-cn formation
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was also detectable by PAGE. It is possible that this short peptide would elute in the 
fraction arbitrarily defined as y-cn, possibly contributing to the slight difference 
between PAGE and FPLC estimations of y-cn. If this were the case it could be 
assumed that the true y-cn levels were slightly lower, and k - cn (and its derived 
products) slightly higher than assumed from FPLC determinations. Micellar size has 
been negatively correlated with k - cn (Davies & Law, 1983); the micellar radius 
decreased by approximately one-third when the relative amount of k - cn increased by 
225% (Dalgleish et al, 1989). In the first experiment, k - cn increased between peak and 
late lactation by an estimated 137%, so some decrease in micellar size would be 
predicted. Micellar diameters were not determined in this work and this aspect could 
be investigated in future studies of lactational changes in milk casein composition. 
Making cheese with milk containing smaller micelles could potentially alter the kinetics 
of aggregation and change the firmness of the curd produced (Dalgleish, 1992).
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CHAPTER 8  
SUMMARY AND CONCLUSIONS
This thesis has examined some of the factors which might affect lactation 
persistency in the goat. We have defined persistency as the rate of decline in milk yield 
after peak lactation and quantified it by linear regression analysis on average daily 
gland milk yields. However, other authors have measured persistency by, for example, 
looking at total milk production over a lactation, or by counting the number of days 
that the animals lactated (Broster & Broster, 1984). So the definition of persistency is 
itself variable, and comparisons between studies should be made with care. The decline 
in yield after peak lactation was studied as changes in milk production during this 
period reflect the activity and differentiative state of the secretory cell population and 
amount of cell loss from the mammary gland which occurs during involution (Wilde 
et al, 1986). The overall aim of this work was to determine some of the factors that 
affect lactation persistency and attempt to slow the reduction in milk yield by the 
application of various treatments which might maintain mammary function.
The mathematical measurement of persistency can be problematic as fluctuations 
in yield due to, for example, a change in the milking regime, or nutritional constraints 
on the animal, can alter the gradient of the regression line (m) and reduce the accuracy 
of its fit (r2). Periods during which there were large fluctuations in yield were generally 
excluded from regression calculations, seen particularly when there were alterations in 
the treatment regime. So the analysis was conducted on periods during which yield 
curves were relatively ’steady’. An example of this is in Chapter 5, experiment 2, 
when the fit of linear regression lines was improved by 42% by excluding the first 
three weeks of the treatment phase. It may be that a more complex mathematical model 
for persistency needs to be constructed but comparisons between animals may become 
more difficult while regression analysis provides a straightforward measure of the rate 
of decline in yield, which is easily comparable between glands and animals.
The goat may not have been the best model to measure alterations in 
persistency. Firstly they typically produce about 3 1 of milk a day while cows regularly 
yield 30 1 a day (Amos et al, 1985), so a 10% improvement in the goat would be 
equivalent to 300ml milk, while the cow would produce an extra 3 litres, so 
measurements of milk yield in the goat need to be more accurate as the changes in 
absolute yield will be much smaller. Also goats proved to be very persistent with a
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median reduction in yield of approximately 60 ml/week, so perhaps there was less 
room for improvement in this species. However mature cows show yield reductions in 
the order of 600ml/week (Amos et al, 1985) which is a similar proportional drop to 
that seen in goats, suggesting that manipulation of persistency will not necessarily be 
any easier in cows. Goats are easy to manage in husbandry terms, the division of their 
udders into two halves is ideal for the application of unilateral treatments, and there 
are economic advantages to studying them. There is also good evidence that goats have 
the potential for increased milk production. In one study, treatments were applied from 
lactation week 19 to week 41, increasing milking frequency to 3X resulted in a 6 % 
increase in yield, bST administration gave a 18% enhancement, and 36% was achieved 
when these treatments were given together (Knight et al, 1990). This indicated that the 
gland had the capacity for higher milk secretion when appropriately stimulated.
A promising avenue for manipulation of lactation is to enhance mammary 
growth during late gestation. Here, this was achieved by giving exogenous growth 
hormone and stimulating compensatory growth by hemimastectomy. The latter 
increased secretory cell numbers and maintained the overall differentiative state of the 
gland but animals were studied for a maximum of 30 days post partum, before peak 
lactation was reached. Consequently the long-term effect on lactation persistency could 
not be determined, and this provides an area for further study. Indications were that 
the proportion of BrdU labelled cells were still well above control levels in final 
samples (lactation week 4), suggesting that cell numbers were being maintained. 
However it is not know what effect the labelling has on the subsequent longevity of the 
cell- it may affect further multiplication, make it more resistant to degradative 
processes such as apoptosis, so the usefulness of further measurements remains to be 
confirmed. Growth hormone also provided a stimulus for mammary growth but the 
long-term effects of its administration during gestation on lactation persistency remain 
to be discovered. The results from this work showed increased mammary size in 
response to treatment which is encouraging for longer term improvements in yield.
Another aim of this work was to elucidate the role of prolactin in established 
lactation by preventing the seasonal drop in prolactin concentrations (Hart, 1975a). We 
were able to significantly increase circulating prolactin concentrations by infusing 
perphenazine, even in lactating goats which had high basal prolactin levels. However 
long-term administration by oral dosing and injection was not successful in elevating 
prolactin, predominantly due to the intolerance of perphenazine given by these routes.
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If recombinant prolactin could be given regularly by, for example, subcutaneous slow 
release injection or osmotic minipump, then quite possibly the fall in prolactin could 
be prevented and the effects of this on milk production could be studied. It may be that 
only low levels of prolactin are required to maintain lactation once it is established, for 
it to be able to, for example, induce and stabilise casein mRNA and extend its half life 
(Teyssot & Houdebine, 1980), thereby facilitating milk secretion. However as a 
consistent elevation of prolactin in ruminants has not been achieved over a lactation, 
its role remains open to debate, and this could provide an area for further study.
Oxytocin was given to goats immediately before each milking to stimulate milk 
ejection and ensure emptying of the mammary glands, particularly the alveolar areas. 
It was hypothesised that this would improve persistency as there would be a reduction 
in the local inhibition of milk secretion. However oxytocin treatments were only partly 
successful in improving persistency, and the changes that were achieved (in Expt 1) 
were numerically small and not statistically significant. This may be, in part, due to 
the administration route- due to its short half life oxytocin was given by intramuscular 
injection immediately before milking and some animals became sensitised to the 
repeated injections. Unfortunately there are few alternative administration routes for 
oxytocin as experimental conditions must be clearly defined with milking commencing 
shortly after oxytocin is given. If not, the full effect of milk ejection may be missed 
due to its short half-life, so giving oxytocin by slow release or continuous infusion is 
not possible. One option might be giving by nasal spray, used in lactating women 
(Winter & Robinson, 1964) but this has never been attempted in goats. The results 
obtained in the experiments described in this thesis may also reflect biological variation 
between animals in the response to treatment; cows with poorer persistency showed 
more response to oxytocin (Sprain et al, 1954). In the first experiment, oxytocin 
treatment was associated with maintenance of mammary tissue mass, suggesting a 
beneficial effect on the mammary gland, perhaps contributing to the preservation of 
secretory cell function. By lactation week 37, three oxytocin animals were producing 
measurable amounts of milk compared to one control animal, again suggesting a 
positive effect on lactation. However these results were not substantiated in the follow 
up experiment conducted the following year. Oxytocin might be preventing or reducing 
involution in the gland and, when administered at physiological levels, may contribute 
to maintaining tight junction integrity, all of which would help to reduce the rate of 
decline in milk yields. It may also be that oxytocin alone is not enough to alter 
persistency but is a contributing factor in the ’well being’ of secretory cells. Perhaps 
the best long-term
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option for oxytocin is selective administration- giving it to animals with poorer lactation 
persistency, established from records of previous lactations, and subsequently studying 
its effects.
The interaction between oxytocin and IX milking was not expected- it was 
expected that IX milking would reduce lactation persistency, but this did not happen. 
It could be argued that the drop in yield on the switch to IX milking affected the linear 
regression analysis of yields, but good fits for the lines were obtained, and the 
difference in yield between glands reduced as lactation progressed, indicating a 
consistent effect. If the result had been a quirk of the statistics then one would expect 
the difference between glands to remain relatively steady but this was not seen. The 
effect was local and it may well reflect an alteration in the storage characteristics in the 
udder. This was studied more closely in the second experiment and during the period 
of oxytocin + IX milking there was an increase in both cisternal volume and 
percentage. This could partly alleviate the negative effect of FIL on milk secretion 
(Wilde et al, 1995) and consequently maintain or even improve persistency. 
Differences in storage characteristics between IX and 2X glands were not found but 
this may reflect the period of milk accumulation not being sufficiently long enough to 
detect changes in the partitioning of milk in the udder, which would probably be most 
marked between 8  and 16 hours after milking.
Application of treatments in early lactation proved to be an effective means of 
manipulating milk yields, and some carry over effects were seen. Suckling proved to 
be a potent stimulus for increasing alveolar capacity, but this was not matched by the 
volume of milk being stored cistemally and there were no apparent carry over effects. 
This may be due to the frequent milk removal by kids not allowing cisternal storage 
to increase as much as it would have if it had been regularly filling up with milk. 
Consequently when switched to regular 2X milking, these glands were subject to 
increased local inhibition of milk secretion by FIL as a greater proportion of their milk 
was stored in alveolar areas, and the positive effect of increased mammary growth on 
yield was subsequently lost. The negative effect of reduced cistern size compared to 
animals with larger cisterns has already been seen in goats and cows (Peaker & 
Blatchford, 1988; Dewhurst & Knight, 1994), supporting this hypothesis.
Mammary growth also appeared to have been stimulated by 3X milking as a 
significant effect of treatment on yield was seen during the post-treatment period in a 
mixed parity group. This corresponded to a significantly increased alveolar volume
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compared to contralateral IX glands after 5 weeks of treatment. Measurements of cell 
proliferation and secretory enzyme activities were not made in this study, but previous 
work has shown that even over short periods (9 days) increased milking frequency 
increases the activity of the secretory cells, while 13 weeks of 3X milking improved 
the metabolic efficiency of milk production (Wilde et al, 1987b).
The apparent lack of response of multiparous animals to 3X milking may reflect 
a reduction in the potential of the gland to respond to growth stimuli, but there is also 
the question of their tolerance for IX milking. This may be due to changes in the 
storage of milk in the mammary gland associated with increasing parity. The cisternal 
capacity of multiparous goats, already large, was increased much more by IX milking 
than that of primiparous goats. Longer periods of milk accumulation could be tolerated 
by milk moving into the large cistern which would not increase the inhibitory effects 
on the gland, and secretion could continue as long as milk was overspilling into these 
areas. Multiparous goats also exhibited poorer lactation persistency, and in this regard 
the explanation may involve factors other than storage characteristics, since the 
observed ability to overcome FIL activity would also be expected to increase 
persistency.
There was an overall trend for improved persistency in IX glands, seen in most 
experiments, regardless of the treatments being applied, and it appeared that regular 
24 hour periods of milk accumulation resulted in more milk moving into cisternal 
areas. This was not confirmed by measurements of alveolar and cisternal volumes made 
5 hours after milking, but this interval was probably too short to detect long-term 
changes, and measurements made at longer intervals, and at various points in the post­
treatment period, would have been more appropriate. The effect was, however, visually 
clear (Plate 6.3) and the area of the interaction between milk secretion and the storage 
of milk in the mammary gland is one worthy of further investigation.
The measurement of persistency was generally determined by regression 
analysis of milk yields but another aspect was considered in this thesis, namely the 
effect that alterations in lactation persistency might have on caseins (milk proteins). 
The most abundant casein in goat milk is /3-casein which can be proteolytically 
degraded by plasmin to produce 7 -casein fragments (Eigel,, 1977b). The activation of 
plasmin is positively correlated with stage of lactation (Politis et al, 1989a) but is this 
a relationship between plasmin and the time after parturition, or a reflection of the 
process of involution occurring in the gland? Unfortunately the treatments applied
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(perphenazine to elevate prolactin and oxytocin to improve milk ejection) did not 
significantly alter persistency, so the question could not be answered in this study. We 
did find a significant correlation between milk yield and 7 -casein percentage in 
declining lactation, so 7 -casein does appear to be a good marker for the process of 
involution. However as milk yields themselves reflect the extent of mammary function, 
the measurement of milk yield itself would be a more direct and straightforward 
measure of mammary function.
In conclusion there are a variety of factors which influence lactation persistency 
in the goat. The role of prolactin remains to be established and oxytocin treatment may 
prove useful in improving persistency some animals, particularly those with poor milk 
ejection. The mammary gland clearly retains the potential for growth both pre-partum 
and in early lactation on the application of appropriate stimuli and alterations in milking 
frequency and the mode of milk removal can also stimulate mammary growth during 
the treatment period. Treatments may also alter milk storage characteristics, but 
responses can be influenced by parity. In particular the tolerance for once-daily milking 
and relationship with lactation persistency is an area worthy of continued investigation.
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